var title_f27_5_27728="Fetus with absent septi pellucidi";
var content_f27_5_27728=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F83166&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F83166&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Fetus with absent septi pellucidi",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 416px; height: 243px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Three-dimensional orthogonal planes of a fetus with absent septi pellucidi. (A) coronal; (B) median; and (C) axial. ",
"Magnetic resonance image of a fetus with absent cavum septi pellucidi. (D) coronal; and (E) axial.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Sarah S Milla, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_5_27728=[""].join("\n");
var outline_f27_5_27728=null;
var title_f27_5_27729="Retrieval of histology specimen";
var content_f27_5_27729=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F71049&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F71049&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Retrieval of histology specimens",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 373px; height: 263px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEHAXUDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACivPL3X9WTxF8QLWK7Ih0vTrO4s18tP3Lusxc525bOxeGz04xXj+ofFbxfD4x8W2UWs5tLLVJba2T7PD+7jDMAudmTgAckn60AfUdFeJeEvHHiHUdAsbq81FmeXXI7NpPIjBMZlC7OFxyDjgA+9d9pOtXtz4k0C2efdbXeiS3ky7FG6VXtwGzjI4kfgcc9OlAHX0UUUAFFFFABRRRQAUUVx2ra3eweM9S0+K4K28OhG9RNi4WXzHXduIz0A46cdKAOxoqK0ZntYXZtzMikt6nHWpCcAn0oAWiuGl1/UF17wPbfadseqNd/aE2L+9CQll5xxg4PGK7mgAooooAKKKKACiiigAorAub66Tx5p2nrNiyl026nki2j5pElt1Vs4yMB3GM4556CtDQbiW60WxnuG3TSQqztgDLEc8CgC/RRXEtrmoDxZ4YsvtOLa9bUhOmxfn8pgI+cZGBnpjPfNAHbUUUUAFFFFABRRRQAUUVxMmuagPF3iGx+07bW0bShCvlr8vnSssnOMnIAHPTtigDtqK8hm8Y66k2rf6eoW31C5hiVooxlEldVXkZJwuAfbnJo8LeMtav7zXo7m/aRLPTROhMCLtk3sM/dGTgAHsMdM0AevUVhRahcN45udNMn+ippsVwseB99pZFJzjPRR3xW7QAUUUUAFFFFABRRRQAUUUUAUtavG07Rr+9RBI1tbyTBCcBiqk4z+FGlXxvkuWKBDDcSQcHOdrYzVHxzIIfBXiCVgxVNPuGIXrxG3Ss/wCGus2PiLw9NrOkSmbTr28nlgkKFC6hypO08jlT1oA5u5UHxr8T1flTolhxz/du68G8ZaaNd/aY1rRzf6jY2d21gz/YbjyjueO2UseCCcSMeRya951Af8Vp8SwGxv0KwBOOnF5/+uvFb9t/7Wt0ww3/ACDTgNj+G079+tAGP8J0uLD9oWDRW1G+vbGxF/8AZxeXBfaTDIGcdApbHJAr6U0Mf8Vd4UbbwfDUwzx/z0tK+cPh+P8AjKVsDhvt+R2/1c1fR+jAjxl4TyOvhu5APPaSz/xoA6nxTqb6L4Y1fVIolmksbOa5WNiQHKIWAJHTOKt2dybh7kFNvkymLrnOADn9aw/icxX4beLGAJI0i7OB1/1L0nw+1/T/ABTos2taLK82m3dzIYJXjKFwuEJweR8yt1xQB01FFFABUN5Kbe0nmADGNGfBOM4GamqtqUbS6ddRoMs8TqPqQaAKHh3V31b7eXjSMW80ca7WzkNbxS8/jKR9AK5PXh/xcfWCwOz/AIRZup4/1z5pvwQ8S6f4s0HVtU0gytaNexxAyx7G3JZ2ytkexBH4Ua6WPxM1lQdw/wCEVJCn186T+f8ASgDo11C7hkigtUWT/Q4nVH4GfmzgjnoB7cdqz72/nbXNIW7uNsMl4FQE7FdvLcgDHX8znHtxyXie+ubXxHqXl3TRQpoVtKFZsIsnnbQ3Xg4JHfPtjNcVpdxe3fxK8GtdzTTut853TZUqTHL/AAZOzI6Lk8DOfmwAD0O5bd4w+FhbBJW/5/7d69SJwMnpXlLAN4p+FLJ93F/3z/y7GvVjnHHWgDn/AAlrVzrH2/7UkKfZ3hVPLB5D28UpJz/tSMB7AV0FeY/AbxNY+L9C1fV9KjuI7U3kdsFuFCvujtIFY4BIx6c/lXp1ABRRRQAVWsL+01CFJbK4jnjeNZVZDnKtnafxwas1yvw/Qx6PZKV2j+zrXb9NrUAJek/8LV0YY4/sW+5/7b2lY+meLzpq6dps1sGhOjreiVH+dSCwI2kYxhRznr2PbWvCf+Fs6QN3A0S9OP8Atva8/pXn+oMv9pWT8bh4ZHXK8b34BH8uPxwKANbU/iPqNxrmj2OmWkNrDc6jbwSvKfMkMTON2B0XPQdeMkdOLbnHjzwQAQ2ZNZ5B7bxz/KvPTGsnjLw0YjuT+1rd+DkZB5O7q2eOTyMAdOnoKfP458Dtggq2s8OMN99RQB6Y7KiM7sFRRkknAApkNxDOZBDKkhjbY+1gdpwGwfQ4IP0IqHVsf2VeZ6eS/wD6CayvCalZdZDBgfticHqP9GgoA36KKKACmTSxwwvLM6xxRqWd3OAoHJJPYU+sbxqAfBuvA4wbC46/9c2oA1opopg5hkSQIxRtrA4YdQfceleaTv8A8XA8Wgqf9boIyB0/fsRn8f512nhRAtpf8YzqF0f/ACK1cX/zUDxhwuDdaIM59JM0AcWzA3euk/aPK/tO/Euz7oxcyY3tglRjsM5GOBTfBpBn8UiSVA39jxYjAxtHmNkjnoeMcn3Oc1DeIp1rVEaKMytqV6Y5WGZF/wBLl+7njjjqR171L4JjbzvGWzaAunQqOTyfPlOSTyTnnJ6kntigD1mDJ+K17/dGi2/5meb/AArqpJEiUNK6opYKCxwMk4A+pJA/GuXtFJ+KWqNg4XRrQZ9Mz3P+FX/F6GTSYABnGoWLfldxH+lAGxDLHPGJIZEkjPRkYEHt1FPrnPh3D5Hg7TkBDDDsCP8AakY/1ro6ACiiigAooooAKKKKAMD4gDPgPxIOedNuenX/AFTVR+GOh2fhjwy+h6WJFsLC7nihEj72Cly3JwM8sa0PHoJ8DeIgMZOnXIGen+qasn4SeIbfxb4PTxBZQyw22oXM0qRy43rhyh3Y4zlSfoRQBh3y/wDFafEvGW/4kViSAcEcXleKXRLftW3UvUsmmP6Y4s/8/jXtN+SPGPxQIGf+JDY/ltvK8Y1EmP8AakDnh/s+mk59f9F9aAM74fqP+GpSBkq39oYOeVGyfuelfR2iIq+J/B2WLOPDlyNx5JG+y7186eB1I/at2HcSG1AdP+mc/QV9HaSSvijweh5zoF4QSP8AppY9PbmgDS+KAB+Gni0HODpF30/64vUfw58P2HhXRbnQ9GV49Osrt1gR3LsoYK5BJ5PzO3XtjrU3xLQyfDjxWi5y2k3YGP8Ari9Z3wl8TW3jPwxL4isYJbe21C6kdIpSC67QIznHHVCeOxFAHa0UUUAFVdVYppl4ynDLC5B99pq1VfUIzNYXMSkAvEygntkGgDgvgloOm+G9F1jTdEgaCxS9ikVGkLtl7K1ZiSe5ZifTngAU3XRj4na0cnnwp9Ok0nf8apfs8eKYvGXhjWdYt7aS1R9RSHyncMQ0dlao3PcZU49vyq34iyvxK1psZz4TbH4TSf40AYXisunibV2hQmX/AIRy1wY5BG//AB8f3jx7849s5rjtDXHxI8MZTzNmpHbJkkcxSc5PLE56nrjjIUV1Hi0+Xr+rOzLGjeHLQbjtx/rzwQ3BHPfp+dcn4bcn4heF3xI2/UBl1LE/6txlieqnBweQcDGADQB6SuD4l+FxB4C3w4/69z2r1Fs7TjrjivLQmzxN8L1XOAb/AK/9cGr1J13Iy9MjFAHn/wAGdC07w5o+p2Oj2wtrU3MM5jDFhveztyxyeeTzXoNeT/s4+Kh4y8Japqy2X2IC/S18nzPM/wBVaW653YHXHpXrFABRRRQAV5d8CPDcvhvT9bWa6juRqd0uqxFAR5ccqjbGc912npxyK9Rrz74QarZavpXm6fcxXC29lZ2s/lEkRzpGd6Hj7wyMj3oA0LpT/wALg0xuMHQroe//AB8W9ee64UGoxPIQkS+F4wcYwv7yQZweOvc/hXodx/yV7T/+wFc/+lEFcBrMiQ+IYZHmjiC+FIMyykYALy9Tn69qAMa0VR4z8NBggY6jBjjGeHPAxx06DA5yO+e8txv8b+CWIIIXWOM9vMSvPdOjjk8ceGNgVcahG4GSQR8/zDt64PA4OO+fRLE7vG3gs4wTa6w+D1A86H/EUAeg6pIsOmXcrpvVIXYrj7wCk4rhvgbomqeG/Bs2ka/eLfapa3kgnuVlaUSblV1O5gGOFZRyOo9MV13iolfC+sEdRZzH/wAcNZ/gi8tNRh1a8066t7yzmviY7i3kEkcgEUakqwJBwVI47gjtQB0lFFFABXN/EoO3w68UrE22RtKulRs4wxiYDntzXSVznxIfyvh/4kcsqhdPnJZjgKNhyTQBkfBTT9T0n4d2Wn6/dG81a1ubyK6uTK0vmuLmX5t7ctnjk81jwEn4heM8Mf8AkI6Mp56YVTiuw8BzJcaLcyxSJLG+pX+10bcGH2qUcGuHgOfiJ4wwSM67pMZz7W0b8fnQByWos/8AaWopyfMvrsnCNk/v5OeCFPpzjHGcjmrXgKZDeeKVI+UWNpkn5s5uJs8gfN7HA9hjFUrqHzb3VZyuU+3XGXwzKpE7nAwdnX+8DjvxitL4Yqz33ijAYDybBPv7xlp5enb/AB69MUAeo6fk/EzXs9BpGnY/7/Xv/wBaqHxnsNS1T4dajY6FcG11W4mtY7acSmLy5DcxYbeOVwecjn0q9pxB+J3iADtpGm/+jr6r3i9449IieV0jRb6yJZ2Cgf6VF3NAGb8Jt3/CsfCokJMo02ASEnJZwg3HPfJyc966yuX+FuD8OPDRDb1awhYN6gqCDXUUAFFFFABRRRQAUUUUAYHxAJHgPxIR1/s25/8ARTU3wVYWGlafd2GkWsNpY293IsdvCu1I84YgDtyxP4074gIZPAfiRFOGbTLkA+/lNWB8E/EreMfBI8QtbLafb7qVxbiTzPKCny8bsDOdmeg60AZ+pf8AI3/EzHBPh+x5A9r2vE9ZbH7TcTOwObTTmb8Ps5OPyr3LUI2bxn8QlUff0Cw/LN71/KvDNdcr+07b8hC1nYA+3yQn+lAFPwcc/tZKM4XzNQGFHQeXcdq+kNLP/FV+DwcZPh+86DGcSWPNfN/gs/8AGXCEAD9/qHGc/wDLK4r6Q08Y8YeD+ME+H74kemZLCgDV+IwJ+HvigLnP9l3WMHB/1TVJ4S06y0lNTsdKtLeysobw+Xb28YjjjzHGx2qOBkknjuTR4/Ut4E8RqDgnTbkZ/wC2TVz/AMFPFUnjfwc/iOW1Wza/u5G+zq+8RhNsYG7AznZnoOtAHfUUUUAFVtTJGm3e0kN5T4I+hqzUV4nmWk6ZxuRlz9RQBw/wisrPT7LXLfTrSG0theW7LHDGI1ydPtCTtHAyTz71D4j/AOSg6r/2K8vb/pqaxf2Z/FE3jHwfrGr3FtHbSNqSweXGxYDy7O2TOT67c+2cc9a2fE3Pj/VE9fC034/vT/j+tAHMeK41PijUkTfk+GrX5lTzMD7Rx8vXt1HHrniuJ8POW+I/hRZmDSnUcksvLMEkyTgYDdMgYC9OpNdb4plx4r1hrjdJBH4btRwTxmYE9ORnnrnPbpzynht5U+JHhmFmUkaiNyZ2mMGN2ChTyPXB55z3AoA9NbjxT8MBnq2oduv7hq9QlyInI64NeXOR/wAJT8LwTkltQI5z/wAsGr1JhuUg9CMUAcT8KoYLfTtUitYYoY1ntvkjQKP+PC17Diu3rx39l7xJfeK/BOr6pqcMENw2piHZAjKgWO0tkUgEk8hQevevYqACiiigAry74CeHrTw7oE62EtxImpx22rS+cVJWaeIF1XAHyjAwDk9eTXqNeXfAHxDZeJPC3n6cs6pYQWumTecgX99DCA+3BOV+YYJx9KAN+fP/AAuKy44Gg3Hb/p4hrgtckca3C6Scf8IrBgovzctLnHHPbjt1rvpxn4wWZycDQp+P+3iKvKPHXiTSNG1u0i1a4mjluPClt5SLbySeYd8o4KKcHJGScDn6UAVtKYnxx4V3OrbtQQ7vN387X53Y+bOAM8YIA9a9Lscjx74PU4z/AGfrBOP+vi1/xryrwRqKa7408PzWS38lja6jHFJeTWTxw+YIpWEYZgCW5A5AI3L25r1mxJbx94RPOP7L1cnJ/wCni0oA67xXIYvC+sSL1SzmYfghrnvhH4ah8HeEz4etLiS5ttPupY45pFCs4Y7znHHBcj8K3vGGf+ES1vAJP2GfgdT+7aqXgHWLDxFob61o0/2jTr+5lkgl8tk3qrbCcMARyh6gUAdJRRRQAVzHxQTzfhv4ohJ2ibTbiHdjO3fGy5x3xnOK6eub+JDpF4B8QSyttiispZHbGdqqpLHA9ACaAMv4LaCPC3w7stDW4Nyun3N5biYpsLhbqXnGTj865y23L8Q/FWATv8SacvBx0sIia7f4eahZav4Vi1LSpfOsby5uriGTay70e4kYHDAEZz3FcpZQ7vHXiJwcZ8T2n440uE/1oA89umElzfTSCRnW8nIddxIHmvhQgIWTqBnn/aztrf8AhQ3mXPiN2bcXuNPQA8kHzZD94cMOeo69eBiubnI/0yVo289ridwd2QVMrc7OjDg8kjpzjBFdL8Htwm14sF2G8sANvJxvcjLd+oIPcY6dKAPRdJbd8UfEw7Lpemr/AORLw/1qv8Y/Dw8W/D6/0Bro2n9oTWsPniPzNn+kRnO3Iz09RTvD8ol+KPjBQOYrPToyf/Ahv/ZqvfELVrDQfDZ1XWLgW2n2l1bSTSlWbaPPQA4UEnkjsaAIvhWpT4Y+EU/u6RaLn1AhUZrqa5z4bYPw68LFfu/2Va4/78rXR0AFFFFABRRRQAUUUUAYPj8bvAfiQYznTbkY/wC2TVV8CN/yHY1WNI4tR2okaBVUeRCcYHHUk/jWr4nhS58NatBL/q5bSZG5xwUIPNcF+zxreoeI/BF3q+tQJb6ldahI08SRmNVKpGowp5Hyqp59c96ANC7jz468cqwGH0CwPQHI33wr51+I2saf4c+OH9s6kz7YksYvlByirBDIz8dW6Lt4GDn6fR12gPxA8X5ySfD1iRkng+bfj8q+Sv2lQT41unwAMWvHf/jzh6/lQB0nww1TTPEf7RdlrWllwJrq9whB+dHt7pwWBA2kcLgZHGeD1+i44prnxb4KWG9ktm/sC+ZmiRSWHmWI2/MCMZI9+K+S/wBl4Z+LOjc/8tZf/SO6r630Vg3i3wSQMD/hHL/1/wCeth60AX/HGmXZ8FeIRJrV66nTrgbTHBg/umzn93/hUelaTqMYmt7HVN3k6wk1zK0aRGSEQoWQCNQOTj0yOpPQ7fjXH/CG69ubaPsFxk+n7tua5T4E61rHiHwMdU8TQmDWLi7kNxEYTDsxtVRsPI+UKffOe9AEnhrRPG9h4o0mbVNbt7zRo9JjhvoS5LSXnO+RfkGQTt5yvGRtFegUUUAFV9S/5B11/wBcn/kasVFdhWtZlc4QowJz2xQBx/wxAEOuFduDdWx4AA/5B1n6VmeKuPiBqhxz/wAIpPyen+trG/Zg1TWtX8Eard+JopI9ROoqhEkHkkxrZ2wjbbgdVCnPfORxitvxXx491I9R/wAIrc8f9tRQB4p8QPG+pWfxL13S7XSYpYLfTbSykkDAyMMLJnDOuASxGBnGM96Ph/c3uqeJNN1aPT40XS9WiEwuZERFWVQoEapvZpMS7sllQbVHOTjm/HpWL4x+L2bnbBaFj0AHkoSfoAOtd58CNMvNW1PxHaG2Nhb2d5Z3k0lwuZXBjR1RUH3SRGCWZiQGA25zgA9GlXHjD4YA5+X+0cZ/6416ddY+yzbs42HOPpXmT8+LvhefVdQP/kGvUJNpRg+NmOc9MUAcZ8MCWh10kED7XbYz/wBg6zrta8e/Ziu9fvfB2tS+LVmXV/7U2us0KxMEFpbCP5QAB8m3tz1r2GgAooooAK8z+BOi6foXhpINKtvs8d1aWd/OPMZ988sALv8AMTjOBwMAY4FemV5J+zd4mHirwfcXIsxafYGh0rb5vmeZ5EKDzOgwDu6c4x1NAHVyk/8AC3rYYGP7ClOfT/SI6+efixIzfEfQvIcFo/CVtv2E5VjOTg46ZBH519DXGP8Ahaq5IB/sJ+3/AE3Wvl74g2FvefE28F1Dv26Pp65DuhGYk/usM9B19BQB6J8JZBb6ZZzXkywrL4pRA8zhQztaKqoCx5Y8AAcnNemaaCPHfhLdjP8AZGrHj/r5s68h+Eej6Pb2d481hZNfDVbVbWSZDPPnETHyzJll5JJK+nPSvZLHjx74X/7A2q98/wDLzY0AdD43OPBmvnJH/EvuOQcY/dt3qv4C0Ww8OeHho+jW/wBm06zuJ0gh8xn2KZGYjcxJPLE8k9al8fNt8C+I2xnGm3JxnGf3TVn/AAr8Q2/i3wVa+ILKGWC31Ca4lSKUgsuJnXnHH8OfxoA62iiigArmPiciy/D7X4JCfLuLR7d8HBKuNjYPrhjXT1yfxXuFs/h3rl2+4x20H2hwvUqjBmA9yAetAFr4faTaaF4Wg0rTkZLKznuIIUZixVFnkAGTycD1rnNMAfxbr7dMeKYuvfGlW9dB8ONVg17wdZavZpIltqDz3cSygBwkkzsAwBIBwRnBP1NYHhcGTxN4nOBx4p9PTTIKAPLLl1+yXjHLRmWViuGLkeZk/L91uRwTxgDPcV1Pwi5/tz5WQ/2jZcF927knj25PPfrXJRXW/T5LZmDysHY/vioZWc9UHOfZRtOe4Jrrfg35Zt9akRTtbVbQfMF5O0enGMn6enGKAO28Kgf8LT8dnnPl6cP/ACFJV34maNZeJPDI0PVUeSw1C6t4ZlR9jbRIr8H6oKo+Eefif4+5zj7APp+4P+NS/FrxBaeE/C0Wv6lHPLZafeQSypbhTIQW2jaGIBOWHccZoA0vhuMfDvwsPTSrX/0StdFWB8PkMXgLw1G3VdMtlP4RLW/QAUUUUAFFFFABRRRQBR15DJoeooMZa2kAz0+6axPAzF7vxMzHczaihJznJ+x21dDqO06fdeZ9zym3fTBry/8AZtv9d1PwVqN14tW4XW31E+eJ4BA+BBCEygVQvyBMccjnvQBuXXHxG8Vnk48N2R4/67X1eBfE3wVD4y8X+IdPiv8A7LrNva6ddWcchAilU24jYOTyPmVAG6DdyMHK+86i234geL2xnHhmzP8A5Fvq+afjH4nn8I/G7TdWtozJF/ZNpHc2+8qLiFo8PGfTI6HnBAbqKAMf9mCCWD4r6WJY3jliupEdGyrK32O7yCOx4/CvqrQGVvFXgYgKAfDt/jn/AKa2HSvMPDNnY33xM8J+LdEnjuLXVpZI5pkzl5I7C62kjkK+xgrL2KZxzk+l6L8vi3wCB/0ANQH/AJEsaAOs8df8iR4h5x/xLrj/ANFNU+hnddasc5P2lM8c/wDHvDUXjfH/AAhev7xlf7PuM/Ty2rkfgJc+IrvwTNL40FwPEBvHF0J4xG4wiBMqAAPk2duetAHpFFFFABVfUv8AkHXX/XJ/5GrFMn2GGQTY8vad2emMc0AcT8KXL2erMxJJmtDn1zp9p/8AXql4sYDx5qO7AX/hFbk89P8AWjP9Kxf2Yjr58Fap/wAJb5v9q/b4/wDWhd3k/YrXyvu8fc2++c5+bNbXioF/H+oIM7j4VuQMdeZR2oA+Z/iNAl78V/GtqXZBPaWsYcD7mYIwDj05Gfxru/hF428TT/EjxVq1x4dMOi6rParebrkBrW42rGpiz/rAd5JUDptO4Y+bgvG99af8Lb8S3YureK2ubaze3lmlSNZl8mMBlyehx9R3weK6f4e6/otnbXkMuoWcl3d6tamG3gmEsjhRCWIC8BQFYl2KqMEZFAHtEwK+Mfhgp7DUBn/tjXpl5/x6T/7jfyry3zkn8W/CqWB1eCaLUJY3XOGQwAqRnnkEH8a9UnZFhkaX/VhSW+mOaAON+GeB/wAJCBnAvbcc/wDYOs67WvIP2ZYfEEHhHW4/F5mbWRqoMhmkWRihtLYx/MpI+4U7/XnNev0AFFFFABXnnwVtbe18M2otYIYRLp9hNJ5UYQO7WybnOByT3J5r0OvHP2XtbvvEHgSe61S2jtZ7aWGwjREZN0MVtD5chBPVg2cjgjGKAO0ucD4oZJAxob/+jxXzB8QpXh8e66YlzcR6BZNGu3dl1twwGO/IHFfUM4A+JjsWPGiMMdv9dXzH4zk2fE3WFAYbdK035u4IgQjigD1X4ISeE9H+JvjXQ9GuYpLqRLGazuHnErXlv9lRiyvn5juJdsf3xjgcdvpoC+OPCYBDD+xNUwR/18WNeQfCDwzoYtb+/i0WxGojVbZYrlogXi/1RxHn7nLMflA646cD2WDA+IXhhcYI0XU+PT/SLGgDc8cosngrxAjjKtp9wCPUeW1O8J2NppuktZ6dbQWlnDczrFBBGI40HmscKo4AyT0qv8Rpza/D3xRcLtzFpd1IN3TiJjz7Vm/B/wAQTeK/h/p+u3VoLKe+luZHtwSfLInkXGSAei0AdnRRRQAVynxRRZvBN7BKoeKeW2gkQjIdHuI1ZSPQhiD7Gurrh/jZff2X8M9Y1IRrKbEwXQjZiBJ5c8b7SR0B24/GgDd8G2Vvp2hLZWUCW9rb3FxFFEgwqIJ3AUDsAMYrl/B4z4i8UljyfFDEfhp8P+Fbnwz1Rtd8C6TrDxLC2oxteGJTkIZXZ9ue+N2M96wPB7f8T3xQWzn/AISpgP8AwBhoA8ptGH2WIOzLvUAIcBec4Xb/AKzGDjj14GK7b4S7vsWqNIGGdZt8BgBt/doMDgf168V882V/fSw6ir6lqgRLu5iRVvZlQIGwEXaRhR6f0r6d8KaXp+h2n2DSraK0tY9QtAEQk5I+UZYkljhVGSScADtQBs+EFB+Ivj6QHnzrKM/hbKf/AGarnxB0y01uy0vTNUtUvNPub0LcQSZ2uqxSOM49GVT+FVfBwP8Awnvj8k8fbLQD/wAA4v8AGs746eKf+EK8I2viH7It41leri3Mvl7y8ckf3sHGN+eh6fjQB1ngpGi8G6DGxJZbCBST3IjWtmqmkQ/Z9Ksoc58uBEz9FAq3QAUUUUAFFFFABRRRQBV1U40u8PpC59P4TXNfDshm8QEDA+2wcf8AcPtK6fUSg0+5Mv8AqxE27jPGDmvLf2bI9fi8Haqni9pm1oalmYyyLIxU2tuY8lSR/qynf685oA2dTOPiB4wGTn/hGLQjAyf9bfV86/tD6d4a1bXLcJrAXxIsUdnlZY2s4WjjH+jzv1jkZi2JM7BgBgo3Ov0Xfgn4j+LACQD4YtPz869r53j+FfhHXNMtryPVL7T3eGCS6tgVzEzxsUVkfBU4RiOTx3OaAOB/Z7vU0T40aF/bE4sYYZLmKQXLeWscjW8sYDZ+6dxC819facPJ8beAYiNpGiaimM56PZf4V8/XngHwRpMw1PWtcvtSnVEEUeY985VQqIqocs5wB6nr1ya9508svjL4ZqV2f8SK+G30GLPj8On4UAdp46/5EjxDnp/Z1x/6Kajwx/r9Z/6+o/8A0lgp/jXb/wAIbr3mDcn2C43DGcjy2rjfgBYa9pvgq4tfF08txriXrG4lluBcMwMcZT5wTu+QoOvagD0uiiigAqC/XdY3C9MxsP0qemylVidnGUAJIx2oA4n4U5/s7UM/3rTnGM/6Ba1U8TYPxCvQc4/4Re43Y6481e/51gfsv6brGk+CNTtfEc7z35v0l3tOZiIns7Zo13ZP3VIXHQbcDjFdD4i3f8LFvNq7z/wjE+FPQnzhxQB5M2m6IdB0m48VeF3JNpCftAs/tkWJPNOVdRkcRhjlc5cA1Bpy6BbxSSeEPBk97ePD5a7bD7Kkm7+B5JAFCnvkHgfhW/pa6g3g/S5PDmu2OpQiytgVvg5ZMNPuzLGCfvfKAVwAhGT1rPv0102ss/iHxBpOiWKREPNYrI0pXbztllxtOM/dUnjgUAdrYhhr3wd3hRJ9hu94XOA32VMgZ5xnPWvU9VO3TLw88QueP9015TpgjOtfBtoWZovsN0UZmJLKbRME555GDz6161eyLFZzySDciRszDGcgCgDkvhv9/wARjuL63B/8F1nXZ15L+zZouqeH/COsabr9yt1qUWpBpJllaUMGtLZkG5uThGVfbbgcAV61QAUUUUAFcX8K0KeG7MEMMWFiuD2xbR12leTfs0y+J5fAU/8Awmi3K36XSpbi4jVG+zC3h8vgAZHJ5POc55BoA7Bh/wAXMZsEr/Y3IxnP76vE7j4eT+JoLXxJoGuWcd7c2cMVyZ7JZ0l8vMYzzkSAxsrHvt6Aivbpx/xXV2xViq6OB7HMr/4V5vbx6enh20l8RaFfQXaWlsrXFl5rpMoa5EZ3RkAtj5mBAIMmDnigDnNB8C65oMbyeIvFsUel2sy3strb262sEjIoO+ZshnRQgJQkKSPrXp+hTfaPF/gicyNMZfDN5IZWOS+ZLA7j7nr+Nef3aaBeQrNo/hTVtfvYGBtrecS+T5g5Xe0r+WFyASWBx6ZrvfDzSP4v8FSSlWdvC90WZW3Dd5tlnB6kehoA6nx4wXwTrxPT7DNn/vg1f0ddtpJxjNxOf/Ir1jfE95I/ht4qeDPnrpdy0WBk7xE23A7ndjjvUHwoutYvfAOmXPieFodalMzXUZj8sq/nPkbe1AHXUUUUAFcx8RlDeGo1bG06jp4ORkf8fsNdPXCfHG7vrD4Z6nd6RG0upwTWklpGkfmF5hdRGNQv8WWwMd84oA6jw4u3S8Bdo8+fjAGP3z+leeWl22nQeOr2FYzNb67dXEfmAkb005GXjvyo4yOM12HwzuLy88BaJc6orJqM9uJbpGj8spMxJkUr/CQxIx2xXDTqP+Ee+ILgEk6pqLYB64sAv9KAPlvRJLldBW6eS2lkuFmu3BLJksTwQFx1Hb1r6Z8KTaodcjTULuxuIro2l8Y7O1aFIJBMI9ql3ZnBDHJbH3RgDnPzdolrd3XhJItPgjmeDSbi9kMhwscUQZnY456sqgDqXHbNfVPh3SHg0Dwzrd5dST6pfmwE21h5MKEB/KjUfw7iDk5Y+uMAAG/4MA/4Tjx+ec/2hbD/AMkoP8au+Nkikk0JJ40kjN7ISjqGDYtLg4wfpVXwaP8AisfHx7/2nb/+kNtXP/tCaxrGg+EtN1Dw1Z/btWjv9sMHktNuDW86udi8nCFm9sZPANAHoukcaVZD/pgn/oIq3UNmqJaQLCwaNUUKw7jHBqagAooooAKKKKACiiigCnrWf7Hv8dfIkx/3ya5b4ZDCa8CMH7ZbZ/8ABdZ11966R2dw8gyixsWGM8Y5ryn9mnSNU0Lwdq2n67dreX8eoq7TLK0oZHs7Z0G5gDwjKuOg24HGKAOw8YeHbq6vY9c0O8htNVt7WS2ljuIy9vewEZ8qXbh1w3KuvK5bhgxU+LWeoa1P4P02LWPAa38kUNqEuIJraeOdVil2yDcwdSQeExx83PavpG5z9nlwQDsPJ7cV85ad/ZyeCtLt9P8AEd/opEdoHtnKn7MxjuPk2vgqCQWwWIwARgGgCl9q1mCznfw/4Cg0y8kTCzXM1tAsIKn5vlbewB5IxyBivZfhtoF5FZadreu30N3fnTo7a0itkaO3s7cqjFEDEszMUQs7YzsUBVAOfEdZl0k6VLFrnjPUtSglAQ2lqVR7skHbCojBJD9NqsM55IGa+kfCGf8AhE9E3IYz9hgyhGNv7teKAIvHGD4K8QZxj+z7jOTj/lm1ReEsiTWAeMXUQxjGP9Et+Ku+KHWPw1qzyLvRbSYsv94bDxXB/s8+Gr/wj4IudF1e4t7m8gvWZ5YHZlIeKJ15YA8BgOnagD0+iiigAqK8/wCPSf8A3G/lUtMmfyonkwTtUtgd8UAcP8JP+QZqGCD81n0Of+Yfa1d+IPhj+3LaHULPUpdK1XT45RDdKDJGYpAvnRSxZAdGCL3BBVWUgiuK/Zd8OT+FPA+paZdTxTym/S63xZ24ltLZwOeeM4/CvXbwbrScFQwKMNpGQeOmO9AHy9eX102j6TJr/gSeaP7DZsupaDqTbZQBL5e4rtPdiQXONy5PIrN0yYDVIZ9A+HGrX13Hh0udYv2KREEfMpk3op5HIIb05rt9J042On2sWm38sVoYw0MUqpcIke0bVRmXeUAxtBZgBwKn+xXNyTHJq10wYL81okdtIQOyuFLr15KlTxwRQB3Pwt8MyxWGleItZ1T+09Sk0yK3tlhBS1s4WCsyQqSSxYhd0jks2xfujiu31gA6RfA9PIf/ANBNVvCsNvbeGNIhskjjtY7SJYkjOVVAg2gH0xirt9L5FlcS7d3lxs+3OM4GcUAcp8OJEkm8TNFIki/2hANyMGB/4l9n3FdlXln7O3hmTwd4S1TQZrqO7a11Hd5yIVDCS2gl6H034/CvU6ACiiigArm/AoI0kZBH7q36/wDXvHXSE4GT0ryf9mzw9rHhnwPeWPiC8S8umvFmjdJmlCwta2/lplgCNoGMdBjjjFAHXeLNC1KbVLTXfDt1HHqdrDJby2dyT9nv4W58tyMlGDAFZADjLAghuPJ/DniTU7bw1Zi1i1yOPy1RoZNPGqeU6yThwJYHL7N52qGQELHxkHj6BYZBGSM9xXjUGnXA0S2g1zRrDX7y3t4oRfQ3CQzzJHuEbSCQrhwHbIEjDOSMZxQBzPifxRqj+Hr64u9Q1aytIkJnlh0lbGQrtO5Y5rt1KMc4DKjtz8oJwK9R+Gmi3v2HTNc1xohd/wBmx2llaxMXWztyFYgyEAySPsjLMQACgCjgs3Kx6PF9oS90/wAIadZapC3+iXOpzxS+Q3ZgIzI/HBwpUnpuXrXqfhq1lsPDmlWlzcvdz29pFFJcOMNKyoAXIycEkZ696AKHxDz/AMIPre0kH7K/Tr0rQ0E5sZTz/wAfVyOf+u71kfFGKS4+G/iiCEAzTabcRR5OMO0bBTntyRz2qp8HdM1TRvh7p2n+ILz7bq1vLdJc3PmtL5r/AGmX5t7fMc+p5oA7OiiigArm/H4J0K1wM/8AE10z/wBLoK6SuB+OljqOpfDLULLRJWh1S4urKO1lWUxGOU3kIVg45XBwcjnigDo/BjbvDdo3OWMh5OesjVwfxD0rU/Dtj4jvdLtf7S0XU47m5ubZZEjmspjasjSx7yFkjYKCyZDKQSu4HaOw+F8U8Hw88Ow3jM93HZRJOzNuLShcOS3fLZOe/Wq3xUNy/hOa0sY1ee+32YZhkRCSJwZCvVto5wOfY4wQD4n03VZYPDEKWdxPa3DabNaMWtZXSWKVSJEOFIwcKwYZwyg17v4B1XX9G8P2OgWrar4s+yfY5rHzdMbTIrf59vlNNPgtH02sEY9gMYA8c/s3WdJ0lNLu9D1gXSQvbkxQq0bEMy8Hd0z/ACr3rwPqmqat4ms7q90S70uyme3soUumDSMYmeVpcjAUEnaEG7PzMSMDIB6x4L0S80m3v7vWbmK51nVLgXl60ClYY38tI1jjB52KkajJ5YgscZwM74kFg/hwqxH+nXGff/iXXldnXk37SFnrt/4S0eDwpcNbauNSMkcqzeUVRbW4MmG/3Nw/GgD1DTf+Qda9/wB0n8hVmkXBUFfu44paACiiigAooooAKKKKAK+oAtYXIUEkxMAB9DXGfCWaG4sNZkt5YpozdW2HjcMD/wAS6z7iu4nkEUMkhGQilsfSvJ/2a/DLeEfCOr6QbwXgTUVnEoj8v/W2dtJgrk9N+M5OevHQAHrE8YmgkibOHUqcHB5Hr2r53htNRt7C00uW10bWtNt7eOJGu5jDMVjUhd4ZJFbG4/MCuSTwK+iyMjB6V5dqvw41qG7d/Dmv2f2LAEdnqtiZzF16TI6ORjAG/c3qx7AHGWFrqMBI0vT9F0SMqVM0cn2mVR0IWNI40/76cj2PSvbfB1oth4R0SzjeWRLexgiDytudgsajLHueOa4LTfh54kmmi/trxFp1tarxJDpGnFJJBjp5sruU+qqD6EHmvTrK2isrOC1twywwRrEgZixCqMDJJJPA6k5oApeKEMnhrVkHVrSZfzQ1jfDzUrHVrbVbvS721vbZruNRNayLIhItYARuBIyCCK6DWGKaRfMFDlYHO09D8p4rz39n7wwng/wfe6NFeNepFeiXz2i8st5lvBJ93Jxjfjr2oA9OooooAKhvVZrO4VF3MY2AHqcdKmqO4lEFvLK33UUsfwGaAPPfglfWmpaNqNzp11b3Vv5lpGZYHDrvWwtgy5HcEYI6joelejV5J+zb4eg8L+EdR0y1nlnQ3MF0zyKAQ8tlbOy8dgTx3wR16n1ugD5E+Ot5e+F/jPDpXhfULvR7C/s1u7iC2f8AdGZjJucRtlQTsXOAM4z1OaithqP/AAvzQvB+ta3f6zoj3En2i3u2CxTmNpgoeNMKy/u1O05BOcjBxSftLHH7QOk4yP8AiVpyBnHM3arEuB+11oeef9Juen/XS5oA+uFUKoVQAoGABwAKg1GMy6fcxqCS8TKAOpyDViorp2jtZnQAsqEgH1xQBxvwu1Ky1aHxBeaXeQ3tm+oRKlxC4dHK2VqpwR6EEH3BFdvXmXwE8O2fhTw3q2j6bLcS2kN+kkb3GN58y0tpDnAA6uR06evWvTaACiiigBHyEbGc47DNcd8Mb6z1DSrubTr23vYUkgiMsEokXcLSDIyOM8+tdfNIIonkboilj+FeYfs9eEF8D+FdV0Zb03rLqAneQxeXtZ7W3YrjJ6Z60AepV81/FPxnrHgf4jWPhbTLDT9Zju7Rbi3a8LQyoC8g8ppFYKwGzhmAODhix+Y/SlfJ37QHP7THhUZI/wBCgGR1/wBZNQBr6F458Tal8VNO8D6tpWlaNNemUyzWrtcy24jSU4Tcxj3ZiPJDAZHB6V9LW0KW9vFBHnZGgRcnJwBgc18rab/yeRpP+9fd8/w3dfVtAGD48dI/B2rvNIkcQgYu8mAqr3JJ4Ax37VP4VuILrSGntJop4HurplkiYMrfv5OhHWs/4n263fw78R2skwgjuLGWF5iM+WrqVLY74Bzjviqvwi0AeFfh/p2hC6F3/Z8lxB54j8vzMTyc7cnH5mgDsaKKKACue8dMqaJbs7qijU9O5JAH/H5D610NcL8btDHib4cX2hm4Ft/aN1ZWwmKb9m67iG7bkZx1xkdKANrwA/m+DdKk3Bw8O8MuMHJJyMcYrK+KbWy2Ggi81CbT0fWbZVniOPnJbarZBBVjhSDwQTnHWrnwsjMPw28MQMwfyNOghDAY3BECg49wM1H8RGuli0H7DBDcSHVIw0MrbRInlybwDgjO3JGeMjkjrQB53fweIoHtPsN3oF5EbW2JmmSaJpWMYLSEJuUgnnAwMVF4W+0Hxxoian4hsb6/M8j/ANn2UQijRQDmUgksxBwoJIA3Hg9sjxFp+jTzae174N1zzjZWq7tOjlaLHkj5MwSBSF6cjHpxWp4FsxD4p0X7F4V/sWyWU+ZPK8YmdgrbYtoJYgDLEscZxgZ6AHvNcZ8Rebvw2CQB9qufmPY/YLr/AOvXZ15T+0R4al8XeH9B0mG7WyJ1M3HnshcAxWlw+3AIPzYIz29+lAHqkYxGg56DrTqQEMAR0NLQAUUUUAFFFFABRRRQBheO77+zPBHiG/37DbafcTBs4wVjYj+VZ/w3axu9KvtU0i7iu7DULsyQzRfcZYo47fj2/cVF8VYLHVPDkegapPLBa6xOtvLLG4QpEitPKST0HlwuCf8AaFWvhfocfhv4e6BpUIIWC0QkHrub5mz75Y0AdRRRRQAUUUUAIyhlKsMgjBFeY/BnxDp2s3mvW2nz77m0jshfxNG6Pb3IhMLxtuAyQYOoyPevT68s8KaPYeGPidrL6XDJHJq17KNRySfNkkjFxBKAeAgxdJkYyx5zgUAep0UUUAFY/jG+j0zwjrl/MWEVrYzzvtGThY2Y4/KtiuS+Ji2V5oUOj6qspsdUuBDcbGZQIUVp5dzKQQpSFlyP7wHegCH4WXmnavo1/rehytNpWpXhktZCpTekUUdtnaQCOYDwQDXZ1zHww0MeG/AGhaWLc2zQ2ys8BOfKd8u6Z6nDMRk88c109AHyP+0rBDH8Yk1a7uFht7PTraLbkbmaQ3GDgkfKAjZxk9ODyRBo+oaV4g/aN0TXdFv0uIBqktvglf3gk+0SK6DO7aAcHcF5IxnnFT9sLP8AwmlxnGPs9hj/AMm64T9ndsfE/wAOj11KLvj/AJZTUAfoLQRkYPSiigDyf4H+IodY1PxLYxmYXmnpZRagkqbfLvFiaCVRycj/AEdefr6V6xXlvhfS9O8OfFDWpbSNbOfUruRLxfMf/TXlQTwTYJ2jbsvI+MZOetepUAFFFFAGR4w1FNI8Ja3qUpISzsZ7hsdcJGzcflWX8OdTsdf0i817SLg3Gm6pePLbuY2T5I1WAcMARnySeR3qL4mPpd3o8Wh62sr2WpsxuEjZlP2eFTNIWZSCqkIEJyOZAO9aHw/0NfDXgnRNHCBGs7SON1ByA+Mvz3+YmgDoK+UPjqA/7UHhVWz/AMeluAAep8ybAr6vr5M+NZEv7U/hpN33YbVTnsS7njP1oAsad/yeJow3Zwb/APDi8NfVdfKGlvu/bJ0zjG174dc/wXVfV9AGN4z0+XVfCGt6fbgme5spoYsdd7IQuPxxWN8LfFGl+LNF1G90K7N5p8eozJHOUZC27bKQVYAjBlK9Oig85yeyrzH4QaRp3g+S48OafF5ST+ddcOzebNFMYZnOfu5Q2p2jj5uB3IB6dRRRQAVxvxP8RaN4Z0vS77xJdC107+0Ey5Vm+dEklQYAJPzRiuyryz4v+H7PxzdwaDdRvL9j8idVWXaElmmCK+OjFIorlip4wfcEAHd+DLGTTfCGh2NwrLNbWMEMgb725YwDn3yDXO/FmMPYaA8tneXNvDq0U0r2gcyWwWOUrLhASQH2Z4I2kkggEV3Vc547gvZtFWTTrQ3clvL5zQpKI5GUKwPl5G0vyMAlQfUUAeMz6nbXAhFl440yOK2ghtZBMbYtmNAhY/MNmSucYGOmB0rb+HawS+LdJurXV73XiTNCZEcfZLVBGWL/ACgq0jNtX7xbBOAADnlovjB4JvoxNJr0kT8YS6spDIDgZHyowP513/wn8R23jO6+36Abi40qxnkilup0ESF9nCxrkseHBJIUAetAHrFch8S3srTSrDUdWuYrXT7K6LTzynCxrLDLbgk9uZhXX1yXxZ0FPEvw41/SpCQs1sX4GTlCHAHvlRz296ANfwhqA1bwnomorjF5YwXAx/txq39a1q5L4ZQ2mneHG0KxuZLmLRp2s0eTBIiIEsIyOoEMsQz3xXW0AFFFFABRRRQAUUVQ124vrbSp5NKto7m+wFiSV9kYYkDc57Iudxxk4BwCcCgDyzxP4ltvE3xfl8BW63FwE04LdPCmY4Fdw9yJW6jMSxRqV6GdgT6exVwXw08LWNjPd+IY7QLeX0SwJdOm2a5hUl/PmG0Ykldnc/7PljAK4He0AFFFFABRRRQAV5V8edVuPCOh/wDCU29g19bQmGO5jjkETRukoktptxB+RZNyMgHzCf0Bz6rVLW9Mtta0e90y/QPa3cLQyDAPDDGRkEZHUZHWgBNB1az13RbHVdMl82yvYUnhfGMqwyMjseeR2NXq4/wRa6nYXl9Fd2vlQySM05CKiNcjG6eMDgpMCHK4yrh85LEjsKACvFfEHin/AISr43v4E0+Brqyt9P26hcxz7BbgyI8ykY+cOqwxcEFTI/XnHreum/Gk3A0kRi9YBI3kPEeSAZMYO4qCWC4+YqFyM5HO/D7Q1tIW1a4t5UurmFIITdL/AKStspZl84kA+a7vJI4PRnwfu5oA7GiiigD5X/aU8Lz+KfGuuQafKx1Gz0myvYrRYi7XKrLcIyjHIbMi44OSccZzXj/wESW3+K/h6KVGjlTVYkdHGGUhZQQQe/WvVv2hPFT+Dv2hNK1QxPLZnSooLuFDgzRGSTcATxkfKw91WrMmi2c/xU8DeMtGmjutP1XULdJbpGO2aURy7XAbkEhWVh2aM55zQB9U0UUUAeU/HzU7zwnoH/CVWNg+opb+XDcQLL5QjIkWSG4LYJIRwVKAfMJjyADn0bw7rFn4h0Kw1fS5fNsr2FZ4m77WGcEdiOhHYgip9TsodS066srkEwXETRPjg4YYOPfmuc8GWOpWF5fpdoqxO5M52BBLcDb/AKRGFGMSqQXHG2RWxu3E0AdZRRWfrxvv7MlGlMkd02FErgt5Sk/M4UA7mC5IXHJABwDmgDy2fxc3i341X3hDTLQ3emadbRC+v45gFtmWXzJYiOQ+8rDEVyCNsnBwcexVzPgjRjp9rJe3EAhurmOOJIz9+G2j3eVE5zy43u7H+/I4yQAa6agAr5P+MoZv2q/DQjwx8q04Pb53r6wr5T+LOW/ax8OjgERWgGTgH52oAr6GSf2y7HcAP31/jA/6Z3NfWlfJuifN+2TY4I+WW/zz/sXP+NfWVABXjfxY8Ut8OfF/h/UpbIHRdV1NDd35JItW8ryZA2B0aMRuAD1hY4NeyVj+KdH/ALY05BAIRqFpKt3YyTAlI7hAdpbHO05KtjnazYweaANdWDKGUgqRkEcgilrnvBVte2Omm0ubcQWMWPscbPmSGMjmFgABiM5VSM5QJnJyT0NADZHWNGeRgqKCWZjgADua8e+EHiWL4jeI9Y1y0sGg03T7+by7skgXspURRMFIBXZbgZBzzNniu78fQ3t3p0VtbwSz2cjg3MUJ+a45UJAflOI3Zv3j9AisP4sjS8L6QNE0aO1LJJcO8lxcyou0SzyuZJXA7AuzEDsMDtQBrVBqBK2Nyw6iNj+hqeq2pkLpt2T0ET/yNAHwj4V8V6P4Y8LanoyyOkt/bQMWm3gpIwglZhtVgRlCBgqcBc8jdX0J+yRbW1p4K1uOxaRrdtRSVS67T89rA54ycDLHHJOMZJNfF+u/8fsfOf8ARbf/ANEpX2p+yUAfAOpOO95CufpY2tAHt9IQGBDAEHgg96WigDx3wh4lh8OfFz/hALqOaEtpv+jzTxhRciN2MHlsD858hmRmIHzW+BXsVcB8SvC1leXlp4kNoHvbKI28lwib5raEsHE8S4OZIpFVwO6+YMMSAez0eW9m02B9Ut0tr7biaON96BgcEqf7pxkZ5wRkA5FAFyiiigAooooAKKKDyKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDwP9rFr7TvDWn3/2aPUPDkl0sep2DoPmODskWTBaJuMBlxztBDAlT4B8Gzeaf8WPCWmwX9xNoVzqKX1up3JHKQroJCnQOPmQ4zggjJGDX3P4o0HT/E/h++0bWIfOsLyPy5Uzg+oIPYggEHsQK+UPAfwv8ReDPipp1nf6fcXFlp2qRXdtqSAmAwufKbI7O+6E4PI8psZ5NAH2HRRRQAUUUUAFFFFABRRTIZFlTegcDJHzoVPBx0IB7fj1oAfXzf8AtV+L9U8K+JfB7RLbSaZva7CNErSCeJ0IZXIyuAV4BAbLBgQa+kK+S/242J1PwivYQ3J/No/8KAMH4NeINU8S/tIaHeavJaSbjfXED20IRGSSKVjtP3iu4t8rElTuHBzX2lXxT+yTps2p+O7K/RSw0Z5Fdzk/up4ZQF9sOuR6+Y1fa1ABRRRQAUUUUAFFFFABVHXSw0PUSjFWFtJgjsdpq9WZrwkHh3VN5V3+zzY2rgY2tgYyecYHv6DpQB8MeMvANvf/AA60Xxt4VeW4hFjDHqluzbjFJGixSSLnnG9TuXkgFWHyn5foz9kjH/CutQx/z/x/+kNrXzv8BfH1noE9x4f8RyIui3zl45Zf9XBKy7HD4BPlyJ8rdcYU9N1fT/7PGlQ6Ho/ivSra4+029lrr28UpIJZFtbYLkjgkAAHHcUAer0UUUAFFFFABRRRQAUUUUAFFFFABRRTZHWNGeRgqKCWZjgADuaAK+qaha6XYyXl/MsNvHgFiCSSSFVVA5ZmYhQoBJJAAJIFeU654r1vVrySG2s5wqB0e0ivvssFq23IF3doCwnwVPkQZK/xMQVI5n4oW+p/EvxT4fstM8QXGlaVbltUEVvGVlSFP9VdM4fh5GBESYyFy55yo7qCxj0qJBbKltY2geKMzBHMasVbecsSzbiS27LMznJJoA888LeHvG3geW9utS8R69rsEsSGOS3uJJZLV8sGUWs2VnOQAyqwcLnbkkY9l8H+L7fXVgikltWmniM9rcWzloL6IHBeInkMp4eM/NGTgkjDHDLG0YyQlre2crIm6NQXXerDkcgKSwGcE59OK8z+KfhvWU+y694S1uTS7mxvf7TvxEoSJiCyvdrAudzhXcPgHzV3DBIwwB9JUVgeEddbWbSSO7WFNStgnniFt0UqsMpNEcndE45U89GU8qa36ACiiigAooooAKztf1m00LTXvb5m27lijjQZkmlYhUjQd2ZiAB6nsKuXlzBZWk91dzRwW0CNLLLIwVURRksSegABOa+ePiLpsnxU8UaTZX97fW9jYyf2hPpsS7VtbUqfKM/Qi5mwWVSw8uPdlQ2S4B0uuarqvie5ubKeG0dFYxTR3M5Gl2hVstG+wiS8nXHzqCIUJ2khlJbh/AvwtuvAN5Lq+n3k3iG5EKjdauLa7syxIJtwZJIZmIBOyVQG+XB6qfUrOFLYQWenxW1jDbFrYRI8eETYpKhGHylTjGDtyxPU5p7xyi4c/Z2ReHW3jIaQkuhZCUHIG4FVII5JPQUAa/grxedT8mz1R4vtM24Wt0imNLsrnehRvminTa2+FuRgkEgMF7Ovm74s+Er/UYrLUtC1i8sNS0+4GoXBhc751B2iYQrhXuEUsoJw7hWQ8gCvbfBfiH+2bVoLlka9gjjkM0QxDeQuMx3MXJ+RwCduSVIZcnAZgDpKKKKACiiigAooqhreqwaRYm5uNzszLFDChG+eVjhI0yQNzHgZIHckAEgAzfGPi3TPC0Fst/dWkd7eMyWkNxcLAshVdzsztwkaKNzPg4GAAzMqt434u8Pab8SrYHxJJdMt6rxaTrEi+V5MuWdTFbrz5DoDtMhLy7T93EbHRg8G6X448eDxN4nX+0YtHka1kaSYmzuLouB5MUbf8soMbS2B5sjEkDaQfT762jvrdre7kcJOACFLRk4ctG6sfusCCffigD5V+BHhnX/CvizxrCbGUanpMEcM09jIXuoUZiweCIgx3CMEVijAMy42fNwfqnwZ4pt9ftLfNxayzzQmeCa2Y+TeQhtpliB+YYJUPGctGzBSSCrNzWj6PdW3i7UNW1Ewec2nx2lxcWhVPPEbuy3Aw25CFcqQQfugAlcVx/wAQPAVpY+M9H8d6DeXWkpYzs2pS2ytJGu9Bi4KkhSm5lM+0jchdshgxoA97orJ8O6v/AGrbTrPCbfULOT7PeQYbCSgA5QkDehBDK2BkEZAOQNagAooooAKKKKACuD+JXjKz0iz1HS457RbsWElxcy3Mu2O0hPyKzAfM7MxCpGvLnIyOtbfjPX20axEdmYf7QuEdonuDiC3jQAyXExyMRRggtyM5VQQWBrxXw94G099S1/xzdJeXN1q0E0mlPfyiSWOEQY+0Hod7khgigGNSFGDlQAfG1fUH7LWu3uh+CLyVd0Fg+qtH9ouHBs5JWjiAilIBeBj8oWXBQlirDOzPhPjnwpB4evJW0jV4dc0hZjbfbYoWhKTKPmjkjblG6kHJVgDtJKsF+hf2TreG6+HOqQXcYktptXMUkbIpSZTDGDG+75WVgfun+tAH01pt9FqFuZIhIjK2yWKVdrxPjJVh2OCD6EEEEggm3Xz74W0zU/A/xMv7/T9Xv7vQtZj8230y4El1JcGJDuhEz/MsiRqWiBB8xFKFgV3D3rT7yDUbC2vbN/MtriNZYnwRuVhkHB5HB6GgCxRRRQAUUUUAFFFFABRRRQAV4b8XfilZR+Kv+EO06xu9WNvC9xqccDKkRYKDFBK7f8smYqJAOoZU+YsyV6Z481mfStM8u0nFlJMrl9Qkj3pZxrgNJtPDuSyqiclmYcEBq4B9ANne6Da3NqsFzPFNeQ2QHm/ZobZQ0cJYcySGeaOd2YndIoGSApoAtaJpEumxTnUnhu9R1Bmm1W4LNIl88iAIqqPmaJGOxMYCoB1IbGpBbRzsoVZERnaRyUVQzvlSMJ8y/wB7eTnCqfYsa6QPMyyy7/nklVcvyGD43EZAyQpQfcGM9KcFEQEEC+Qpd5MSQMcnYFKIOr8McB/m69AAKAJAWVyq3Gy8y6yss5LxShgxBYjI/dlflI+6QR3NOaJH3RW0XkmYeZlEWNQuQ+9VYFmYZHHYkHpzTBL5J8tBJBJFst1WLcpVRL23A5+9wwGT0PTIIt32afG5FjCkuYmUON+wMR97eMfNj5eoPU0AeaeKtdn+GF+17DY3t3pcSf2lpItIwpt4JHCz2UxIwLXc0bIVGY2MfDACvfPDGvad4n0Gy1jRbhbiwu4xJG46j1UjswOQR2IIrzrxFZxyQ2DXoRoDfxtIHiIFzHMTbXCOh45SU5HA+UMOnNzR7e+8IeJoNOik+0QyIqCEABr63Xaiyr91RPAu1XA/1kYVh8wCgA9NooooAKKK5rx5e3drpQS1FzFDKcXF1bDdLGmQNkS9TNIzKidhuLZ+UKwB5T8WfiLqs/ja18MeGvDh1a2tUa7mlnZ0gnmRgkYBHEkcczKGXOWkCplSDnoNF0OPSNOhhvLhr28uGa4u75o/mv5pkUu+wABowWC7TgqqoByPmkudDNrf+G9MuYEF/cM+oC2i+a3tUtowkFsvC/u43uEIYjl8tgZwt3zIkZBGlyZZC7F0GTJKVDH5T99lIIccDHTnigBslwZrYwy/NDESxjdQ6neAoYADb5WA7DDHofanPFC8NuIgqcsrshcIkodeY2GWLsr4GCQeg6YNnMsAj2meF23KBEisY5NqgBYySqggnEY5yCcnnFVEEJdL63iDonknycIAm/cOScbT5hwowc9MjkACrK8LeRCGgaZ2YSBWj29JDwoI3jPOSOuVI6DzHWtWvPh1PcahpOmy3ljCjatYxWvyx2YllRbq3Y5+W3O5H2AHY5RsYGR6c+DE6y+fGu5SFlGxmjEmBuXPLrtU+YScgdOTWPr7WoOmXF1HHJbHUIpWV7QESpKxtJlkXkYKTNkkFSAnOcCgD07wvrtj4m8P2Os6TIZLK8jEsZIww9VYdiDkEeorUrg9GttQ0DxMunqDPFIo2PyBcWy4VSzYwJ4sqpyR5keG+ZlIXvKACiiigCO4mitreWe4lSKCJS8kkjBVRQMkkngADvXz74l17xh4r+Jk9nYQXGkeHkRNOtrh4c3IaZGkkuIMH93N5CvjdllUqNqvLg+ueNLfVb2S1gs7eGe03qRE5O2abJI875flhTaH4OXbavAyGoWej/2Z4llEF1IRY6bvMs0g3zy3ExaWRzjGT9mXHACjIUKMAAGjpttb6Zp9tDpsEcen2kfkWwhwUSEcod3cALjHJ988mz5UYeSRlSKJhyCcgAZIZ8k7l3E4PH4jFSIC022KNopVw4ZlAxyQT029OoHODzzTGCySpiSWNSNyFG2qjZIO715I4JPUkUAV1BOG2SIsLiUIQi7X27fLweF6hwDnPB5HFPaCO8hMdxDbzWaq6MZDkSrllYHkhht3ZUjHJ6Zp6zPIiHyt7O2A7EENhTjDAYxkcFhyeOnNR3cY81TN5ruMozxvg7mRVUk474I44H8wDxfUdc1n4X69YQadpEut6RZ3sdistoxkul0yYE21uUOTKFk3rE+7honj435b6D02+ttSsYbyxmWa2mXcjr3H8wexB5B4NcVrdjZX3i/T7e/iW5ivre506R0wp6JcId4wwZdjFSD8pOQQTV/whYaxp2q38V55bQO2+eXZsWeXAxPEASF3KMSJ8oDqWA+ckgHX0UUUAFZ+vavbaJpz3l5vZQyxxxRjdJNIxwkaDuzEgAfngc1oVwuvaRrGteJ1jkka3tVUrHPCcfZYTw7IxXBnl5Tj/Vx7iCGb5gDyTw1L4p8ceKdVHjS0ttO0x7xrua0VjJIbaBjFHbSyZKG2Mu9jxhykzYCkV60xuFnFxNG0byyKzgBUG75QUz97dkM4IC549qqaEn77XZ4VSC3OotYWtsFRgsMESQqqKQBtD+YdvbdWoQxaZkSHy1SQuGfqgAIVmPzdSWDJx6dOQD5U+Pnhefwd4sbVlhm/4RvxANl5CnGyUfMVIyQHHyum45JBzn5gfRP2ZLOTSfA2uw5iumh1mSPzYMNGVEUTLJk/ejbAwQpbkEA5xXqXiLRtN8S6DqWk6zCLm1dWyCUVFGcxyIf7+wHDAZ4wSM1neD/DyeGrE2GmRYDeS0MjSb3CrGsHmurgKNyRjK87QV5OQKANDxFo417RrmyupprBH2+TOZSDbTx5eGUMTkMsm05Xg7cc5xXD+CPijPofjW10XxVp39n2Grw+Z9tiGLddQWRo7hiMAxK0gAZT92TLHKyb69Ejlt5XRYWSMAFY9jCRMAkFWZuoDbWIPPPH3aw7DTW1rW/EcFpDbpqEUdvqEEt1EGjeSVHt54Hx9+JxahXIGMncBuUGgD1iiua8BjUY9HFvfx3K28WBam7P+kKnIMUv95kIK+YCQ67WyxJJ6WgAooooAKKKKACiiigBskaSqBKiuAwYBhnBByD9Qea4jxqWTxnoZ8u4dZNPvU/cTeU2RJbOADkZyFPHoDXc1yvxIsrm48Prd2Nut1Pp8ouTbNH5nnxbWSVAMElzG7lQOrhO2aAOeYy7mdo3gdI5VVvNGEdVJOf4lPOSVJDEgnIAJs3Mro00siJKru53ujKOEABD55bb/EAudwPYgttpVuEt763ZmtbhRIk9rGro8YwolV/uxhkJfbyQrdxwHwCO0Y3RkZGCBmULuURgEhlPLPGW2gDjjjnuARSFjlpYWS3ZMna8buQSFDK3MZJIx2xk47VPIgU3N1OqywbTvZYvMUfOAVyzDIK7flUcHJz2DcCaQsuyQqNwNvskC7nYMgU8bc4w7flxzLEFd4552eYxsI/ml5WRV5V89Jc7vug59R3AM3XX821VVFtulurW3MkcgbiW5jAUJwUHG47s8cDPFemkA4yASOR7V55ptv8A2/4ws1AJ07Rj9qlKtkPcGMLAkgIzvVHkkKjAG+E+leiUAFFFFABRRRQBwfxASSDxN4fvtkT2/wBmvbR/Mcp8zCKZcMOhP2YjkgdeapOv+kxZEKPtLp5ZIRHWLdvxgl15OCMHgn2rqPHel3Gp6Cz6fAlxqdjIt7ZxO+xZJUz+7J6YdS0ZzwA5PauYsr1dRtItRh86eK5c5JkVZR5RXKsOCsy7GDoP7jAc5JAFhSWGQfZkh3sxKeZGo2oIxsYj74QEY3HLAt2wSackirafaxDGIEVg3lTHMsWVXBkI5kJGemQpNaKRIiOvlylJSHxbqVdxlSWUcH7xX5WOePSoIJjNdJOGS4KKZFAzEsJLBSEBUfuyQCTuZgzHGBxQBWnS7jV3jETojSqoMYJDBxlf3nzbiMjaML97OKp+IIXns0sYhaeZLe2kDvCGz813GcBT9xAiZI9RwPTVt0NuDJFC7kMLdg+SY3AUFGbHLfeKsPlyOeCMR+GbZ9c8WWZYN9g0AGQjOP8ASWj2RRuCDl0id2OCAPNj444APTaKKKACiiigArlbySZPHTwAKq3OnRPC7RFxuimZX6EdBcR/metdVXO+NbC4ntLa/sBK9zp8hla3iUFrqAqRLAMkfMynK8j50TJxmgCYFi4VZHCqSzHAOdrcgN0IOCSOvPtgQsWhZ1jbzFVFO4O0oGNzElWPz9jkc5+lR2FzZarpthqNlc295BcqsnnooDSKwIyoPAPHK9sHoRV2ORy5iiUBeXWSEDjryuchs4IxgdDjjFAFWYOzTwr87bgkoUDIXyyQy5P7snou44H609g2YxHNKJHyWBkb5TwuMfc6gZX64zmowlukafMjRHlY5sOAnDYHOCMg/MSTngccUtzfQ6fbT3MzqkMEJllmlIHloAC5ZuzDdnCjn6mgCkyR3XjnRYndjJa21zeBAmwJykK7lzxkPJg99p9K7CuY8EWUrR3muX1u9vfaqUcRyqVljt0BEKSKT8r4LOwAGGkYdsnp6ACiiigAooooA4LQ4rq3v/ElnOxxb6nLcxYQqXikiSUbXzhfnaRcn+6frVopkzKi4UnyxKqiIOWVCvOTj0BQEdeDSeM420nWLfxAXlWxMIs76QEFbUBiYrllOPkQvIrnOAshZvlQ0+8tbbzSxEG+JZEMpBYR7SW2ux58vO3oDgjHIUYAHBpZdwKMiebhfMVp05wPlHDLj5hgjHA9KrqrGXJAeUHzXZUDFcSEMG6K3OSSMMBt9BU02xLVx9m8u1R1VjGgwcMoKcnOQwJDAjt0qC5iZ5wkpR7hiJMBG8xGIILpHxtYkknnODng80ARBjEjRhndE2mTzz5yl9xdsgKpyAM7hnqMZqfwYlzL4v1+4nCmGK0sbJZFXaC6+dKwA7ALPHgHkZ59Kp319a6Vps90yRN5ZxmzXzWd2cqscRZuS5xGFGPn+ldJ4J0eXR9DVb0k6jdO13efvDIBK/JRWPVEG2Nf9lFoA3qKKKACiiigAooooAKKKKACgGiigDzXW9AvPDE8s+jWlze+H5Wmme1tQGudNkkyzvbof9ZE7Elogdyk/ICDsBpV7aaq7zaJfxXHly/OFucyKuxSVKkbo5AAvUDlucV6VWLq/hXQdYvVvNT0ewub5U8tbp4F85V5+USY3AcngHuaAOduIZIGuJZUkhiUef5ZbdtIYF8nI6447AEsRxWZbXV7rEz2vhTfc7yFl1mWVnt7dclw6HgTvkY2Lx0LsM7T1Z8DeGH2faNEs7rY29Rdp54Vs5yN+cH3rpAMDA6UAZvh/RrXQtLisbPzHC5aSaU7pZ5Dy0kjfxOx5J9a0qKKACiiigAooooAK4PxJ4WubLVZtY8OwPcx3TA6hpSzCLzmPHnwMxCxzAckHCyYG4gjdXeUUAeWQa3pU0iW01+ul3DOzNaXpktbgkqvmAhyGboMOM8AkEil1a8tLVvO1C902AbsoZrxI41kIQ4+Zsbmxzg8AE4JJI9I1PTbHVbQ2uqWVte2xOTFcRLIhP0YEVm6V4Q8NaPcLPpPh7R7GdekltZRRMPoVUGgDh7OHUfEEwg8O281nZgPDLqt6kmECsroYEfBmJJ4Y/uxgkmTAB9F0PSbTRNNisbBGWFCWLO5d5HY5Z3Y8s7EkljySSav0UAFFFFABRRRQAUUUUAcjqWgXmlXt3qXhhIZVnLS3GkTtshnlLAmWJ+RDIRuJ4Kuxy2CS9U28Q21tOo1G11bTb1Y1O25sWlVTnIAkiRo2wMjKuSM8iu6ooA4W212wd0h0601O/l5byoNMmRJDtIIMjBIhnIwGYYq7pWi6jqksN74nEUMEbJNb6RC3mRwyKcq8smB5rj5SFACKwBAdlV662igAooooAKKKKACiiigBk8Uc8MkM8aSRSKUdHUFWUjBBB6g1wkuh6p4ZCRaNbSazo6xtDDAZVF3YKRwsbyECWMf3WYMo4BYEKO+ooA80XxJoqtNJPezWEpba8WqWbwNzjd8rquNxw3cHqO9Nh1q2uJBDpNjea3PH+9SO3gYKWHILyvtiVjzklyTu6ELivTaKAOS8N+G7s3cWq+Jmt5NRjJa3tbZiYLTgruyQDLIQSPMZRgEqoUFt3W0UUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAf/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Schematic representation shows histology specimen retrieval by 19-gauge TBNA. The 19-gauge needle is advanced over the 21-gauge needle, which is used as an obturator.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Minai, OA, Dasgupta, A, Mehta, AC. Transbronchial needle aspiration of central and peripheral lesions. In: Bolliger, CT, Mathur, PN (Eds), Progress in Respiratory Research-Interventional Bronchoscopy. Karger, Basel, Switzerland, 1999.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_5_27729=[""].join("\n");
var outline_f27_5_27729=null;
var title_f27_5_27730="Acetylcholine: Pediatric drug information";
var content_f27_5_27730=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"13\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Acetylcholine: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?6/35/6707?source=see_link\">",
"    see \"Acetylcholine: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?16/57/17299?source=see_link\">",
"    see \"Acetylcholine: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F130090\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Miochol&reg;-E",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F130091\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Miochol&reg;-E",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1056228\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Cholinergic Agent, Ophthalmic",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Ophthalmic Agent, Miotic",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1056223\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?6/35/6707?source=see_link\">",
"      see \"Acetylcholine: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Ophthalmic: Adults: Instill 0.5-2 mL of 1% injection (5-20 mg)",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F130075\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Powder for solution, intraocular, as chloride:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miochol&reg;-E: 20 mg (2 mL) [supplied with diluent; reconstitution results in 1:100 solution]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F130061\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1056231\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Ophthalmic: Instill into anterior chamber before or after securing one or more sutures; instillation should be gentle and parallel to the iris face and tangential to the pupil border; in cataract surgery, acetylcholine should be used only after delivery of the lens",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1056226\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Prepare solution immediately before use; do not use solution which is not clear and colorless",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1056230\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Produces complete miosis in cataract surgery, keratoplasty, iridectomy and other anterior segment surgery where rapid miosis is required",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F130123\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Acetylcholine may be confused with acetylcysteine",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F130121\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Bradycardia, flushing, hypotension",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Clouding, corneal edema, decompensation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Dyspnea",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Diaphoresis",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1056234\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to acetylcholine chloride or any component; acute iritis and acute inflammatory disease of the anterior chamber",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1056222\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Systemic effects rarely occur, but can cause problems for patients with acute CHF, bronchial asthma, peptic ulcer, hyperthyroidism, GI spasm, and urinary tract obstruction",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1056221\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Open under aseptic conditions only",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13298676\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F130070\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Acetylcholinesterase Inhibitors: May enhance the adverse/toxic effect of Cholinergic Agonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Beta-Blockers: May enhance the adverse/toxic effect of Cholinergic Agonists. Of particular concern are the potential for cardiac conduction abnormalities and bronchoconstriction. Management: Administer these agents in combination with caution, and monitor for conduction disturbances.  Avoid methacholine with any beta blocker due to the potential for additive bronchoconstriction.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1056220\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Causes contraction of the sphincter muscles of the iris, resulting in miosis and contraction of the ciliary muscle, leading to accommodation",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F1056233\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: Miosis occurs promptly",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration: &sim;10-20 minutes",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13221 Version 31.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-61.234.146.186-DA858D2583-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_5_27730=[""].join("\n");
var outline_f27_5_27730=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130090\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130091\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056228\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056223\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130075\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130061\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056231\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056226\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056230\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130123\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130121\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056234\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056222\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056221\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13298676\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130070\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056220\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056233\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13221\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13221|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?6/35/6707?source=related_link\">",
"      Acetylcholine: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?16/57/17299?source=related_link\">",
"      Acetylcholine: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f27_5_27731="Blepharitis PI";
var content_f27_5_27731=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F83051&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F83051&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Blepharitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 278px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Blepharitis is an inflammation of the eyelids that causes redness and swelling. The skin of the eyelids might also scale or flake, as in this picture.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_5_27731=[""].join("\n");
var outline_f27_5_27731=null;
var title_f27_5_27732="Calcifications in sponge kidney";
var content_f27_5_27732=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F50100%7ENEPH%2F76195&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F50100%7ENEPH%2F76195&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Calcifications in medullary sponge kidney",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 228px; height: 274px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Plain film of the abdomen with tomography in a patient with medullary sponge kidney. There are clusters of calcium stones limited to the upper (not well seen) and lower calyces (arrows) which are the only involved pyramids.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     From Rose, BD, Pathophysiology of Renal Disease, 2d ed, McGraw-Hill, New York, 1987.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Calcifications in medullary sponge kidney",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 342px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    CT scan demonstrates bilateral calcifications at the corticomedullary junction in both kidneys as is typically seen with medullary sponge kidney. There is an absence of interstitial calcifications as may be seen with nephrocalcinosis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jonathan Kruskal, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_5_27732=[""].join("\n");
var outline_f27_5_27732=null;
var title_f27_5_27733="Doppler mitral inflow AR";
var content_f27_5_27733=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F52332&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F52332&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Restrictive mitral inflow Doppler patterns in severe aortic regurgitation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 284px; height: 459px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The hemodynamic mechanism for the restrictive mitral inflow pattern on continuous wave Doppler is the same as for early closure of the mitral valve seen on the M-mode echocardiogram, ie, rapid increase in left ventricular diastolic pressure. The continuous wave Doppler in panel A shows an abnormally short deceleration time (147 ms), measured along the line joining point A and B (arrow), and short pressure half time (PHT) of 43 ms, a result of a rapid and early rise in left ventricular diastolic pressure due to competition for filling of the ventricle between the normal inflow, represented by the mitral inflow signal, and the regurgitant flow represented by diastolic \"noise\"\" in the background. The continuous wave Doppler of mitral inflow in severe aortic regurgitation obtained from transesophageal echocardiogram is seen on panel B.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_5_27733=[""].join("\n");
var outline_f27_5_27733=null;
var title_f27_5_27734="Mesalamine (mesalazine): Pediatric drug information";
var content_f27_5_27734=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Mesalamine (mesalazine): Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?21/44/22215?source=see_link\">",
"    see \"Mesalamine (mesalazine): Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?32/34/33317?source=see_link\">",
"    see \"Mesalamine (mesalazine): Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F193412\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Apriso&trade;;",
"     </li>",
"     <li>",
"      Asacol&reg; HD;",
"     </li>",
"     <li>",
"      Asacol&reg; [DSC];",
"     </li>",
"     <li>",
"      Canasa&reg;;",
"     </li>",
"     <li>",
"      Delzicol&trade;;",
"     </li>",
"     <li>",
"      Lialda&reg;;",
"     </li>",
"     <li>",
"      Pentasa&reg;;",
"     </li>",
"     <li>",
"      Rowasa&reg;;",
"     </li>",
"     <li>",
"      sfRowasa&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F193413\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      5-ASA;",
"     </li>",
"     <li>",
"      Asacol&reg;;",
"     </li>",
"     <li>",
"      Asacol&reg; 800;",
"     </li>",
"     <li>",
"      Mesasal&reg;;",
"     </li>",
"     <li>",
"      Mezavant&reg;;",
"     </li>",
"     <li>",
"      Novo-5 ASA;",
"     </li>",
"     <li>",
"      Novo-5 ASA-ECT;",
"     </li>",
"     <li>",
"      Pentasa&reg;;",
"     </li>",
"     <li>",
"      Salofalk&reg;;",
"     </li>",
"     <li>",
"      Salofalk&reg; 5-ASA",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1060194\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       5-Aminosalicylic Acid Derivative",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Anti-inflammatory Agent",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Anti-inflammatory Agent, Rectal",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1060188\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?21/44/22215?source=see_link\">",
"      see \"Mesalamine (mesalazine): Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Children and Adolescents:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Crohn&rsquo;s disease; treatment (mild to moderate disease); maintenance of remission:",
"     </b>",
"     Limited data available: Oral: 50-100 mg/kg/day divided every 6-12 hours (Fish, 2004); maximum dose: 1",
"     <b>",
"      g",
"     </b>",
"     /dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Ulcerative colitis (including proctitis); treatment (mild to moderate disease); induction and maintenance of remission:",
"     </b>",
"     Limited data available: Usual course of therapy is 3-8 weeks: Oral: 30-60 mg/kg/day divided every 6-12 hours; doses as high as 100 mg/kg/day have been used; maximum daily dose: 4",
"     <b>",
"      g",
"     </b>",
"     /day (Asacol: 4.8",
"     <b>",
"      g",
"     </b>",
"     /day) (Baldassano, 1999; Fish, 2004; Leichtner, 1995; Tomomasa, 2004)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Older Children and Adolescents: Rectal:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Enema (Rowasa): 4",
"     <b>",
"      g",
"     </b>",
"     once daily at bedtime (Baldassano, 1999)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Suppository (Rowasa):  500 mg once daily at bedtime; some have used twice daily (Baldassano, 1999; Heyman, 2010)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Ulcerative colitis:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Treatment: Oral: Usual course of therapy is 3-8 weeks:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Capsule (Pentasa&reg;): 1",
"     <b>",
"      g",
"     </b>",
"     4 times daily;",
"     <b>",
"      Note:",
"     </b>",
"     Apriso&trade; capsules are approved for maintenance of remission only.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Tablet: Initial:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;\">",
"     Asacol&reg;: 800 mg 3 times daily for 6 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;\">",
"     Asacol&reg; HD: 1.6",
"     <b>",
"      g",
"     </b>",
"     3 times daily for 6 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;\">",
"     Lialda&reg;: 2.4-4.8",
"     <b>",
"      g",
"     </b>",
"     once daily for up to 8 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Maintenance of remissions: Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Capsule:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;\">",
"     Apriso&trade;: 1.5",
"     <b>",
"      g",
"     </b>",
"     once daily in the morning",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;\">",
"     Pentasa&reg;: 1",
"     <b>",
"      g",
"     </b>",
"     4 times daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Tablet:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;\">",
"     Asacol&reg;: 1.6",
"     <b>",
"      g",
"     </b>",
"     /day in divided doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;\">",
"     Lialda&reg;: 2.4",
"     <b>",
"      g",
"     </b>",
"     once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     <b>",
"      Note:",
"     </b>",
"     Asacol&reg; HD tablets are approved for treatment only.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Distal ulcerative colitis, proctosigmoiditis, or proctitis (mild to moderate), treatment:",
"     </b>",
"     Retention enema: Adults: 60 mL (4",
"     <b>",
"      g",
"     </b>",
"     ) at bedtime, retained overnight, ~8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Ulcerative proctitis, treatment:",
"     </b>",
"     Rectal suppository (Canasa&reg;): Adults: Insert 1 suppository (1000 mg) in rectum once daily at bedtime; retained for at least 1-3 hours to achieve maximum benefit",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Note:",
"     </b>",
"     Duration of rectal therapy is 3-6 weeks; some patients may require rectal and oral therapy concurrently.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F193391\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, controlled release, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Pentasa&reg;: 250 mg, 500 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, delayed and extended release, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Apriso&trade;: 0.375 g [contains phenylalanine 0.56 mg/capsule]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, delayed release, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Delzicol&trade;: 400 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Suppository, rectal:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Canasa&reg;: 1000 mg (30s, 42s) [contains saturated vegetable fatty esters]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Suspension, rectal: 4 g/60 mL (7s, 28s)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Rowasa&reg;: 4 g/60 mL (7s) [contains potassium metabisulfite, sodium benzoate; packaged  with wipes]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Rowasa&reg;: 4 g/60 mL (28s) [contains potassium metabisulfite, sodium benzoate; packaged with wipes]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     sfRowasa&trade;: 4 g/60 mL (7s, 28s) [contains sodium benzoate]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, delayed release, enteric coated, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Asacol&reg;: 400 mg [DSC]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Asacol&reg; HD: 800 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Lialda&reg;: 1.2 g",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F193376\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Rectal suspension",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1060198\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Oral: Swallow tablets or capsules whole; do not break, chew, or crush",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Capsule:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Apriso&trade;: Administer with or without food; do not administer with antacids. The capsule should be swallowed whole per the manufacturer&rsquo;s labeling; however, opening the capsule and placing the contents (delayed release granules) on food with a pH &lt;6 is not expected to affect the release of mesalamine once ingested (data on file, Salix Pharmaceuticals Medical Information). There is no safety/efficacy information regarding this practice. The contents of the capsules should not be chewed or crushed.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Pentasa&reg;: If a patient is unable to swallow the capsule, some clinicians support opening the capsules and placing the contents (controlled release beads) on yogurt or peanut butter (Crohn&rsquo;s &amp; Colitis Foundation of America). There are currently no published data evaluating the safety/efficacy of this practice. The contents of the capsules should not be chewed or crushed.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Tablet: Do not break outer coating of Asacol&reg;, Asacol&reg; HD, or Lialda&reg; tablets; Lialda&reg;: Should be administered with a meal.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rectal:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Enema: Shake well before use; retain enema for 8 hours or as long as practical",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Suppository: Avoid excessive handling; retain suppository for at least 1-3 hours for maximum benefit",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1060191\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Oral: Store at controlled room temperature.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Apriso&trade;, capsules: 20&deg;C to 25&deg;C (68&deg;F to 77&deg;F); excursions permitted to 15&deg;C to 30&deg;C (59&deg;F to 86&deg;F)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Asacol&reg;, Asacol&reg; HD, tablets: 20&deg;C to 25&deg;C (68&deg;F to 77&deg;F)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Lialda&reg;, tablets: 15&deg;C to 25&deg;C (59&deg;F to 77&deg;F); excursions permitted to 30&deg;C (86&deg;F)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Pentasa&reg;, capsules: Store at 25&deg;C (77&deg;F); excursions permitted to 15&deg;C to 30&deg;C (59&deg;F to 86&deg;F)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rectal:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Enema: Store at 20&deg;C to 25&deg;C (68&deg;F to 77&deg;F). Once foil wrap is open, any bottles remaining after 14 days should be discarded. Contents may darken with time (do not use if dark brown).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Suppository: Store below 25&deg;C (below 77&deg;F). May store under refrigeration; do not freeze. Protect from direct heat, light, and humidity.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1060197\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment and maintenance of remission of ulcerative colitis (UC); treatment of proctosigmoiditis and proctitis (FDA approved in adults; see manufacturer&rsquo;s labeling for specific indications); has also been used for Crohn&rsquo;s disease",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F193463\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Mesalamine may be confused with mecamylamine, megestrol, memantine, metaxalone, methenamine",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Apriso&trade; may be confused with Apri&reg;",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Asacol&reg; may be confused with Ansaid&reg;, Os-Cal&reg;, Visicol&reg;",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Lialda&reg; may be confused with Aldara&reg;",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Pentasa&reg; may be confused with Pancrease&reg;, Pangestyme&reg;",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F193461\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse effects vary depending upon dosage form.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Chest pain, peripheral edema, vasodilation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Anxiety, chills, dizziness, fatigue, fever, headache, insomnia, malaise, migraine, nervousness, pain, paresthesia, vertigo",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Acne vulgaris, alopecia, pruritus, skin rash",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Increased serum triglycerides",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Abdominal distention, abdominal pain, abnormal stools, constipation, diarrhea, dyspepsia, eructation, exacerbation of ulcerative colitis, flatulence, gastroenteritis, gastrointestinal hemorrhage, hemorrhoids, nausea, rectal hemorrhage, rectal pain, tenesmus, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Polyuria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic &amp; oncologic: Hematocrit/hemoglobin decreased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hepatic: Cholestatic hepatitis, increased serum ALT increased, increased serum transaminases",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Infection: Infection",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local: Pain on insertion of enema tip",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Musculoskeletal: Arthralgia, arthritis, back pain, hypertonia, leg/joint pain, myalgia, weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ophthalmic: Conjunctivitis, visual disturbance",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Otic: Ear pain, tinnitus",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Renal: Decreased creatinine clearance, hematuria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Bronchitis, cough, dyspnea, nasopharyngitis, pharyngitis, sinusitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Diaphoresis, flu-like symptoms, intolerance syndrome",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rare but important or life-threatening: Abnormal T waves on ECG, agranulocytosis, albuminuria, anxiety, anemia, angioedema, aplastic anemia, bloody diarrhea, cholestatic jaundice, cholecystitis, drug fever, dysuria, edema, eosinophilia, eosinophilic pneumonitis, erythema nodosum, exacerbation of asthma, facial edema, fibrosing alveolitis, gastrointestinal bleeding, granulocytopenia, Guillain-Barre syndrome, hepatic failure, hepatic necrosis, hepatitis, hepatocellular damage, hepatotoxicity, hypersensitivity pneumonitis, hypertension, hypotension, increased blood urea nitrogen, increased gamma-glutamyl transferase, increased lactate dehydrogenase, increased serum alkaline phosphatase, increased serum bilirubin, increased serum creatinine, interstitial nephritis, interstitial pneumonitis, irregular menses, jaundice, Kawasaki-like syndrome, leukopenia, lupus-like syndrome, lymphadenopathy, minimal change nephrotic syndrome, myocarditis, nephrotoxicity, neutropenia, oligospermia, palpitations, pancreatitis, pancytopenia, paresthesia, perforated peptic ulcer, pericardial effusion, pericarditis, peripheral neuropathy, pharyngolaryngeal pain, pleurisy, pneumonitis, pyoderma gangrenosum, rectal polyp, renal disease, renal failure, skin photosensitivity, systemic lupus erythematosus, tachycardia, tenesmus, thrombocythemia, thrombocytopenia, transverse myelitis, vasodilation",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1060201\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to mesalamine, aminosalicylates, salicylates, or any component including saturated vegetable fatty acid esters (Canasa&trade; suppositories)",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1060187\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with renal impairment or a history of renal disease; renal disease, including minimal change nephropathy, acute/chronic interstitial nephritis, nephrotic syndrome, and rarely renal failure has been reported. Use with caution with other medications converted to mesalamine; evaluate  renal function prior to initiation of mesalamine products and periodically during treatment. Use with caution in patients with hypersensitivity to sulfasalazine, patients with hepatic impairment, and patients with conditions predisposing to the development of myocarditis or pericarditis. Oral products are formulated to slowly release therapeutic quantities of drug; capsules have an ethylcellulose coating or enteric coating in a polymer matrix creating a controlled/extended release throughout the GI tract; tablets are coated with an acrylic-based resin and release drug after reaching the terminal ileum; use delayed release formulations with caution in patients with pyloric stenosis due to prolonged gastric retention; Asacol&reg; HD 800 mg tablet has not been shown to be bioequivalent to two Asacol&reg; 400 mg tablets. Apriso&trade; contains phenylalanine which must be avoided in patients with phenylketonuria.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1060186\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Myocarditis and pericarditis should be considered in patients with chest pain; this cardiac hypersensitivity reaction has occurred rarely with mesalamine-containing products; pancreatitis should be considered in any patient with new abdominal complaints; has been implicated in the production of an acute intolerance syndrome or exacerbation of colitis (&lt;3%), prompt discontinuation is required if this develops.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Some products may contain sulfites which may cause allergic reactions in susceptible individuals. Rowasa&reg; and sfRowasa&trade; suspensions contain sodium benzoate; benzoic acid (benzoate) is a metabolite of benzyl alcohol; large amounts of benzyl alcohol (&ge;99 mg/kg/day) have been associated with a potentially fatal toxicity (&ldquo;gasping syndrome&rdquo;) in neonates;",
"     <i>",
"      in vitro",
"     </i>",
"     and animal studies have shown that benzoate displaces bilirubin from protein binding sites; avoid use of Rowasa&reg; and sfRowasa&trade; suspensions in neonates.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299675\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F193385\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antacids: May diminish the therapeutic effect of Mesalamine. Antacid-mediated increases in gastrointestinal pH may cause the premature release of mesalamine from specific sustained-release mesalamine products. Management: Avoid concurrent administration of antacids with sustained-release mesalamine products.  Separating antacid and mesalamine administration, and/or using lower antacid doses may be adequate means of avoiding this interaction.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cardiac Glycosides: 5-ASA Derivatives may decrease the serum concentration of Cardiac Glycosides.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     H2-Antagonists: May diminish the therapeutic effect of Mesalamine. Histamine H2-Antagonist-mediated increases in gastrointestinal pH may cause the premature release of mesalamine from specific sustained-release mesalamine products. Management: Consider avoiding concurrent administration of high-dose histamine H2-receptor antagonists with sustained-release mesalamine products.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Heparin: 5-ASA Derivatives may enhance the adverse/toxic effect of Heparin. Specifically, the risk for bleeding/bruising may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Heparin (Low Molecular Weight): 5-ASA Derivatives may enhance the adverse/toxic effect of Heparin (Low Molecular Weight). Specifically, the risk for bleeding/bruising may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Proton Pump Inhibitors: May diminish the therapeutic effect of Mesalamine. Proton pump inhibitor-mediated increases in gastrointestinal pH may cause the premature release of mesalamine from specific sustained-release mesalamine products. Management: Consider avoiding concurrent administration of high-dose proton pump inhibitors (PPIs) with sustained-release mesalamine products.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thiopurine Analogs: 5-ASA Derivatives may decrease the metabolism of Thiopurine Analogs.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Varicella Virus-Containing Vaccines: 5-ASA Derivatives may enhance the adverse/toxic effect of Varicella Virus-Containing Vaccines. The primary concern is the potential development of Reye's Syndrome, a condition that has been associated with the use of salicylates in children with varicella infections.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F193387\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B/C (product specific)  (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F5304690\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal reproduction studies with mesalamine have not demonstrated teratogenicity or fertility impairment. Dibutyl phthalate (DBP) is an inactive ingredient in the enteric coating of Asacol&reg; and Asacol&reg; HD; adverse effects in male rats were noted at doses greater than the recommended human dose. Mesalamine is known to cross the placenta. An increased rate of congenital malformations has not been observed in human studies. Preterm birth, still birth and decreased birth weight have been observed; however, these events may also be due to maternal disease.",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1060185\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Mesalamine (5-aminosalicylic acid) is the active component of sulfasalazine; the specific mechanism of action of mesalamine is unknown; however, it is thought that it modulates local chemical mediators of the inflammatory response, especially leukotrienes; action appears topical rather than systemic",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1060200\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oral: Capsule: ~20% to 40%; Tablet: 20% to 28%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Rectal: Variable and dependent upon retention time, underlying GI disease, and colonic pH",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: Mesalamine (5-ASA): ~43%; N-acetyl-5-ASA: ~78%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic and via GI tract to N-acetyl-5-aminosalicylic acid",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5-ASA: 0.5-15 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     N-acetyl-5-ASA: 2-15 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak serum concentration:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oral: Capsule: Apriso&trade;: ~4 hours; Pentasa&reg;: 3 hours; Tablet: Asacol&reg;: 4-12 hours; Asacol&reg; HD: 10-16 hours; Lialda&reg;: 9-12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Rectal: 4-7 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: Most metabolites are excreted in urine (&lt;8% as unchanged drug); feces  (&lt;2%)",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1060193\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?32/34/33317?source=see_link\">",
"      see \"Mesalamine (mesalazine): Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Symptomatic exacerbation of colitis/IBD may occur when beginning treatment; this should resolve in a short time. May cause fatigue, dizziness, or insomnia (avoid driving or engaging in tasks requiring alertness until response to drug is known); mild gastrointestinal disturbance (eg, gas, constipation, nausea); back, joint, or muscle pain; or flu-like syndrome or cough (consult prescriber if persistent). Report immediately severe new abdominal pain or diarrhea; chest pain or rapid heartbeat; unusual pain (back, joint, muscle, or chest) or swelling of extremities; rash; ringing in ears or change in hearing; or other persistent adverse effects or lack of improvement. May rarely cause photosensitivity reactions (eg, exposure to sunlight may cause severe sunburn, skin rash, redness, or itching); avoid direct exposure to sunlight.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Oral: Swallow tablets or capsules whole; do not break, crush, or chew. Notify prescriber if unable to swallow the medication. Notify prescriber if whole or partial tablets are repeatedly found in stool; should be taken with a meal.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Enema: May cause staining of clothing and undergarments. Do not use if solution is dark brown.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Suppository: Do not refrigerate; store at room temperature. Remove foil wrapper; avoid excessive handling. May cause staining of clothing and undergarments.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Baldassano RN and Piccoli DA, \"Inflammatory Bowel Disease in Pediatric and Adolescent Patients,\"",
"      <i>",
"       Gastroenterol Clin North Am",
"      </i>",
"      , 1999, 28(2):445-58.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?27/5/27734/abstract-text/10372276/pubmed\" id=\"10372276\" target=\"_blank\">",
"        10372276",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Fish D and Kugathasan S, \"Inflammatory Bowel Disease,\"",
"      <i>",
"       Adolesc Med Clin",
"      </i>",
"      , 2004, 15(1):67-90.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?27/5/27734/abstract-text/15272257/pubmed\" id=\"15272257\" target=\"_blank\">",
"        15272257",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Grand RJ, Ramakrishna J, and Calenda KA, &ldquo;Inflammatory Bowel Disease in the Pediatric Patient,&rdquo;",
"      <i>",
"       Gastroenterol Clin North Am",
"      </i>",
"      , 1995, 24(3):613-32.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?27/5/27734/abstract-text/8809239/pubmed\" id=\"8809239\" target=\"_blank\">",
"        8809239",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Leichtner AM, \"Aminosalicylates for the Treatment of Inflammatory Bowel Disease,\"",
"      <i>",
"       J Pediatr Gastroenterol Nutr",
"      </i>",
"      , 1995, 21(3):245-52.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?27/5/27734/abstract-text/8523207/pubmed\" id=\"8523207\" target=\"_blank\">",
"        8523207",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Tomomasa T, Kobayashi A, Ushijima K, et al, \"Guidelines for Treatment of Ulcerative Colitis in Children,\"",
"      <i>",
"       Pediatr Int",
"      </i>",
"      , 2004, 46(4):494-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?27/5/27734/abstract-text/15310325/pubmed\" id=\"15310325\" target=\"_blank\">",
"        15310325",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12584 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-125.39.66.147-9C35C7E240-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_5_27734=[""].join("\n");
var outline_f27_5_27734=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193412\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193413\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060194\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060188\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193391\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193376\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060198\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060191\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060197\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193463\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193461\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060201\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060187\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060186\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299675\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193385\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193387\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5304690\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060185\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060200\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060193\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12584\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12584|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?21/44/22215?source=related_link\">",
"      Mesalamine (mesalazine): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?32/34/33317?source=related_link\">",
"      Mesalamine (mesalazine): Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f27_5_27735="Vascular rings";
var content_f27_5_27735=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Vascular rings",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/5/27735/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/5/27735/contributors\">",
"     Amy L Juraszek, MD, FAAP, FACC",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/5/27735/contributors\">",
"     David R Fulton, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/5/27735/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/5/27735/contributors\">",
"     John K Triedman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/5/27735/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/5/27735/contributors\">",
"     Melanie S Kim, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?27/5/27735/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 10, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vascular rings are congenital anomalies of the aortic arch that result in compression of the tracheobronchial tree",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    esophagus, leading to respiratory and gastrointestinal symptoms. They can be classified as either complete, when both the trachea and esophagus are fully encircled by a vascular anomaly, or incomplete without full encirclement of both structures.",
"   </p>",
"   <p>",
"    The different forms of vascular rings and slings, their clinical manifestations, diagnosis, and treatment are discussed here.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ANATOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Beginning at the fourth week of embryogenesis, the aortic arch develops from six symmetrical paired aortic arch vessels and the paired dorsal aortae. During the next few weeks of embryogenesis, remodeling and rearrangement of these structures result in the formation of the normal left aortic arch [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27735/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The right and left third arches persist as the right and left carotid arteries",
"     </li>",
"     <li>",
"      The left fourth arch persists as the transverse arch",
"     </li>",
"     <li>",
"      The left sixth arch persists as the ductus arteriosus",
"     </li>",
"     <li>",
"      The right and left subclavian arteries arise from the seventh intersegmental arteries along the posterior body wall and are remodeled into the final aortic arch",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Abnormal development of this complex vascular remodeling process results in malformations, which lead to the different forms of vascular rings.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Complete vascular rings &mdash; Aortic arch anomalies, which completely encircle both the trachea and esophagus, include the following:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Double aortic arch",
"     </li>",
"     <li>",
"      Right aortic arch with an aberrant left subclavian artery and left ductus arteriosus or ligamentum",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Incomplete vascular rings &mdash; Aortic arch anomalies, which do not fully encircle both the trachea and esophagus, include the following:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Pulmonary artery sling",
"     </li>",
"     <li>",
"      Innominate artery compression",
"     </li>",
"     <li>",
"      Aberrant right subclavian artery",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Left aortic arch",
"    </span>",
"    &nbsp;&mdash;&nbsp;The normal left aortic arch crosses over the left mainstem bronchus, and typically descends along the left side of the spine. The aortic arch gives rise to three vessels:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Innominate (or brachiocephalic) artery, which bifurcates into the right common carotid artery and the right subclavian artery",
"     </li>",
"     <li>",
"      Left common carotid artery",
"     </li>",
"     <li>",
"      Left subclavian artery",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The ductus arteriosus arises from the undersurface of the arch opposite the origin of the left subclavian artery. Following birth, it involutes into the ligamentum arteriosum.",
"   </p>",
"   <p>",
"    There are a few anatomic variants of aortic arch branching that are not associated with any symptoms and include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A common brachiocephalic trunk trifurcates into the right subclavian, the right common carotid, and the left common carotid arteries.",
"     </li>",
"     <li>",
"      Four vessels can arise directly from the arch with two different patterns:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      In addition to the usual three vessels, a vertebral artery can arise from the arch between the left common carotid and the left subclavian.",
"     </li>",
"     <li>",
"      An aberrant right subclavian artery can arise posteriorly to the left subclavian artery; if the ductus arteriosus is left-sided, then there is not compression of the trachea or esophagus [",
"      <a class=\"abstract\" href=\"UTD.htm?27/5/27735/abstract/2\">",
"       2",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Right aortic arch",
"    </span>",
"    &nbsp;&mdash;&nbsp;A right aortic arch crosses the right mainstem bronchus and descends along the right side of the spine. Rarely, the descending portion of a right aortic arch may cross the midline and descend along the left side of the spine, which is termed a circumflex aortic arch.",
"   </p>",
"   <p>",
"    Right aortic arches with mirror-image branching do not cause compression upon the trachea or esophagus, because the ductus arteriosus either arises from the undersurface of the arch opposite the right subclavian artery (true \"mirror-image\") or from the bifurcation of the innominate artery, and then takes an anterior course in the mediastinum to the pulmonary artery without compromising the trachea or esophagus.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Complete vascular rings",
"    </span>",
"    &nbsp;&mdash;&nbsp;The complete vascular rings, which completely encircle the trachea and esophagus, are more often associated with significant symptoms than incomplete forms [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27735/abstract/2-4\">",
"     2-4",
"    </a>",
"    ]. As a result, the majority of cases in retrospective reviews are due to complete rather than incomplete vascular rings [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27735/abstract/2-4\">",
"     2-4",
"    </a>",
"    ]. Almost all of the reported cases (90 percent) in these case series are due to either a double aortic arch, or a right aortic arch and an aberrant left subclavian artery and left-sided ductus arteriosus [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27735/abstract/2-6\">",
"     2-6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Double aortic arch",
"    </span>",
"    &nbsp;&mdash;&nbsp;In double aortic arch, the paired aortic arch arteries fail to remodel appropriately, which results in two aortic arches both connecting the ascending and descending aortas. The ascending aorta bifurcates anteriorly to the trachea and esophagus, with one arch coursing to the left of the trachea and esophagus and the other to the right (",
"    <a class=\"graphic graphic_figure graphicRef73066 \" href=\"UTD.htm?26/47/27381\">",
"     figure 1",
"    </a>",
"    ). The arches rejoin into a single descending aorta posterior to the trachea and esophagus, thereby completely encircling the two structures.",
"   </p>",
"   <p>",
"    The right common carotid and right subclavian arteries arise from the rightward arch, and the left common carotid and left subclavian arteries arise from the leftward arch. The ductus arteriosus may arise from either arch or both arches, but a single left-sided ductus is most commonly seen. There may be atretic segments of the arches, which must be identified prior to surgical repair. Typically, the right arch is larger and more cephalad in its course, and the left arch is smaller and more caudally located.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     R aortic arch with aberrant L subclavian artery and L ductus arteriosus/ligamentum",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a right aortic arch with an aberrant left subclavian artery and left-sided ductus arteriosus or ligamentum, the ductus arteriosus arises posteriorly in the mediastinum, courses anteriorly to the left of the trachea and esophagus, and connects to the pulmonary artery (",
"    <a class=\"graphic graphic_figure graphicRef61348 \" href=\"UTD.htm?31/57/32660\">",
"     figure 2",
"    </a>",
"    ). The trachea and esophagus are completely encircled by the right-sided aortic arch, the base of the left subclavian artery and ductus arteriosus resulting in a complete vascular ring.",
"   </p>",
"   <p>",
"    In many cases, the left subclavian artery and ductus arteriosus arise from the diverticulum of Kommerell, a vascular structure with a similar diameter to the descending aorta, and a larger diameter than the left subclavian artery. This vascular structure may contribute to the posterior compression of the esophagus and trachea, and may produce symptoms even after surgical division of the vascular ring, if it is not resected at the time of surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27735/abstract/7,8\">",
"     7,8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Other causes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other rare causes of complete vascular rings include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Left aortic arch with a right descending aorta and right ductus arteriosus",
"     </li>",
"     <li>",
"      Right aortic arch with a left descending aorta and left ductus arteriosus",
"     </li>",
"     <li>",
"      Left aortic arch with an aberrant right subclavian and a right ductus arteriosus",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Incomplete vascular rings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although incomplete vascular rings can compress the tracheal bronchial tree",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    esophagus leading to respiratory or gastrointestinal symptoms, they are often asymptomatic and are found incidentally.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pulmonary artery sling &mdash; Pulmonary artery sling is a rare vascular anomaly in which the left pulmonary artery arises from the right pulmonary artery (late bifurcation of the branch pulmonary arteries). The aberrant left pulmonary artery passes between the trachea and the esophagus prior to entering the left lung, leading to compression of the trachea",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      esophagus. Pulmonary artery sling is frequently associated with complete tracheal cartilaginous rings, therefore these patients should have a careful airway assessment.",
"     </li>",
"     <li>",
"      Innominate artery compression syndrome &mdash; This syndrome occurs when the innominate (or brachiocephalic) artery originates later along the course of the transverse arch, resulting in a more leftward takeoff than normal. Tracheal compression results when the aberrant innominate artery passes anterior to the trachea.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     INCIDENCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Aortic arch anomalies are rare malformations accounting for approximately 1 to 3 percent of congenital heart disease [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27735/abstract/9\">",
"     9",
"    </a>",
"    ]. Males have a 1.4 to 2 times greater risk of having a vascular ring to females [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27735/abstract/2-4\">",
"     2-4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Published reports are primarily observational case series of patients with vascular rings treated by surgical repair at tertiary centers [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27735/abstract/2-6\">",
"     2-6",
"    </a>",
"    ]. As a result, complete vascular rings, which are more commonly associated with significant symptoms, represent the majority of cases, as demonstrated by the following [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27735/abstract/2-4\">",
"     2-4",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a retrospective review from 1991 to 2002 of 64 patients who underwent surgical repair in a tertiary center in Boston, two-thirds of the patients had complete vascular rings [",
"      <a class=\"abstract\" href=\"UTD.htm?27/5/27735/abstract/2\">",
"       2",
"      </a>",
"      ]. The most common form of vascular ring was right aortic arch and an aberrant left subclavian artery and left-sided ductus arteriosus with 34 cases, followed by double aortic arch (27 cases), and three cases of an aberrant left subclavian.",
"     </li>",
"     <li>",
"      In a second review from 1993 to 2003 of 38 patients from a tertiary center in Omaha, Nebraska, almost all the patients had complete vascular rings, including 24 with right aortic arch with an aberrant left subclavian artery and left ductus arteriosus or ligamentum and 12 with double aortic arch [",
"      <a class=\"abstract\" href=\"UTD.htm?27/5/27735/abstract/3\">",
"       3",
"      </a>",
"      ]. There was a single case of an aberrant right subclavian artery and a single case of an innominate artery compression syndrome.",
"     </li>",
"     <li>",
"      In a third review from 1974 to 2000 of 82 patients from a tertiary center in Kansas, diagnoses included 31 cases of double aortic arch, 22 cases of right aortic arch with an aberrant left subclavian artery and left ductus arteriosus or ligamentum, 20 cases of innominate artery compression syndrome, 6 cases of aberrant subclavian arteries, and 3 cases of pulmonary slings [",
"      <a class=\"abstract\" href=\"UTD.htm?27/5/27735/abstract/4\">",
"       4",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical presentation of vascular rings varies from critical airway obstruction in neonates to incidental diagnosis in otherwise asymptomatic adults. The literature is based upon observational case series of the most severely affected patients that require surgical repair [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27735/abstract/2-6\">",
"     2-6",
"    </a>",
"    ]. In these retrospective reviews, the majority of patients present by 1 year of age with significant tracheal and esophageal symptoms.",
"   </p>",
"   <p>",
"    The most commonly reported presenting symptoms are due to tracheal compression. Stridor is the most frequent finding followed by recurrent respiratory infections, respiratory distress, wheezing, and cough [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27735/abstract/2-6\">",
"     2-6",
"    </a>",
"    ]. Esophageal complaints are commonly elicited during the history and include dysphagia, feeding difficulty, and vomiting.",
"   </p>",
"   <p>",
"    Patients with incomplete vascular rings may be asymptomatic",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Associated anomalies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Associated anomalies are common in children with vascular rings with a reported prevalence of up to 50 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27735/abstract/3,8,10\">",
"     3,8,10",
"    </a>",
"    ]. The majority of these anomalies will be a second cardiac lesion such as ventricular septal defect, tetralogy of Fallot, coarctations of the aorta, or a patent ductus arteriosus [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27735/abstract/3,8\">",
"     3,8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Noncardiac anomalies include tracheoesophageal fistula, cleft lip-palate, subglottic stenosis, and genetic or malformation syndromes (eg, DiGeorge syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27735/abstract/11\">",
"     11",
"    </a>",
"    ], Down syndrome, or CHARGE syndrome). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/37/32343?source=see_link\">",
"     \"DiGeorge syndrome: Epidemiology and pathogenesis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/15/26874?source=see_link\">",
"     \"Clinical features and diagnosis of Down syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Physical findings will vary greatly based upon the degree of tracheal and esophageal compression by the surrounding vessels.",
"   </p>",
"   <p>",
"    Parents usually describe \"noisy breathing\" that results from the associated tracheobronchomalacia. These infants are noted to have stridor and rhonchi that worsen with agitation.",
"   </p>",
"   <p>",
"    Severely symptomatic infants display signs of respiratory effort",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    distress that include nasal flaring, intercostal retractions, tachypnea, or intermittent cyanosis. Some infants will lie with their back arched and neck extended to minimize tracheal compression. Wheezing",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    coarse upper airway sounds may be heard during auscultation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinician must have a high degree of suspicion to diagnosis a vascular ring because vascular rings are relatively uncommon causes of respiratory distress in children compared to other conditions. (See",
"    <a class=\"local\" href=\"#H17\">",
"     'Differential diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    A chest radiograph including posterior, anterior, and lateral views should be the initial study to identify the underlying cause of respiratory symptoms. Magnified high KV airway films may be useful to identify a significantly compressed trachea. Anterior bowing of the trachea in the lateral view is suggestive of a vascular ring.",
"   </p>",
"   <p>",
"    Following the chest radiography, several diagnostic procedures are available in the evaluation of a child with a suspected vascular ring. However, the choice and sequence of these tests have not been rigorously assessed [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27735/abstract/3\">",
"     3",
"    </a>",
"    ]. As a result, the diagnostic approach is dependent upon the local expertise, experience, medical costs, and available technology of the medical center [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27735/abstract/3,12\">",
"     3,12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The different diagnostic procedures including their advantages and limitations are as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"       Barium",
"      </a>",
"      contrast esophagogram &mdash; Barium contrast esophagogram (barium swallow) had been the recommended screening test to detect vascular rings prior to the increased availability of computed tomographic (CT) and magnetic resonance (MR) angiography. It demonstrates a posterior indentation of the esophagus in all vascular rings except for the pulmonary sling, in which an anterior indentation and increased space between the trachea and esophagus are found. However, the precise anatomy of the vascular anomaly or the presence of another cardiac anomaly cannot be determined by esophagogram.",
"     </li>",
"     <li>",
"      Bronchoscopy &mdash; Bronchoscopy is often used to determine the cause of upper airway symptoms. In children with vascular rings, it will indicate the level of compression but be unable to determine the anatomy of the vascular anomaly or the presence of another cardiac anomaly. Bronchoscopy is an invasive procedure and may worsen the child's symptoms because of tracheal edema.",
"      <br/>",
"      <br/>",
"      The use of bronchoscopy is dependent upon the institution, with some centers using this study routinely preoperatively or intraoperatively to ensure proper endotracheal tube positioning in a controlled manner rather than blind intubation [",
"      <a class=\"abstract\" href=\"UTD.htm?27/5/27735/abstract/8\">",
"       8",
"      </a>",
"      ]. Other centers reserve bronchoscopy for specific indications, such as determining the cause of upper airway symptoms [",
"      <a class=\"abstract\" href=\"UTD.htm?27/5/27735/abstract/3\">",
"       3",
"      </a>",
"      ]. In addition, some patients based upon presenting symptoms may have first been evaluated by an otorhinolaryngologist or pulmonologist, who may perform bronchoscopy as part of the initial evaluation. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Differential diagnosis'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      CT or MR angiography &mdash; With the increased availability of CT and MR angiography (MRA), these two modalities are increasingly used in the evaluation of children with suspected vascular rings. They provide three-dimensional visualization of the vascular anatomy, which accurately makes the diagnosis of a vascular ring and gives detailed anatomic information needed to plan the operative procedure.",
"      <br/>",
"      <br/>",
"      There are advantages and disadvantages of each modality. CT requires an exposure to ionizing radiation, but with modern multidetector scanners, a study may be completed in seconds, thus limiting the need for patient sedation. MR does not have any exposure to radiation, but requires conscious sedation or anesthesia, especially for the infant and young child, because image acquisition takes longer (30 to 60 minutes).",
"      <br/>",
"      <br/>",
"      In some centers, the use of CT and MRI angiography are limited because of the increased cost and potential complications of these procedures [",
"      <a class=\"abstract\" href=\"UTD.htm?27/5/27735/abstract/4\">",
"       4",
"      </a>",
"      ]. In contrast, other centers use CT and MRI to assess all patients with vascular rings [",
"      <a class=\"abstract\" href=\"UTD.htm?27/5/27735/abstract/2,3,8\">",
"       2,3,8",
"      </a>",
"      ]. The choice of imaging modalities will depend on institutional expertise and preference [",
"      <a class=\"abstract\" href=\"UTD.htm?27/5/27735/abstract/2-4,8,12,13\">",
"       2-4,8,12,13",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Echocardiography &mdash; Echocardiography is often used as a complementary procedure to identify the presence of another cardiac lesion [",
"      <a class=\"abstract\" href=\"UTD.htm?27/5/27735/abstract/2-6,8\">",
"       2-6,8",
"      </a>",
"      ]. With experienced personnel, echocardiography can clarify vascular anatomy and visualize vascular rings [",
"      <a class=\"abstract\" href=\"UTD.htm?27/5/27735/abstract/14\">",
"       14",
"      </a>",
"      ]. However, it is not as reliable in defining arch anatomy because echocardiography cannot detect atretic segments without patent lumens and it poorly visualizes the airway. In addition, in some patients, the examination is limited because of diminished acoustic windows.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Our approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;In our practice, we initially obtain a chest radiograph to evaluate pulmonary pathology and the sidedness of the aortic arch. This is followed by echocardiography to identify the arch branching pattern and intracardiac anatomy, and",
"    <span class=\"nowrap\">",
"     MRI/MRA",
"    </span>",
"    to define the vascular anatomy.",
"   </p>",
"   <p>",
"    We do not routinely perform",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"     barium",
"    </a>",
"    esophagograms as they do not generally add any additional information to that obtained by",
"    <span class=\"nowrap\">",
"     MRI/MRA.",
"    </span>",
"    As noted above, we prefer MRA to CT angiography (CTA) because of the increased radiation exposure of CT in young patients, although conscious sedation may be needed. Other institutions with more experience with CT, or less expertise or availability in pediatric sedation, may prefer CT imaging.",
"   </p>",
"   <p>",
"    We do not routinely perform bronchoscopy but reserve this procedure for patients who exhibit",
"    <span class=\"nowrap\">",
"     signs/symptoms",
"    </span>",
"    of airway obstruction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Antenatal diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Observational studies have reported that fetal sonography can diagnose vascular rings [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27735/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. In one study from 2002 to 2007, 19 fetuses were diagnosed with isolated vascular rings at a mean gestational age of 23 weeks using \"3-vessel and trachea\" \"supra-aortic branch\" views [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27735/abstract/17\">",
"     17",
"    </a>",
"    ]. There were eight cases of left aortic arch with aberrant right subclavian artery, five cases of double aortic arch, and six cases of right aortic arch with aberrant left subclavian artery. Chromosomal abnormalities were detected in three fetuses (two with trisomy 21 and one with 22q11 microdeletion), and the pregnancy was terminated in all three cases.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of vascular rings is broad because there are many conditions that can present with similar respiratory and esophageal complaints. However, prolonged and recurrent respiratory difficulties and dysphagia should alert the clinician to consider vascular rings in the differential diagnosis.",
"   </p>",
"   <p>",
"    The initial diagnostic evaluation of chest radiography and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"     barium",
"    </a>",
"    contrast esophagogram will differentiate vascular rings from many conditions with similar presentations including the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Tracheoesophageal fistula",
"     </li>",
"     <li>",
"      Gastroesophageal reflux",
"     </li>",
"     <li>",
"      Recurrent pneumonia",
"     </li>",
"     <li>",
"      Asthma",
"     </li>",
"     <li>",
"      Esophageal motility disorders",
"     </li>",
"     <li>",
"      Other causes of external compression of either the trachea or esophagus such as mediastinal tumors",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Direct visualization with a flexible or rigid laryngoscopy",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    bronchoscopy will differentiate the following disorders of the airway that present with stridor from vascular rings [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27735/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Laryngomalacia",
"     </li>",
"     <li>",
"      Laryngeal webs or cysts",
"     </li>",
"     <li>",
"      Subglottic stenosis",
"     </li>",
"     <li>",
"      Tracheomalacia",
"     </li>",
"     <li>",
"      Vocal cord paralysis or polyps",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The only definitive treatment is surgery, which was first described by Gross in 1945 [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27735/abstract/18\">",
"     18",
"    </a>",
"    ]. Clinical outcome is excellent following surgical correction with resolution of symptoms in the majority of patients with low risk of morbidity and even rarer risk of death [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27735/abstract/2-4,8\">",
"     2-4,8",
"    </a>",
"    ]. As a result of the excellent outcome, surgical intervention is indicated in symptomatic patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Complete vascular rings",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with complete vascular rings, surgical division releases the complete circle formed by the vascular and ligamentous structures around the trachea and esophagus.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Double aortic arch &mdash; The preoperative imaging studies are used to identify atretic or stenotic segments of the arches, which become the selected sites for surgical divisions (",
"      <a class=\"graphic graphic_figure graphicRef73066 \" href=\"UTD.htm?26/47/27381\">",
"       figure 1",
"      </a>",
"      ). The division point is made in the smaller of the two arches, which is usually the left [",
"      <a class=\"abstract\" href=\"UTD.htm?27/5/27735/abstract/8\">",
"       8",
"      </a>",
"      ]. The approach is generally made via left thoracotomy, which allows excellent exposure of the division point. The ductus or ligamentum also must be divided to release the ring. In cases with a right-sided ductus, a right thoracotomy is indicated [",
"      <a class=\"abstract\" href=\"UTD.htm?27/5/27735/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Right aortic arch with an aberrant left subclavian artery and left ductus &mdash; Surgical approach is via a left thoracotomy and the ductus or ligamentum is identified and divided [",
"      <a class=\"abstract\" href=\"UTD.htm?27/5/27735/abstract/5\">",
"       5",
"      </a>",
"      ]. If a prominent diverticulum of Kommerell is present, some centers advocate performing a resection of the diverticulum and reimplanting the aberrant left subclavian artery into the left common carotid artery to remove any potential substrate for recurrent symptoms of tracheal or esophageal compression [",
"      <a class=\"abstract\" href=\"UTD.htm?27/5/27735/abstract/8\">",
"       8",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Incomplete vascular rings",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pulmonary artery sling &mdash; In patients with extrinsic tracheal compression without fixed stenosis, the left pulmonary artery is relocated from its right-sided origin to the main pulmonary artery, anterior to the trachea. In cases with complete tracheal rings, the affected tracheal segment must be resected or a tracheoplasty procedure is required. These procedures require that the patient is placed upon cardiopulmonary bypass support [",
"      <a class=\"abstract\" href=\"UTD.htm?27/5/27735/abstract/19,20\">",
"       19,20",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Innominate artery compression syndrome &mdash; In patients with severe symptoms (apnea, severe stridor, or recurrent infections), surgical correction is recommended. The current approach is an aortopexy procedure, which lifts both the aortic arch and innominate artery anteriorly and to the left by suturing them to the posterior aspect of the sternum [",
"      <a class=\"abstract\" href=\"UTD.htm?27/5/27735/abstract/21\">",
"       21",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Alternative surgical techniques",
"    </span>",
"    &nbsp;&mdash;&nbsp;Recently, video-assisted thoracoscopic surgical (VATS) techniques [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27735/abstract/22,23\">",
"     22,23",
"    </a>",
"    ] and endoscopic robotic assisted techniques [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27735/abstract/24\">",
"     24",
"    </a>",
"    ] have been adapted to vascular ring ligation and division. Because an open thoracotomy is not required, the length of recovery may be shortened [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27735/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. A single center retrospective study compared short term results of VATS and open thoracotomy vascular ring division and found similar outcomes with respect to operative time, intensive care unit length of stay and hospital length of stay between the two groups [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27735/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patient selection and preoperative imaging are critical for application of these techniques, as ligamentous structures are much safer to divide under thoracoscopic conditions than systemic arterial vessels with patent lumens. Patient size also may limit the use of endoscopic techniques, with a young infant being too small to undergo this procedure.",
"   </p>",
"   <p>",
"    These alternative techniques are still in the development phase and are not widely available. It is unclear whether they will be as cost effective as the open thoracotomy approach.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Pharmacologic treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no role for pharmacologic treatment for vascular rings. Although some patients with vascular rings may have received medical therapy including steroids or bronchodilators for respiratory symptoms (stridor or wheezing), there is generally no demonstrated improvement, as the symptoms are caused by mechanical compression.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     OUTCOME",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinical outcome in patients who undergo surgical correction for vascular rings is generally excellent. In the current era, operative mortality for vascular ring division is virtually zero; the few deaths reported in patients from recent series have had other medical issues including associated congenital heart malformation or significant pulmonary disease [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27735/abstract/2-6,8\">",
"     2-6,8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In children with vascular rings, symptoms of tracheal or esophageal compression typically improve following surgical repair as illustrated by the following two case series.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one report of 82 children, 57 patients (70 percent) were free of symptoms within one year of the operation. In seven patients, respiratory symptoms due to tracheomalacia persisted four to six months after surgery [",
"      <a class=\"abstract\" href=\"UTD.htm?27/5/27735/abstract/4\">",
"       4",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In another series of 38 patients, all but two patients had respiratory symptoms prior to surgery [",
"      <a class=\"abstract\" href=\"UTD.htm?27/5/27735/abstract/3\">",
"       3",
"      </a>",
"      ]. After surgical repair, slightly more than half of the patients were symptom free and those with respiratory problems had improvement of their condition following surgery. Approximately two-thirds of patients with feeding issues were symptom free after surgery. Of the seven patients with noncardiac anomalies (eg, tracheoesophageal fistula, DiGeorge syndrome, or CHARGE syndrome), only one with Down syndrome had complete resolution of symptoms.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Long-term medical issues in affected children after surgical repair include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with associated tracheomalacia and other anomalies may continue to be symptomatic after the surgical repair of the ring [",
"      <a class=\"abstract\" href=\"UTD.htm?27/5/27735/abstract/3,4\">",
"       3,4",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Patients with a prominent diverticulum of Kommerell may have persistent airway or esophageal compression symptoms, if the diverticulum was not surgically resected [",
"      <a class=\"abstract\" href=\"UTD.htm?27/5/27735/abstract/8\">",
"       8",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      One long-term study suggests that in some asymptomatic patients, there may be abnormalities in pulmonary function [",
"      <a class=\"abstract\" href=\"UTD.htm?27/5/27735/abstract/26\">",
"       26",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vascular rings are rare congenital anomalies of aortic arch development that result in compression of the tracheobronchial tree",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    esophagus and present with respiratory or esophageal symptoms.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Vascular rings can be classified as either complete, when both the trachea and esophagus are fully encircled by an aortic arch anomaly, or incomplete without full encirclement of both structures. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Anatomy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Complete vascular rings are more commonly associated with significant symptoms and represent the majority of patients that undergo surgical correction for vascular ring anomalies. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Incidence'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In case series of surgically corrected patients with vascular rings, most patients present by 1 year of age with significant tracheal (stridor, recurrent respiratory infections, respiratory distress, wheezing, and cough) and esophageal (dysphagia, feeding difficulty, and vomiting) symptoms. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Associated anomalies are common in children with vascular rings, especially cardiac anomalies. Vascular rings can be seen in genetic or malformation syndromes such as DiGeorge or Down syndrome. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Associated anomalies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Symptomatic infants display signs of increased respiratory effort with nasal flaring, intercostal retractions, tachypnea, and intermittent cyanosis. Some infants will lie with their back arched and neck extended to minimize tracheal compression. Wheezing",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      coarse upper airway sounds may be heard during auscultation. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Physical examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The clinician must have a high index of suspicion to diagnosis a vascular ring because vascular rings are relatively uncommon causes of respiratory distress in children compared to other conditions.",
"     </li>",
"     <li>",
"      The diagnostic approach is dependent upon the local expertise, experience, medical costs, and available technology of the medical center.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In our center, our diagnostic evaluation, which delineates the vascular anatomy and detects any additional pulmonary or intracardiac pathology, includes chest radiography, echocardiography, and magnetic resonance imaging (MRI) and angiography. Bronchoscopy is reserved for patients with concerns of airway patency. We do not routinely perform",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"     barium",
"    </a>",
"    esophagograms because they do not provide any additional information to that given by MRI.",
"   </p>",
"   <p>",
"    We prefer MRI to computerized tomography (CT) because of its lower radiation exposure to young children. Other centers prefer the use of CT imaging to MRI because it generally does not require conscious sedation in young children.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We recommend surgical correction for symptomatic patients (",
"      <a class=\"grade\" href=\"._grade_3?title=Grade 1C\">",
"       Grade 1C",
"      </a>",
"      ). Clinical outcome is excellent with resolution of symptoms and surgical risks are low. We do not recommend surgical intervention for asymptomatic patients who are incidentally diagnosed with vascular rings (",
"      <a class=\"grade\" href=\"._grade_3?title=Grade 1C\">",
"       Grade 1C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Treatment'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H23\">",
"       'Outcome'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27735/abstract/1\">",
"      Davies M, Guest PJ. Developmental abnormalities of the great vessels of the thorax and their embryological basis. Br J Radiol 2003; 76:491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27735/abstract/2\">",
"      Shah RK, Mora BN, Bacha E, et al. The presentation and management of vascular rings: an otolaryngology perspective. Int J Pediatr Otorhinolaryngol 2007; 71:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27735/abstract/3\">",
"      Humphrey C, Duncan K, Fletcher S. Decade of experience with vascular rings at a single institution. Pediatrics 2006; 117:e903.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27735/abstract/4\">",
"      Woods RK, Sharp RJ, Holcomb GW 3rd, et al. Vascular anomalies and tracheoesophageal compression: a single institution's 25-year experience. Ann Thorac Surg 2001; 72:434.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27735/abstract/5\">",
"      Backer CL, Mavroudis C, Rigsby CK, Holinger LD. Trends in vascular ring surgery. J Thorac Cardiovasc Surg 2005; 129:1339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27735/abstract/6\">",
"      Turner A, Gavel G, Coutts J. Vascular rings--presentation, investigation and outcome. Eur J Pediatr 2005; 164:266.",
"     </a>",
"    </li>",
"    <li>",
"     Van Son, JA, Konstantinov, IE, Burckhard, F. Kommerell and Kommerell's diverticulum. Tex Heart Inst J 2002, 29:109.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27735/abstract/8\">",
"      Backer CL, Hillman N, Mavroudis C, Holinger LD. Resection of Kommerell's diverticulum and left subclavian artery transfer for recurrent symptoms after vascular ring division. Eur J Cardiothorac Surg 2002; 22:64.",
"     </a>",
"    </li>",
"    <li>",
"     Powell AJ, Mandell VS. Vascular rings and slings. In: Nadas' Pediatric Cardiology, 2nd, Kean JF, Lock JE, Fyler DC (Eds), Saunders Elsevier, Philadelphia 2006. p.811.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27735/abstract/10\">",
"      Bakker DA, Berger RM, Witsenburg M, Bogers AJ. Vascular rings: a rare cause of common respiratory symptoms. Acta Paediatr 1999; 88:947.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27735/abstract/11\">",
"      McElhinney DB, McDonald-McGinn D, Zackai EH, Goldmuntz E. Cardiovascular anomalies in patients diagnosed with a chromosome 22q11 deletion beyond 6 months of age. Pediatrics 2001; 108:E104.",
"     </a>",
"    </li>",
"    <li>",
"     Hernanz-Schulman, M. Vascular rings: a practical approach to imaging diagnosis. Pediatr Radiol 2005, 35:961.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27735/abstract/13\">",
"      Fogel MA, Pawlowski TW, Harris MA, et al. Comparison and usefulness of cardiac magnetic resonance versus computed tomography in infants six months of age or younger with aortic arch anomalies without deep sedation or anesthesia. Am J Cardiol 2011; 108:120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27735/abstract/14\">",
"      Lillehei CW, Colan S. Echocardiography in the preoperative evaluation of vascular rings. J Pediatr Surg 1992; 27:1118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27735/abstract/15\">",
"      Yoo SJ, Min JY, Lee YH, et al. Fetal sonographic diagnosis of aortic arch anomalies. Ultrasound Obstet Gynecol 2003; 22:535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27735/abstract/16\">",
"      Patel CR, Lane JR, Spector ML, Smith PC. Fetal echocardiographic diagnosis of vascular rings. J Ultrasound Med 2006; 25:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27735/abstract/17\">",
"      Tuo G, Volpe P, Bava GL, et al. Prenatal diagnosis and outcome of isolated vascular rings. Am J Cardiol 2009; 103:416.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27735/abstract/18\">",
"      GROSS RE. Surgical relief for tracheal obstruction from a vascular ring. N Engl J Med 1945; 233:586.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27735/abstract/19\">",
"      Backer CL, Mavroudis C, Dunham ME, Holinger LD. Pulmonary artery sling: results with median sternotomy, cardiopulmonary bypass, and reimplantation. Ann Thorac Surg 1999; 67:1738.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27735/abstract/20\">",
"      Grillo HC, Wright CD, Vlahakes GJ, MacGillivray TE. Management of congenital tracheal stenosis by means of slide tracheoplasty or resection and reconstruction, with long-term follow-up of growth after slide tracheoplasty. J Thorac Cardiovasc Surg 2002; 123:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27735/abstract/21\">",
"      Jones DT, Jonas RA, Healy GB. Innominate artery compression of the trachea in infants. Ann Otol Rhinol Laryngol 1994; 103:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27735/abstract/22\">",
"      Koontz CS, Bhatia A, Forbess J, Wulkan ML. Video-assisted thoracoscopic division of vascular rings in pediatric patients. Am Surg 2005; 71:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27735/abstract/23\">",
"      Al-Bassam A, Saquib Mallick M, Al-Qahtani A, et al. Thoracoscopic division of vascular rings in infants and children. J Pediatr Surg 2007; 42:1357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27735/abstract/24\">",
"      Suematsu Y, Mora BN, Mihaljevic T, del Nido PJ. Totally endoscopic robotic-assisted repair of patent ductus arteriosus and vascular ring in children. Ann Thorac Surg 2005; 80:2309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27735/abstract/25\">",
"      Kogon BE, Forbess JM, Wulkan ML, et al. Video-assisted thoracoscopic surgery: is it a superior technique for the division of vascular rings in children? Congenit Heart Dis 2007; 2:130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27735/abstract/26\">",
"      Marmon LM, Bye MR, Haas JM, et al. Vascular rings and slings: long-term follow-up of pulmonary function. J Pediatr Surg 1984; 19:683.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5757 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-118.195.65.247-6C4A8C19E1-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_5_27735=[""].join("\n");
var outline_f27_5_27735=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H24\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ANATOMY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Left aortic arch",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Right aortic arch",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Complete vascular rings",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Double aortic arch",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - R aortic arch with aberrant L subclavian artery and L ductus arteriosus/ligamentum",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Other causes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Incomplete vascular rings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      INCIDENCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Associated anomalies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Our approach",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Antenatal diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Complete vascular rings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Incomplete vascular rings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Alternative surgical techniques",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Pharmacologic treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      OUTCOME",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/5757\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5757|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?26/47/27381\" title=\"figure 1\">",
"      Double aortic arch",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?31/57/32660\" title=\"figure 2\">",
"      Right aortic arch LL",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/15/26874?source=related_link\">",
"      Clinical features and diagnosis of Down syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/37/32343?source=related_link\">",
"      DiGeorge syndrome: Epidemiology and pathogenesis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f27_5_27736="Hydrocarbon poisoning";
var content_f27_5_27736=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Hydrocarbon poisoning",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/5/27736/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/5/27736/contributors\">",
"     William J Lewander, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/5/27736/contributors\">",
"     Alfred Aleguas, Jr, PharmD, DABAT, CSPI",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/5/27736/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/5/27736/contributors\">",
"     Michele Burns Ewald, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/5/27736/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/5/27736/contributors\">",
"     James F Wiley, II, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?27/5/27736/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 6, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hydrocarbons are organic substances that contain carbon and hydrogen. They are generally liquid at room temperature [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27736/abstract/1\">",
"     1",
"    </a>",
"    ]. All petroleum distillates (eg, kerosene, gasoline, mineral seal oils, and naphtha) are hydrocarbons; however, not all hydrocarbons are petroleum distillates. Turpentine, for example, is a hydrocarbon made from pine oil. Hydrocarbons are often mixed with agents that have systemic toxicity, such as camphor, aniline dyes, heavy metals, and pesticides.",
"   </p>",
"   <p>",
"    Ingestion of large quantities of hydrocarbons alone by children is unusual because hydrocarbons are foul-tasting. Poisoning in young children typically results from an exploratory occurrence that can be prevented through safe packaging and storage. In contrast, in teenagers and adults, aspiration may occur during intentional behaviors (eg, during inhalant abuse, or when attempting to siphon gasoline). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/61/33753?source=see_link\">",
"     \"Inhalant abuse in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hydrocarbon ingestion accounts for one to two percent of non-pharmaceutical exposures in children younger than six years of age reported to US poison control centers [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27736/abstract/2\">",
"     2",
"    </a>",
"    ]. Although rare, hydrocarbon aspiration may cause death secondary to respiratory failure. Hydrocarbons were implicated in almost 10 percent of all single substance fatalities in this pediatric population [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27736/abstract/2\">",
"     2",
"    </a>",
"    ]. Gasoline, chlorofluorocarbon propellants, motor oils, lighter",
"    <span class=\"nowrap\">",
"     fluid/naphtha,",
"    </span>",
"    lamp oil, and mineral spirits, are the most commonly ingested substances [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27736/abstract/2\">",
"     2",
"    </a>",
"    ]. In young children, the ingestion typically occurs as a result of exploratory behavior. Frequently, the hydrocarbon is unsecured or improperly stored in a drinking container (eg, soda bottle). Toxicity in adolescents often arises from inhalant abuse of hydrocarbons. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/61/33753?source=see_link\">",
"     \"Inhalant abuse in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Product safety",
"    </span>",
"    &nbsp;&mdash;&nbsp;Since 2001, the US consumer product safety commission has required child-resistant packaging for products that have low viscosity and contain &ge;10 percent hydrocarbon by weight (",
"    <a class=\"graphic graphic_table graphicRef51981 \" href=\"UTD.htm?21/18/21804\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27736/abstract/3\">",
"     3",
"    </a>",
"    ]. In 1997, the European Union attempted to minimize lamp oil aspiration by setting standards for viscosity and surface tension, the main determinants of aspiration risk. A follow-up study in 2005 showed no effect on number or severity of hydrocarbon aspiration in the years since the directive [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27736/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLASSES OF HYDROCARBONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The four structural classes of hydrocarbons are:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Aromatic hydrocarbons",
"     </li>",
"     <li>",
"      Aliphatic hydrocarbons",
"     </li>",
"     <li>",
"      Halogenated hydrocarbons",
"     </li>",
"     <li>",
"      Terpene hydrocarbons",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Aromatic hydrocarbons are cyclic compounds containing a benzene ring (eg, benzene, toluene, and xylene). They are used primarily in solvents, glues, nail polishes, paints, and paint removers [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27736/abstract/1\">",
"     1",
"    </a>",
"    ]. Halogenated hydrocarbons are fluorinated, chlorinated, or brominated (eg, methylene chloride, chloroform, carbon tetrachloride, trichloroethylene, tetrachloroethylene). The terpenes include turpentine and pine oil. The aliphatic hydrocarbons are petroleum distillates such as gasoline, kerosene, and naphtha. They are found in furniture polishes, lamp oil, and lighter fluid [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27736/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     HYDROCARBON TOXICITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hydrocarbons also can be classified according to their potential for toxicity [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27736/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Low toxicity (unless complicated by gross aspiration) &ndash; Examples include asphalt, tars,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?13/0/13316?source=see_link\">",
"       mineral oil",
"      </a>",
"      , petroleum jelly, motor oil, and axle grease.",
"     </li>",
"     <li>",
"      Aspiration hazard &ndash; Clinical effects are typically limited to direct pulmonary damage and subsequent inflammation. Examples include turpentine, gasoline, kerosene, mineral seal oil (furniture polish), charcoal, mineral spirits, or outdoor torch and cigarette lighter fluids.",
"     </li>",
"     <li>",
"      Systemic toxicity &ndash; Halogenated and aromatic hydrocarbons are absorbed readily through the gastrointestinal",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      respiratory systems. Systemic effects include cardiac arrhythmias secondary to myocardial sensitization and central nervous system (CNS) depression. Systemic toxicity also occurs after ingestion of compounds that combine aliphatic hydrocarbons with toxic additives (eg, organophosphates, heavy metals, camphor).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Determinants of pulmonary aspiration",
"    </span>",
"    &nbsp;&mdash;&nbsp;The aspiration hazard of the hydrocarbons is determined by three properties [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27736/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Volatility &ndash; The ability to vaporize or to exist in a gaseous form. The greater the volatility, the greater the risk of pulmonary absorption and CNS depression.",
"     </li>",
"     <li>",
"      Surface tension &ndash; The adherence (or cohesiveness) of molecules along a liquid surface. Lower surface tension allows compounds to spread or \"creep\" over a larger area.",
"     </li>",
"     <li>",
"      Viscosity &ndash; The resistance to flow through an orifice or the tendency of a compound to resist \"stirring\". Lower viscosity facilitates deeper penetration into the tracheobronchial tree.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The aspiration hazard of hydrocarbons is inversely related to viscosity and surface tension and directly related to volatility [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27736/abstract/5\">",
"     5",
"    </a>",
"    ]. Thus, hydrocarbons with decreased viscosity, low surface tension, and high volatility are more likely to be aspirated and cause pulmonary injury. The low viscosity permits greater penetration into the distal airways while the low surface tension facilitates spread over a larger area. As an example, simple petroleum distillates (kerosene, gasoline, liquid furniture polish) are chiefly aspiration hazards. They have high potential to cause aspiration pneumonitis, but rarely cause systemic symptoms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Acute systemic toxicity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute systemic toxicity following hydrocarbon exposure is most commonly seen with aromatic and halogenated hydrocarbons and is primarily determined by their volatility",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    degree of absorption from the gastrointestinal tract [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27736/abstract/5\">",
"     5",
"    </a>",
"    ]. Acute effects include central nervous system (CNS) depression (eg, lethargy, coma, inebriation), seizures,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    ventricular arrhythmias caused by myocardial sensitization to endogenous and administered catecholamines (eg, epinephrine). In addition, hepatic and acute renal tubular necrosis has been described after poisoning with halogenated hydrocarbons, especially carbon tetrachloride.",
"   </p>",
"   <p>",
"    Gases such as methane, ethane, propane, and butane cause asphyxia by replacing alveolar gas and are readily absorbed into the circulatory system. After absorption, they also have the potential to cause CNS depression, seizures, and ventricular arrhythmias due to myocardial sensitization to catecholamines [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27736/abstract/1,5\">",
"     1,5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other hydrocarbons have specific CNS effects after ingestion including CNS depression (pine oil, gasoline, naphtha) and seizures (camphor) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27736/abstract/6,7\">",
"     6,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Systemic absorption is not a major contributor to pulmonary injury except in the setting of massive ingestion [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27736/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hydrocarbon aspiration impacts the respiratory and central nervous systems. The respiratory system is primarily affected by direct injury. Low viscosity, low surface tension, and solvent properties of aspirated hydrocarbons together determine a compound's ability to cause chemical pneumonitis [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27736/abstract/1,5\">",
"     1,5",
"    </a>",
"    ]. The primary pathologic finding is severe necrotizing pneumonia. Other findings include direct destruction of the airway epithelium, alveolar septae, and pulmonary capillaries, as well as solubilization of the lipid surfactant layer. Secondary changes include atelectasis, interstitial inflammation, and hyaline membrane formation. The inflammatory response from chemical irritation generally causes temperature elevation, usually within hours of exposure.",
"   </p>",
"   <p>",
"    Volatile hydrocarbons are highly lipid soluble. They enter the circulation through the lungs and rapidly diffuse throughout the body and into the central nervous system (CNS) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27736/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. Neurons, which have a high lipid content, are particularly susceptible to the solvent properties [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27736/abstract/10\">",
"     10",
"    </a>",
"    ]. CNS manifestations also occur secondary to severe pulmonary injury and hypoxia. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Acute systemic toxicity'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Initial presentation and diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients who ingest aliphatic hydrocarbons (eg, kerosene, pine oil) are children who are initially asymptomatic and have a history of exposure. Those patients with symptoms (eg, respiratory distress, hypoxemia) soon after ingestion typically progress rapidly to respiratory failure.",
"   </p>",
"   <p>",
"    When history of hydrocarbon exposure is lacking, characteristic odors can help identify the presence and type of hydrocarbons ingested:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Kerosene and other aliphatic hydrocarbons &ndash; Petroleum distillate odor",
"     </li>",
"     <li>",
"      Pine oil &ndash; Pine scent",
"     </li>",
"     <li>",
"      Halogenated hydrocarbons &ndash; Sweet solvent odor",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although exposure to some hydrocarbons may be confirmed by detection of urinary metabolites (eg, trichloroethanol after chlorinated hydrocarbon exposure, hippuric acid after toluene exposure) or directly measured in the blood (eg, toluene), these laboratory studies are not rapidly available and do not change management priorities. Thus the diagnosis of hydrocarbon exposure is based on clinical features.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Physical findings after hydrocarbon exposure",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Vital signs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Between 30 and 60 percent of patients with hydrocarbon aspiration have fever at the time of presentation (38 to 40&ordm;C (100.4 to 104&ordm;F)) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27736/abstract/11\">",
"     11",
"    </a>",
"    ]. Persistence beyond 48 hours suggests bacterial superinfection [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27736/abstract/11\">",
"     11",
"    </a>",
"    ]. Pulse oximetry may show decreased oxygen saturation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Respiratory",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulmonary manifestations secondary to aspiration generally occur within 30 minutes, although their onset may be delayed for 12 to 24 hours [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27736/abstract/11\">",
"     11",
"    </a>",
"    ]. Immediate signs of aspiration include coughing, choking, gagging, and vomiting. Respiratory examination findings vary with the degree of pulmonary injury and may include tachypnea, dyspnea, cyanosis, wheezing, diminished resonance on percussion, suppressed or tubular breath sounds, rales, nasal flaring,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    grunting respirations. Displacement of alveolar gas by vaporized hydrocarbon may aggravate hypoxemia caused by inflammation and edema.",
"   </p>",
"   <p>",
"    The major pulmonary complications of hydrocarbon aspiration include asphyxia, necrotizing chemical pneumonitis, lipoid pneumonia, and hemorrhagic pulmonary edema, which quickly progresses to shock and respiratory arrest [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27736/abstract/12\">",
"     12",
"    </a>",
"    ]. Pneumothorax, subcutaneous emphysema of the chest wall, and pleural effusion, including empyema, may also occur. Secondary bacterial or viral infection may exacerbate the chemical pneumonitis. Pneumatoceles rarely develop in areas of extensive consolidation during the recovery period [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27736/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/53/40793?source=see_link\">",
"     \"Spontaneous pneumothorax in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Central nervous system",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hydrocarbon ingestion or inhalation may rapidly have direct central nervous system (CNS) effects, including somnolence, headache, ataxia, dizziness, blurred vision, weakness, fatigue, lethargy, stupor, seizures, and coma, depending on the amount ingested. In addition, hypoxia caused by hydrocarbon aspiration may cause secondary CNS toxicity, including drowsiness, tremors, or seizures [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27736/abstract/15\">",
"     15",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/62/22506?source=see_link\">",
"     \"Acute toxic-metabolic encephalopathy in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Cardiovascular",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cardiac dysrhythmias and myocardial dysfunction may occur after hydrocarbon ingestion or inhalation. Solvent hydrocarbons (eg, halogenated hydrocarbons), in particular, are known to produce fatal ventricular arrhythmias because they sensitize the myocardium to endogenous and exogenous catecholamines (\"sudden sniffing death\"). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/61/33753?source=see_link&amp;anchor=H9#H9\">",
"     \"Inhalant abuse in children and adolescents\", section on 'Cardiovascular effects'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Gastrointestinal",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ingestion of aliphatic hydrocarbons causes direct local irritation to the pharynx, esophagus, stomach, and small intestine, with edema and mucosal ulceration. Orogastric and intestinal irritation may be associated with nausea and hematemesis [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27736/abstract/1\">",
"     1",
"    </a>",
"    ]. These effects usually are mild and rarely require treatment.",
"   </p>",
"   <p>",
"    Halogenated hydrocarbons may cause hepatic",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    renal tubular necrosis one to two days after ingestion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Hematologic",
"    </span>",
"    &nbsp;&mdash;&nbsp;Leukocytosis occurs early in the clinical course of hydrocarbon aspiration unrelated to pneumonitis and may last as long as one week [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27736/abstract/16\">",
"     16",
"    </a>",
"    ]. Hemolysis, hemoglobinuria, and consumptive coagulopathy rarely occur after large ingestions [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27736/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Ancillary studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children who ingest hydrocarbons should receive a chest radiograph four to six hours after exposure or sooner if they show signs of pulmonary aspiration (",
"    <a class=\"graphic graphic_algorithm graphicRef70145 \" href=\"UTD.htm?0/43/703\">",
"     algorithm 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Symptomatic patients should also undergo measurement of the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Blood gas",
"     </li>",
"     <li>",
"      Complete blood count",
"     </li>",
"     <li>",
"      Serum glucose",
"     </li>",
"     <li>",
"      Serum electrolytes",
"     </li>",
"     <li>",
"      Urinalysis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition to these studies, those children exposed to halogenated hydrocarbons should have measures of liver injury (aspartate aminotransferase (AST) and alanine aminotransferase (ALT)) and renal function (blood urea nitrogen and serum creatinine) performed.",
"   </p>",
"   <p>",
"    The initial blood gas findings after hydrocarbon aspiration typically show a mild respiratory alkalosis with hypoxemia. If hypoxemia is not corrected, the patient will later develop a metabolic acidosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Radiographic findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients who ultimately manifest pulmonary aspiration after hydrocarbon ingestion, the radiographic findings of hydrocarbon aspiration are evident within two hours of exposure in 88 percent and by 12 hours in 98 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27736/abstract/18\">",
"     18",
"    </a>",
"    ]. These findings frequently precede the development of physical findings.",
"   </p>",
"   <p>",
"    Initial radiograph findings consist of multiple, small, patchy densities with ill-defined margins (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef71987 \" href=\"UTD.htm?21/46/22240\">",
"     image 1",
"    </a>",
"    ). The lesions become larger and coalesce as the injury progresses. In some cases, the radiographic findings may be minimal at a few hours and then rapidly progress to extensive infiltrates. Emphysema or pneumothorax may develop. Radiographic abnormalities typically peak between two and eight hours after aspiration. The resolution of radiographic changes is gradual and lags behind clinical improvement, which usually occurs three to five days after aspiration. Pneumatoceles may develop during this latent period.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinician should consider the following alternative diagnoses when hydrocarbon exposure is not certain or is associated with findings suggestive of other poisonings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Bronchopneumonia &ndash; Patients with bronchopneumonia typically have fever and tachypnea and may appear similar to patients with hydrocarbon aspiration. However, patients with pneumonia do not display a characteristic petroleum distillate odor and do not have findings of chemical pneumonitis on chest radiograph (see",
"      <a class=\"local\" href=\"#H10\">",
"       'Initial presentation and diagnosis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H19\">",
"       'Radiographic findings'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      Salicylate overdose &ndash; Patients who have ingested salicylates may have fever and tachypnea with altered mental status but typically do not have abnormal chest radiographs soon after ingestion. Some clinicians may think the fruity odor of ketoacidosis is similar to that caused by halogenated hydrocarbon ingestion.",
"     </li>",
"     <li>",
"      Other toxins &ndash; Any toxin that produces metabolic acidosis (eg, iron,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"       metformin",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?39/21/40279?source=see_link\">",
"       isoniazid",
"      </a>",
"      , toxic alcohol) or cellular hypoxia (eg, carbon monoxide, cyanide) may cause tachypnea. Blood gas measurement will often differentiate these toxins from hydrocarbon exposure with its typical respiratory alkalosis, and in more serious cases, arterial blood hypoxemia.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Hydrocarbons are sometimes used as solvents for other dangerous toxins (eg, organophosphates). Thus, the clinician should seek to identify the exact compound that was ingested when managing a patient with hydrocarbon poisoning to ensure timely recognition and treatment of all possible toxic agents.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Successful management of hydrocarbon aspiration requires recognition of pulmonary toxicity and rapid initiation of appropriate supportive care.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Stabilization",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial treatment depends on the degree of immediate toxicity, including the presence of respiratory distress and altered mental status:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with severe respiratory distress, unresponsive to oxygen and beta-2 bronchodilators (eg,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/61/16344?source=see_link\">",
"       albuterol",
"      </a>",
"      ) or significant altered mental status (lethargy, coma) shortly after hydrocarbon ingestion should undergo endotracheal intubation. (See",
"      <a class=\"local\" href=\"#H27\">",
"       'Pulmonary management'",
"      </a>",
"      below and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/55/1912?source=see_link\">",
"       \"Rapid sequence intubation in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/29/24026?source=see_link\">",
"       \"Rapid sequence intubation (RSI) in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients with seizures should receive intravenous benzodiazepine therapy (eg,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?8/8/8329?source=see_link\">",
"       lorazepam",
"      </a>",
"      0.1",
"      <span class=\"nowrap\">",
"       mg/kg)",
"      </span>",
"      in addition to support of airway and breathing. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/11/19642?source=see_link\">",
"       \"Status epilepticus in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/50/30505?source=see_link\">",
"       \"Management of status epilepticus in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients with mild to moderate respiratory symptoms on presentation are at risk for the development of significant chemical pneumonitis with progression to respiratory failure over the next 24 to 48 hours. In addition to supplemental oxygen, as needed, and close monitoring, they should have chest radiographs performed at the time of presentation. These patients should also remain NPO (nothing by mouth) during the initial observation period and receive maintenance intravenous fluids.",
"     </li>",
"     <li>",
"      Patients who are asymptomatic at presentation warrant serial examinations with monitoring. These patients should also remain NPO (nothing by mouth) during the initial observation period. Radiographic evaluation should occur at four to six hours after hydrocarbon ingestion or sooner if they become symptomatic or have additional pulmonary aspiration risk (",
"      <a class=\"graphic graphic_algorithm graphicRef70145 \" href=\"UTD.htm?0/43/703\">",
"       algorithm 1",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     External decontamination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prior to initiating decontamination of patients with external hydrocarbon exposure, the health care team should don personal protective equipment appropriate to the hazard posed by the specific chemical. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/33/11801?source=see_link&amp;anchor=H4#H4\">",
"     \"Topical chemical burns\", section on 'Protection of providers'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Contaminated clothing should be removed to prevent continued inhalation exposure. Affected skin and hair should also be cleansed as many hydrocarbons cause irritation [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27736/abstract/19\">",
"     19",
"    </a>",
"    ]. Certain hydrocarbon compounds (eg, gasoline, methylene chloride) cause cell membrane injury and dissolution of lipids, which results in skin necrosis and burns with prolonged exposure. Treatment of dermal and ocular exposure initially consists of copious water irrigation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/33/11801?source=see_link&amp;anchor=H27#H27\">",
"     \"Topical chemical burns\", section on 'Hydrocarbons'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Gastrointestinal decontamination",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients who have ingested a hydrocarbon, we recommend NOT performing either syrup of ipecac administration or gastric lavage with a large bore orogastric tube [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27736/abstract/5\">",
"     5",
"    </a>",
"    ]. In these patients, the risk of additional aspiration outweighs the potential benefit obtained from these procedures [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27736/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]. Some toxicologists suggest nasogastric lavage for the removal of hydrocarbons with significant systemic toxicity in the rare patient who has ingested a large amount (eg, suicidal ingestion of trichloroethylene) and who presents within one hour of ingestion.",
"   </p>",
"   <p>",
"    This recommendation is based on randomized controlled trials in poisoned patients that evaluated the use of syrup of ipecac or gastric lavage with a large bore orogastric tube [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27736/abstract/21-24\">",
"     21-24",
"    </a>",
"    ]. These studies found no definite clinical benefit from induced vomiting or gastric lavage after any ingestion. Furthermore, both of these procedures may increase the risk of aspiration, especially after hydrocarbon ingestion.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/52/39750?source=see_link\">",
"     Activated charcoal",
"    </a>",
"    (AC) should NOT be administered to patients with a single agent ingestion of a hydrocarbon without systemic toxicity for the following reasons:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      AC administration increases the risk of spontaneous vomiting and additional pulmonary aspiration.",
"     </li>",
"     <li>",
"      AC does not bind well to hydrocarbons.",
"     </li>",
"     <li>",
"      In this instance, toxicity arises from pulmonary aspiration rather than systemic toxin absorption.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h3\">",
"     Systemic toxicity likely",
"    </span>",
"    &nbsp;&mdash;&nbsp;Consultation with a regional poison control center is strongly advised when determining the need to provide gastrointestinal decontamination procedures in patients who have ingested hydrocarbons. (See",
"    <a class=\"local\" href=\"#H89613333\">",
"     'Additional resources'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    For patients who have ingested large quantities of hydrocarbons with significant potential for systemic toxicity and who present for care within 60 minutes of ingestion, we suggest gastric emptying using nasogastric lavage [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27736/abstract/5\">",
"     5",
"    </a>",
"    ]. These agents can be remembered by using the mnemonic \"CHAMP\":",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      C: Camphor",
"     </li>",
"     <li>",
"      H: Halogenated hydrocarbons (eg, trichloroethane, trichloroethylene)",
"     </li>",
"     <li>",
"      A: Aromatic hydrocarbons (eg, benzene, toluene, xylene)",
"     </li>",
"     <li>",
"      M: Metal additives (eg, arsenic, mercury) in hydrocarbon base",
"     </li>",
"     <li>",
"      P: Pesticide additives (eg, organophosphates) in hydrocarbon base",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Some experts also suggest nasogastric lavage in patients who ingest large amounts of aliphatic hydrocarbons (eg, suicide attempt in an adult patient) because of the potential for systemic absorption with central nervous system and pulmonary toxicity [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27736/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This recommendation is based on clinical experience regarding how to manage this uncommon scenario and randomized trials that indicate little benefit of gastric lavage more than 60 minutes after an ingestion [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27736/abstract/5,23,24\">",
"     5,23,24",
"    </a>",
"    ]. Nasogastric lavage should only be performed when the risk of systemic toxicity from gastrointestinal absorption of the hydrocarbon is equal to or exceeds the increased risk of pulmonary aspiration associated with nasogastric lavage.",
"   </p>",
"   <p>",
"    Nasogastric lavage should be withheld in patients with a depressed mental status who may not be able to protect their airway, unless endotracheal intubation is performed first. The following measures, performed before nasogastric lavage, may minimize the risk of aspiration:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Endotracheal intubation with a balloon-cuffed endotracheal tube",
"     </li>",
"     <li>",
"      Left lateral decubitus with mild Trendelenburg positioning (eg, head inclined 20 degrees below the feet)",
"     </li>",
"     <li>",
"      Pinching off the nasogastric tube and withdrawing it quickly after the procedure is complete",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    We suggest that patients who ingest hydrocarbons that are combined with an adsorbable toxic additive (eg, organophosphates) or who coingest other toxic substances that bind (eg, prescription medications) receive",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/52/39750?source=see_link\">",
"     activated charcoal",
"    </a>",
"    (1",
"    <span class=\"nowrap\">",
"     g/kg)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27736/abstract/1,5\">",
"     1,5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The recommendation of AC administration in this select group of patients who ingest hydrocarbons derives from indirect evidence of benefit in volunteers, animal studies, and evidence of benefit following ingestions of other substances [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27736/abstract/25\">",
"     25",
"    </a>",
"    ]. Because of adverse effects, such as vomiting and dehydration, the combination of a cathartic (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/0/29699?source=see_link\">",
"     sorbitol",
"    </a>",
"    ) and AC should be used sparingly, if at all, and only a single dose of a cathartic should be given to any patient. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/1/37913?source=see_link&amp;anchor=H27#H27\">",
"     \"Decontamination of poisoned children\", section on 'Cathartics'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/1/37913?source=see_link&amp;anchor=H10032467#H10032467\">",
"     \"Decontamination of poisoned children\", section on 'Activated charcoal'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/58/16297?source=see_link&amp;anchor=H18993978#H18993978\">",
"     \"Gastrointestinal decontamination of poisoned adults\", section on 'Cathartics'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/58/16297?source=see_link&amp;anchor=H18993761#H18993761\">",
"     \"Gastrointestinal decontamination of poisoned adults\", section on 'Activated charcoal'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Pulmonary management",
"    </span>",
"    &nbsp;&mdash;&nbsp;The treatment of hydrocarbon pneumonitis is supportive and includes oxygen and close monitoring of respiratory status.",
"   </p>",
"   <p>",
"    Bronchospasm should be treated with selective beta-2 agonists. Epinephrine and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?22/31/23029?source=see_link\">",
"     isoproterenol",
"    </a>",
"    should be avoided because they can cause fatal ventricular dysrhythmia in the hydrocarbon-sensitized myocardium. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Cardiovascular'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Endotracheal intubation and conventional mechanical ventilation are indicated in patients with respiratory failure or in situations where mental status makes them unable to maintain their airway [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27736/abstract/1,26\">",
"     1,26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Extracorporeal membrane oxygenation (ECMO) and high frequency ventilation are therapeutic options for the small minority of children who have hydrocarbon pneumonitis and respiratory failure with severe hypoxemia unresponsive to conventional mechanical ventilation [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27736/abstract/27-29\">",
"     27-29",
"    </a>",
"    ]. The value of these interventions in adults is not known. However, children are more likely to have the ability to regenerate new lung tissue after injury.",
"   </p>",
"   <p>",
"    In a case series that evaluated survival after ECMO, 13 of 19 children (68 percent) with hydrocarbon pneumonitis survived versus 459 of 883 children (52 percent) who had other respiratory disease [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27736/abstract/30\">",
"     30",
"    </a>",
"    ]. This experience suggests that the pulmonary injury sustained by children with hydrocarbon pneumonitis is reversible in some patients and that ECMO may be life-saving in selected patients with severe hydrocarbon pneumonitis unresponsive to conventional mechanical ventilation.",
"   </p>",
"   <p>",
"    Case reports also indicate that high frequency ventilation (eg, jet ventilation, high frequency oscillatory ventilation, or high frequency percussion ventilation) may be life-saving for children with severe hydrocarbon pneumonitis unresponsive to conventional mechanical ventilation [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27736/abstract/29,31,32\">",
"     29,31,32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Corticosteroids have shown no beneficial effect on the course of hydrocarbon aspiration in observational studies and may be harmful [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27736/abstract/33,34\">",
"     33,34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pneumonitis caused by hydrocarbon aspiration should not be treated routinely with antibiotics unless signs of secondary infection, including the following, are present:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Recurrence of fever after the first 48 hours [",
"      <a class=\"abstract\" href=\"UTD.htm?27/5/27736/abstract/35\">",
"       35",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Increasing infiltrate in chest radiograph",
"     </li>",
"     <li>",
"      Leukocytosis after the first 48 hours",
"     </li>",
"     <li>",
"      Sputum or tracheal aspirate positive for bacteria",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Pneumatoceles usually resolve spontaneously and do not require specific treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27736/abstract/13,14\">",
"     13,14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h1\">",
"     DISPOSITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinical findings and radiographic results largely determine patient disposition after hydrocarbon ingestion (",
"    <a class=\"graphic graphic_algorithm graphicRef70145 \" href=\"UTD.htm?0/43/703\">",
"     algorithm 1",
"    </a>",
"    ). Indications for immediate admission of patients who have ingested or aspirated hydrocarbons include [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27736/abstract/18,36\">",
"     18,36",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Symptomatic patient",
"     </li>",
"     <li>",
"      Patient with suicidal intent or massive ingestion",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Indications for admission that become apparent up to six hours after hydrocarbon ingestion include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patient with a normal or mildly abnormal initial chest radiograph who develops symptoms during the observation period",
"     </li>",
"     <li>",
"      Patient who develops symptoms related to toxic additives during the observation period (eg, heavy metal or organophosphate insecticide)",
"     </li>",
"     <li>",
"      Patient with mild symptoms and normal chest radiograph who fails to improve during the observation period",
"     </li>",
"     <li>",
"      All patients for whom close follow-up cannot be established",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Indications for discharge after six hours of observation include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Asymptomatic patient with normal chest radiograph obtained four or more hours post exposure",
"     </li>",
"     <li>",
"      Asymptomatic patient with mildly abnormal chest radiograph who does not develop symptoms during the observation period and who can receive timely outpatient follow-up the next day",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although most children survive without complications or sequelae, some progress rapidly to respiratory failure and death. Central nervous system effects (eg, somnolence, convulsions, and coma)",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    pulmonary symptoms may dominate the course.",
"   </p>",
"   <p>",
"    The prognosis is affected by the volume of ingestion or aspiration, the specific agent involved, and the adequacy of medical care. The typical clinical course averages two to five days. The mild CNS depression that is seen soon after ingestion seldom produces serious morbidity provided that pulmonary involvement does not occur.",
"   </p>",
"   <p>",
"    The small airways are at greatest risk for long-term injury [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27736/abstract/36\">",
"     36",
"    </a>",
"    ]. One study examined pulmonary function in 17 children 8 to 14 years after hydrocarbon aspiration [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27736/abstract/10\">",
"     10",
"    </a>",
"    ]. More than 80 percent had at least one pulmonary function abnormality. The clinical significance of these findings is uncertain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H89613333\">",
"    <span class=\"h1\">",
"     ADDITIONAL RESOURCES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Regional poison control centers in the United States are available at all times for consultation on patients who are critically ill, require admission, or have clinical pictures that are unclear (1-800-222-1222). In addition, some hospitals have clinical",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    medical toxicologists available for bedside consultation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    inpatient care. Whenever available, these are invaluable resources to help in the diagnosis and management of ingestions or overdoses. The World Health Organization provides a listing of international poison centers at its website:",
"    <a class=\"external\" href=\"file://www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html\">",
"     www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Regional poison control centers in the United States are available at all times for consultation on patients who are critically ill, require admission, or have clinical pictures that are unclear (1-800-222-1222). In addition, some hospitals have clinical",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    medical toxicologists available for bedside consultation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    inpatient care. Whenever available, these are invaluable resources to help in the diagnosis and management of ingestions or overdoses. The World Health Organization provides a listing of international poison centers at its website:",
"    <a class=\"external\" href=\"file://www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html\">",
"     www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Clinical features",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hydrocarbons are a diverse group of organic carbon compounds that cause respiratory distress and chemical pneumonitis after ingestion as a result of pulmonary aspiration. Physical findings of pulmonary aspiration may be delayed until several hours after ingestion. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Respiratory'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Acute systemic toxicity varies by specific agent ingested. Potential systemic toxicity includes central nervous system depression, seizures, and cardiac arrhythmias. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Classes of hydrocarbons'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H5\">",
"       'Hydrocarbon toxicity'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H9\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     Decontamination",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with external hydrocarbon exposure should have contaminated clothing removed. Treatment of dermal and ocular exposure consists of copious water irrigation. Prior to initiating decontamination of patients with external hydrocarbon exposure, the health care team should don personal protective equipment appropriate to the hazard posed by the specific chemical. (See",
"      <a class=\"local\" href=\"#H24\">",
"       'External decontamination'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/33/11801?source=see_link&amp;anchor=H4#H4\">",
"       \"Topical chemical burns\", section on 'Protection of providers'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For patients who have ingested a hydrocarbon, we recommend NOT performing gastric emptying procedures with syrup of ipecac administration or gastric lavage with a large bore orogastric tube (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Gastrointestinal decontamination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/52/39750?source=see_link\">",
"       Activated charcoal",
"      </a>",
"      (AC) should NOT be administered to patients with a single agent ingestion of a hydrocarbon without systemic toxicity. (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Gastrointestinal decontamination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients who have ingested a large amount of hydrocarbons with significant potential for systemic toxicity and who present for care within 60 minutes of ingestion, we suggest gastric emptying using nasogastric lavage (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H26\">",
"       'Systemic toxicity likely'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest that patients who ingest hydrocarbons that are combined with an adsorbable toxic additive (eg, organophosphates) or who coingest other toxic substances that are adsorbable (eg, prescription medications) receive",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/52/39750?source=see_link\">",
"       oral activated charcoal",
"      </a>",
"      (1",
"      <span class=\"nowrap\">",
"       g/kg)",
"      </span>",
"      (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H26\">",
"       'Systemic toxicity likely'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Treatment of hydrocarbon poisoning is primarily supportive and involves close assessment of respiratory status, including chest radiograph. Specific interventions include supplemental oxygen, inhaled",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/61/16344?source=see_link\">",
"       albuterol",
"      </a>",
"      for bronchospasm, initiation of NPO (nothing by mouth) status, and endotracheal intubation for patients with signs of respiratory failure. Administration of exogenous catecholamines (eg, epinephrine), prophylactic antibiotics, or corticosteroids should be avoided. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Stabilization'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H27\">",
"       'Pulmonary management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Clinical findings and radiographic results largely determine patient disposition after hydrocarbon ingestion (",
"      <a class=\"graphic graphic_algorithm graphicRef70145 \" href=\"UTD.htm?0/43/703\">",
"       algorithm 1",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Lewander WJ, Aleguas A. Petroleum distillates and plant hydrocarbons. In: Haddad and Winchester's Clinical Management of Poisoning and Drug Overdose, 4th, Shannon MW, Borron SW, Burns MJ.  (Eds), Saunders Elsevier, Philadelphia 2007. p.1343.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27736/abstract/2\">",
"      Bronstein AC, Spyker DA, Cantilena LR Jr, et al. 2009 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 27th Annual Report. Clin Toxicol (Phila) 2010; 48:979.",
"     </a>",
"    </li>",
"    <li>",
"     Barone S. Child-resistant packaging. Consumer product safety review 2002; 6:3. www.cpsc.gov/cpscpub/pubs/cpsr_nws23.pdf (Accessed on August 05, 2009).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27736/abstract/4\">",
"      Van Gorcum TF, Hunault CC, Van Zoelen GA, et al. Lamp oil poisoning: did the European guideline reduce the number and severity of intoxications? Clin Toxicol (Phila) 2009; 47:29.",
"     </a>",
"    </li>",
"    <li>",
"     Gummin DD, Hryorzuk DO. Hydrocarbons. In: Goldfrank's Toxicologic Emergencies, 8th, Flomenbaum NE, Goldfrank LR, Hoffman RS, et al.  (Eds), McGraw-Hill, New York 2006. p.1429.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27736/abstract/6\">",
"      Khine H, Weiss D, Graber N, et al. A cluster of children with seizures caused by camphor poisoning. Pediatrics 2009; 123:1269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27736/abstract/7\">",
"      Welker JA, Zaloga GP. Pine oil ingestion: a common cause of poisoning. Chest 1999; 116:1822.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27736/abstract/8\">",
"      Dinwiddie SH. Abuse of inhalants: a review. Addiction 1994; 89:925.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27736/abstract/9\">",
"      McHugh MJ. The abuse of volatile substances. Pediatr Clin North Am 1987; 34:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27736/abstract/10\">",
"      Gurwitz D, Kattan M, Levison H, Culham JA. Pulmonary function abnormalities in asymptomatic children after hydrocarbon pneumonitis. Pediatrics 1978; 62:789.",
"     </a>",
"    </li>",
"    <li>",
"     Ellenhorn MJ. The hydrocarbon products. In: Ellenhorn's Medical Toxicology: Diagnosis and Treatment of Human Poisoning, 2nd, Ellenhorn MJ, Schonwald S, Ordog G, Wasserberger.  (Eds), Williams &amp; Wilkins, Baltimore 1997. p.1420.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27736/abstract/12\">",
"      Prasad R, Karmakar S, Sodhi R, Karmakar S. Bilateral hemorrhagic pleural effusion due to kerosene aspiration. Lung India 2011; 28:130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27736/abstract/13\">",
"      Bergeson PS, Hales SW, Lustgarten MD, Lipow HW. Pneumatoceles following hydrocarbon ingestion. Report of three cases and review of the literature. Am J Dis Child 1975; 129:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27736/abstract/14\">",
"      Thalhammer GH, Eber E, Zach MS. Pneumonitis and pneumatoceles following accidental hydrocarbon aspiration in children. Wien Klin Wochenschr 2005; 117:150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27736/abstract/15\">",
"      Wolfsdorf J, Paed D. Kerosene intoxication: an experimental approach to the etiology of the CNS manifestations in primates. J Pediatr 1976; 88:1037.",
"     </a>",
"    </li>",
"    <li>",
"     Food and Drug Administration. Poison control case report summary-calendar year 1982. Rockville, MD 1984.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27736/abstract/17\">",
"      Banner W Jr, Walson PD. Systemic toxicity following gasoline aspiration. Am J Emerg Med 1983; 1:292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27736/abstract/18\">",
"      Anas N, Namasonthi V, Ginsburg CM. Criteria for hospitalizing children who have ingested products containing hydrocarbons. JAMA 1981; 246:840.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27736/abstract/19\">",
"      Arena JM. Hydrocarbon poisoning--current management. Pediatr Ann 1987; 16:879.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27736/abstract/20\">",
"      Shannon M. Ingestion of toxic substances by children. N Engl J Med 2000; 342:186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27736/abstract/21\">",
"      Krenzelok EP, McGuigan M, Lheur P. Position statement: ipecac syrup. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol 1997; 35:699.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27736/abstract/22\">",
"      Position paper: Ipecac syrup. J Toxicol Clin Toxicol 2004; 42:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27736/abstract/23\">",
"      Vale JA. Position statement: gastric lavage. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol 1997; 35:711.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27736/abstract/24\">",
"      Vale JA, Kulig K, American Academy of Clinical Toxicology, European Association of Poisons Centres and Clinical Toxicologists. Position paper: gastric lavage. J Toxicol Clin Toxicol 2004; 42:933.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27736/abstract/25\">",
"      Chyka PA, Seger D. Position statement: single-dose activated charcoal. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol 1997; 35:721.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27736/abstract/26\">",
"      Zucker AR, Berger S, Wood LD. Management of kerosene-induced pulmonary injury. Crit Care Med 1986; 14:303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27736/abstract/27\">",
"      Scalzo AJ, Weber TR, Jaeger RW, et al. Extracorporeal membrane oxygenation for hydrocarbon aspiration. Am J Dis Child 1990; 144:867.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27736/abstract/28\">",
"      Liebelt EL, DeAngelis CD. Evolving trends and treatment advances in pediatric poisoning. JAMA 1999; 282:1113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27736/abstract/29\">",
"      Bysani GK, Rucoba RJ, Noah ZL. Treatment of hydrocarbon pneumonitis. High frequency jet ventilation as an alternative to extracorporeal membrane oxygenation. Chest 1994; 106:300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27736/abstract/30\">",
"      Chyka PA. Benefits of extracorporeal membrane oxygenation for hydrocarbon pneumonitis. J Toxicol Clin Toxicol 1996; 34:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27736/abstract/31\">",
"      Mabe TG, Honeycutt T, Cairns BA, et al. High-frequency percussive ventilation in a pediatric patient with hydrocarbon aspiration. Pediatr Crit Care Med 2007; 8:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27736/abstract/32\">",
"      Lee, LK, Shannon, MS, Arnold, JH. The use of high frequency oscillatory ventilation in hydrocarbon pneumonitis. Int J Med Toxicol 2003; 6:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27736/abstract/33\">",
"      Marks MI, Chicoine L, Legere G, Hillman E. Adrenocorticosteroid treatment of hydrocarbon pneumonia in children--a cooperative study. J Pediatr 1972; 81:366.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27736/abstract/34\">",
"      Steele RW, Conklin RH, Mark HM. Corticosteroids and antibiotics for the treatment of fulminant hydrocarbon aspiration. JAMA 1972; 219:1434.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27736/abstract/35\">",
"      Karlson KH Jr. Hydrocarbon poisoning in children. South Med J 1982; 75:839.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27736/abstract/36\">",
"      Klein BL, Simon JE. Hydrocarbon poisonings. Pediatr Clin North Am 1986; 33:411.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6489 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-122.72.76.133-B3AA2FA6DE-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_5_27736=[""].join("\n");
var outline_f27_5_27736=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H30\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Product safety",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLASSES OF HYDROCARBONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      HYDROCARBON TOXICITY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Determinants of pulmonary aspiration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Acute systemic toxicity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Initial presentation and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Physical findings after hydrocarbon exposure",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Vital signs",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Respiratory",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Central nervous system",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Cardiovascular",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Gastrointestinal",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Hematologic",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Ancillary studies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Radiographic findings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Stabilization",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      External decontamination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Gastrointestinal decontamination",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      - Systemic toxicity likely",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Pulmonary management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      DISPOSITION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H89613333\">",
"      ADDITIONAL RESOURCES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Clinical features",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Decontamination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/6489\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6489|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?0/43/703\" title=\"algorithm 1\">",
"      Hydrocarbon ingestion management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6489|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?21/46/22240\" title=\"diagnostic image 1\">",
"      Hydrocarbon aspiration radiogragh",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6489|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?21/18/21804\" title=\"table 1\">",
"      Hydrocarbon containing products",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/62/22506?source=related_link\">",
"      Acute toxic-metabolic encephalopathy in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/1/37913?source=related_link\">",
"      Decontamination of poisoned children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/58/16297?source=related_link\">",
"      Gastrointestinal decontamination of poisoned adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/61/33753?source=related_link\">",
"      Inhalant abuse in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/50/30505?source=related_link\">",
"      Management of status epilepticus in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/29/24026?source=related_link\">",
"      Rapid sequence intubation (RSI) in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/55/1912?source=related_link\">",
"      Rapid sequence intubation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/53/40793?source=related_link\">",
"      Spontaneous pneumothorax in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/11/19642?source=related_link\">",
"      Status epilepticus in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/33/11801?source=related_link\">",
"      Topical chemical burns",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f27_5_27737="Children with special health care needs";
var content_f27_5_27737=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Children with special health care needs",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/5/27737/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/5/27737/contributors\">",
"     Lindsey K Grossman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/5/27737/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/5/27737/contributors\">",
"     Teresa K Duryea, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/5/27737/contributors\">",
"     Carolyn Bridgemohan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/5/27737/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/5/27737/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?27/5/27737/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 5, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mission of pediatric health care providers changed considerably during the 20",
"    <sup>",
"     th",
"    </sup>",
"    century. Effective therapies were developed for many life-threatening infectious diseases and congenital abnormalities. Preventive health care (eg, immunization and anticipatory guidance for injury prevention) became more important. Many children with conditions that once were universally fatal now survive into adolescence, early adulthood, and beyond. Pediatric health care providers must be prepared to provide care to an increasing number of these children with special health care needs (CSHCN).",
"   </p>",
"   <p>",
"    The traditional approach to chronic conditions in children is a categorical one, based upon an organ system, diagnosis-specific view of the condition, and an emphasis on pathophysiology and biomedical treatment. A noncategorical approach emphasizes the psychological, developmental, educational, and social aspects of the condition [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/1-4\">",
"     1-4",
"    </a>",
"    ] and facilitates the development of programs to better assist CSHCN and their families.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The World Health Organization (WHO) defines impairment as an abnormality in body structure or appearance or in the function of an organ or system. A disability is an impairment that restricts activity. A handicap is a disability that causes an individual to be limited by society.",
"   </p>",
"   <p>",
"    A chronic disorder is a serious health condition lasting at least one year that produces or is virtually certain to produce one or more of the following [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Disability or limitation of function or activity",
"     </li>",
"     <li>",
"      Disfigurement",
"     </li>",
"     <li>",
"      Dependency on medications or special diet for normal function",
"     </li>",
"     <li>",
"      Dependency on medical technology",
"     </li>",
"     <li>",
"      Need for medical care or services beyond what usually is required for children of the same age",
"     </li>",
"     <li>",
"      Need for ongoing treatment at home",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In 1995, the Department of Health and Human Services Maternal and Child Health Bureau (MCHB) defined children with special health care needs (CSHCN) as those who have or are at increased risk of developing a chronic physical, developmental, behavioral, or emotional condition and who also require health and related services of a type or amount beyond that usually required by children [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The range of conditions requiring special needs is broad and includes, but is not limited to, problems such as cystic fibrosis, asthma, diabetes, food allergy, sickle cell disease, juvenile idiopathic arthritis (formerly juvenile rheumatoid arthritis), genetic disorders, spina bifida, neuromuscular disease, epilepsy, congenital heart disease, trauma-related injury, and human immunodeficiency syndrome, as well as disorders of speech, language, learning, and behavior. (See appropriate topic reviews).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence and prevalence of disability among children is difficult to determine. Data from the 1994 Health Interview Survey on Disability indicate that approximately 30 percent of American children younger than 18 years of age had, or were at risk for, a chronic condition; 18 percent had special health care needs (",
"    <a class=\"graphic graphic_figure graphicRef62527 \" href=\"UTD.htm?18/39/19070\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/6\">",
"     6",
"    </a>",
"    ]. In the 2006-2008 National Health Interview Surveys, approximately 15 percent of children &le;18 years of age in the United States were reported to have one or more developmental disabilities (eg, attention deficit hyperactivity disorder, intellectual disability, cerebral palsy, autism, seizures, stuttering, moderate to profound hearing loss, blindness, learning disorders,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    other developmental delays) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/7\">",
"     7",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    The prevalence of chronic illness among American children continues to increase with the decreased mortality from once-fatal diseases (eg, cystic fibrosis, acute lymphocytic leukemia), improved survival of premature infants (eg, chronic lung disease, hearing impairment, developmental delay), and the dramatic increase in childhood asthma. Respiratory diseases, speech and intelligence impairments, and",
"    <span class=\"nowrap\">",
"     mental/nervous",
"    </span>",
"    system disorders are the most common activity-limiting conditions [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The prevalence of special health care needs is higher among older children, boys, African-Americans, children from single-parent homes, and children whose parents have lower educational attainment [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/6-10\">",
"     6-10",
"    </a>",
"    ]. Compared with children with chronic conditions from more affluent families, children with chronic conditions from poor families are more likely to be without a usual source of health care or to be uninsured (21 versus 10 percent in 1988) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/11\">",
"     11",
"    </a>",
"    ]. Children with special health care needs (CSHCN) with more severe conditions are more likely to have unmet needs for primary care, as well as for specialty services, than those less severely affected [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     SURVEY TOOLS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several survey tools are used in studying these populations.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The Questionnaire for Identifying Children with Chronic Conditions (QuICCC) utilizes Stein's noncategorical approach with this population [",
"      <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/13\">",
"       13",
"      </a>",
"      ]. A short version of this questionnaire (QuICCC-R) may be used to screen populations of children for chronic illness [",
"      <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/14\">",
"       14",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The Children with Special Health Care Needs (CSHCN) Screener is a survey that uses parental responses to five questions regarding consequences experienced by children with ongoing health conditions to identify CSHCN [",
"      <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/15\">",
"       15",
"      </a>",
"      ]. In one comparison study, the CSHCN Screener and QuICCC-R had approximately 90 percent agreement when administered to two random samples of children [",
"      <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/16\">",
"       16",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A module for children with special health care needs has been developed and tested as an addition to the widely used Consumer Assessment of Health Plans Survey (CAHPS). The CAHPS Supplemental Item Set for Children with Chronic Conditions can be used to&nbsp;identify CSHCN among a managed care organization's population and to test the quality of services received by these children. The core questions have been incorporated into the Child Medicaid Questionnaire, which is available from the Agency for Healthcare Research and Quality (",
"      <a class=\"external\" href=\"file://\">",
"      </a>",
"      <a class=\"external\" href=\"https://www.cahps.ahrq.gov/Surveys-Guidance/Item-Sets/~/media/Files/SurveyDocuments/HP/Medicaid/Get_Surveys/1155a_engchildmed_40.pdf\">",
"       https://www.cahps.ahrq.gov/Surveys-Guidance/Item-Sets/~/media/Files/SurveyDocuments/HP/Medicaid/Get_Surveys/1155a_engchildmed_40.pdf",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      The National Association of Children's Hospitals and Related Institutions (NACHRI) developed the Classification of Congenital and Chronic Health Conditions (CCCHC) in 1997 using the more traditional biomedical approach [",
"      <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/17\">",
"       17",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The American Academy of Pediatrics has been engaged in the Functional Outcomes Project since 1992 to develop disease-specific measures of quality outcome monitoring [",
"      <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/18\">",
"       18",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     IMPLICATIONS OF CHRONIC CONDITIONS IN CHILDHOOD",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic health conditions have biologic, developmental, psychological, and social implications for children [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Biologic",
"    </span>",
"    &nbsp;&mdash;&nbsp;The biologic implications depend largely upon the state of the art in medical treatment for the condition. The state-of-the-art treatment may result in cure, improvement in long-term outcome, or palliation of symptoms.",
"   </p>",
"   <p>",
"    Routine health care maintenance, including immunization, screening (particularly visual assessment and hearing), and anticipatory guidance (including nutrition and physical activity), is as important for children with special health care needs (CSHCN) as is treatment for the chronic condition [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/19-22\">",
"     19-22",
"    </a>",
"    ]. In addition, children with chronic conditions often develop acute intercurrent illnesses that must be distinguished from acute manifestations of their chronic condition and treated appropriately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/59/24505?source=see_link&amp;anchor=H23#H23\">",
"     \"Visual development and vision assessment in infants and children\", section on 'Vision assessment in children with special needs'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Pediatric health care providers who care for CSHCN should be prepared to plan treatment strategies, monitor outcomes, coordinate visits and diagnostic tests with subspecialists, train caregivers, or educate other service providers in the community who may be involved with the child, particularly in emergency situations [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. Forms are available to assist in collecting and maintaining a comprehensive data source on each child (",
"    <a class=\"external\" href=\"file://www.medicalhomeinfo.org/for_families/care_notebook/emergency_plan.aspx\">",
"     file://www.medicalhomeinfo.org/for_families/care_notebook/emergency_plan.aspx",
"    </a>",
"    ). A comprehensive written care plan should be developed in conjunction with the family as key members of the health care team and, if the child is old enough, the patient, as well. This plan should include a comprehensive problem list, a list of contact information of all providers, a complete medication list, and a detailed plan for the child's care for the next year. The family should receive a copy of the plan each time it is updated, and updated copies should be sent to all providers involved in the care of the child.",
"   </p>",
"   <p>",
"    Pediatric health care providers should also be aware that children with disabilities are at greater risk of child abuse and neglect than children without disabilities and that disabilities may be the result of child abuse or neglect [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/25-28\">",
"     25-28",
"    </a>",
"    ]. As with all pediatric populations, health care providers should monitor for signs or symptoms of child abuse and refer the child for appropriate treatment if indicated. Acknowledging family strengths, addressing family stressors, offering support and assistance with parenting skills, and helping parents to obtain home health or respite care services may help in the prevention of maltreatment of these children [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/26\">",
"     26",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/54/26473?source=see_link\">",
"     \"Physical abuse in children: Epidemiology and clinical manifestations\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/58/32679?source=see_link\">",
"     \"Support services for the care of chronically ill children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Development/learning",
"    </span>",
"    &nbsp;&mdash;&nbsp;CSHCN may have altered physical and psychosocial development as a result of their chronic condition. Most of these children and their families have different developmental experiences and expectations than those of healthy children. Developmental difficulties are most likely to occur at periods of normal developmental transitions (eg, school entry or adolescence). Modifications necessitated by the condition that are acceptable to the child at one stage of development may actually hinder progression to the next stage. As an example, parental dedication of hours each day to permit home care for a technology-dependent eight-year-old child can create a dependency that inhibits the child's need for independence later in adolescence.",
"   </p>",
"   <p>",
"    Few aspects of a child's life are as important as his or her formal education. The ability of children with chronic conditions to receive an appropriate education was severely limited until the passage of PL 94-142 in 1975 and PL 99-457 in 1986. These laws, now grouped under the Individuals with Disabilities Education Act (IDEA), guarantee all children in the United States early intervention and school-age education that is suited to their individual needs and in the least restrictive environment. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/38/37480?source=see_link\">",
"     \"Definitions of specific learning disability and laws pertaining to learning disabilities\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    More information regarding IDEA can be obtained from the following Web sites:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      <a class=\"external\" href=\"file://www.ed.gov/offices/OSERS/IDEA/overview.html\">",
"       www.ed.gov/offices/OSERS/IDEA/overview.html",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"external\" href=\"file://www.nichcy.org/laws/idea\">",
"       www.nichcy.org/laws/idea",
"      </a>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This law mandates that CSHCN receive a multidisciplinary evaluation to determine their eligibility for special education services. The child's disability must interfere with the educational process or normal school performance to meet eligibility requirements [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/29\">",
"     29",
"    </a>",
"    ]. Examples of qualifying conditions include, but are not limited to, intellectual disability (mental retardation), hearing deficiencies, visual impairments, speech and language impairments, specific learning disabilities, emotional disturbances, and orthopedic impairments. (See appropriate topic reviews).",
"   </p>",
"   <p>",
"    The results of the multidisciplinary evaluation are used to formulate an individual family services plan (IFSP) for the preschool child or an individualized education program (IEP) for the older child. The IFSP or IEP should be designed to optimize the child's learning experience by addressing his or her particular developmental and educational needs. In addition to classroom teaching",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    tutoring, physical therapy, occupational therapy, speech therapy, and family services may be provided. The family should be involved in the development of the IFSP and IEP and must agree with the recommendations.",
"   </p>",
"   <p>",
"    The pediatric health care provider is involved in the determination of eligibility by making the clinical diagnosis of a qualifying condition and helping to determine the child's functional ability and special needs. The pediatric health care provider also may make the referral to the early intervention or special education program and review the IFSP and IEP with the family [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/29\">",
"     29",
"    </a>",
"    ]. In addition, he or she may help the family to obtain appropriate transportation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    assistive technology devices as needed [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Increasing demands on the public school system may prevent CSHCN from receiving the evaluation and services to which they are entitled. Pediatric health care providers can advocate with the local school system to ensure that their patients receive the services that they require to maximize educational potential [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/30\">",
"     30",
"    </a>",
"    ]. Personal acquaintance with the local school personnel greatly facilitates advocacy for CSHCN. However, when this is not possible, the word \"IDEA\" written on a prescription slip, signed by the pediatric health care provider, and handed to the school principal may help to speed up an IEP evaluation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/58/32679?source=see_link&amp;anchor=H9#H9\">",
"     \"Support services for the care of chronically ill children\", section on 'Education'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Transportation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The safe school bus transportation of CSHCN may require certain adaptations or personnel. Safe transportation of CSHCN is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/60/11209?source=see_link&amp;anchor=H11#H11\">",
"     \"Promoting safety in children with disabilities\", section on 'Safe transportation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Psychologic",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most CSHCN do not have serious psychologic problems; however, the rate of psychologic difficulties is greater among children with chronic conditions than among their healthy peers [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/31-33\">",
"     31-33",
"    </a>",
"    ]. This increased rate persists into adulthood. Problems, if they are present, most often appear during adolescence. This is not surprising because the adolescent's need to achieve independence may be hindered if the child's condition requires assistance from parents, teachers, and health professionals. Pediatric health care providers who care for CSHCN should screen them for psychologic problems and refer them to mental health specialists if indicated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Social",
"    </span>",
"    &nbsp;&mdash;&nbsp;The social implications of chronic illness in childhood may be the most debilitating and difficult to overcome [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/34\">",
"     34",
"    </a>",
"    ]. The chronic illness of a child has a great impact on the life of the family. The amount of time required for health care visits, therapies, and hospitalizations may result in social isolation from friends and extended family [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/35\">",
"     35",
"    </a>",
"    ]. Parents may have difficulty finding time to devote to the healthy siblings of the chronically ill child. The home environment may be altered by home nursing, therapy, or special equipment, such as a wheelchair.",
"   </p>",
"   <p>",
"    The pediatric health care provider may be able to facilitate connections with other families who have had similar experiences and are willing to provide parent-to-parent support. In addition, pediatric practitioners can inform the family about possible sources of respite care, if any are available. The National Respite Locator service (",
"    <a class=\"external\" href=\"file://www.respitelocator.org/\">",
"     www.respitelocator.org",
"    </a>",
"    ) can identify local respite care providers. The family should be aware that respite care programs may not be reimbursable.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     FINANCIAL ISSUES",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to the biologic, developmental, educational, psychologic, and social implications, chronic conditions also affect the family's economic status. The family may need to pay out of pocket for medication",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    therapy that is not fully covered by insurance [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/36,37\">",
"     36,37",
"    </a>",
"    ]. Indeed, families of children with special health care needs (CSHCN) have higher out-of-pocket expenses than others [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/38\">",
"     38",
"    </a>",
"    ]. Survey data indicate that CSHCN with inadequate insurance coverage have poorer outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/39\">",
"     39",
"    </a>",
"    ] and that enrollment in a state Children's Health Insurance Program (CHIP) improved medical care for CSHCN (decline in unmet needs for prescription medications and specialty care) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Interviews with the families of 38,866 CSHCN identified through the 2001 National Survey of Children with Special Health Care Needs indicated that although 95 percent of CSHCN had insurance, coverage was inadequate to meet health care needs in 32 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/41\">",
"     41",
"    </a>",
"    ]. Data from the 2000 Medical Expenditure Panel Survey indicate that families of CSHCN incurred greater out-of-pocket medical expenses per $1000 of family income than those of children without special health care needs ($6.20 versus $3.06) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The potential for career advancement for one or both parents may be limited geographically by the need to maintain a therapeutic relationship with the child's health care providers. Having a child with poor health status (as measured by chronic condition or disability status, activity limitations, hospitalizations, and general reported health) is associated with reduced parental employment, although the causality of this relationship has not been determined [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    When compared with normal children, children with limitations in their daily functioning (ie, disabilities) use more services than those without these impairments (",
"    <a class=\"graphic graphic_table graphicRef68016 \" href=\"UTD.htm?17/38/18027\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/36,43-45\">",
"     36,43-45",
"    </a>",
"    ]. Not surprisingly, then, the cost of health care is much higher for chronically ill children, with the highest cost incurred by the most severely affected children (",
"    <a class=\"graphic graphic_figure graphicRef77535 \" href=\"UTD.htm?35/50/36653\">",
"     figure 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/17,45\">",
"     17,45",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Medicaid and SSI",
"    </span>",
"    &nbsp;&mdash;&nbsp;The costs of health care of children with special needs are paid in several ways. Medicaid or the Children's Health Insurance Program (CHIP) covers some expenses if the family's income places them in an eligible category according to their state's criteria. Following enrollment into CHIP, CSHCN have been shown to demonstrate significant decrease in unmet medical needs and improvement in overall quality of care without a concomitant increase in expensive emergency department or hospitalization services [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some CSHCN may be eligible for Supplemental Security Income (SSI). The SSI program, originally conceived to provide assistance to disabled workers, was later expanded to include children [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/47\">",
"     47",
"    </a>",
"    ]. A monthly cash stipend and Medicaid coverage are awarded to eligible applicants.",
"   </p>",
"   <p>",
"    Eligibility is determined by the state's Disability Determination Service Agency based upon written information provided by the pediatric health care provider (",
"    <a class=\"graphic graphic_table graphicRef77994 \" href=\"UTD.htm?2/5/2140\">",
"     table 2",
"    </a>",
"    ), parents, and others. The Social Security Administration (SSA) considers a child to have a disability if [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/47\">",
"     47",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The child has a physical or mental impairment that results in marked and severe functional limitations",
"     </li>",
"     <li>",
"      The condition has lasted, or is expected to last, at least a year or is expected to cause death within a year",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Certain medical conditions are \"presumptively eligible\" for SSI benefits (",
"    <a class=\"graphic graphic_table graphicRef80349 \" href=\"UTD.htm?1/41/1692\">",
"     table 3",
"    </a>",
"    ). Children with these conditions may receive SSI benefits for up to six months during the formal eligibility evaluation. The details of SSI eligibility determination are beyond the scope of this review. However, a copy of \"Disability Evaluation Under Social Security\" may be obtained from the SSA Office of Public Affairs, Public Information Distribution Center, PO Box 17743, Baltimore, MD 21235; Phone: 410-965-0945, Fax: 410-965-0696.",
"   </p>",
"   <p>",
"    Parents can visit an SSA office or contact the SSA by phone (1-800-772-1213) to apply for SSI benefits for a disabled child [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Title V of the Social Security Act",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other governmental assistance is available to some CSHCN through Title V of the Social Security Act. This program, administered by the Department of Health and Human Services Maternal and Child Health Bureau (MCHB) through state departments of health, varies dramatically from state to state but usually serves as the payer of last resort for otherwise uncovered health care services, especially care by pediatric specialists.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Commercial insurance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Coverage for CSHCN through commercial insurance poses special challenges and opportunities. Some traditional indemnity policies have not covered \"preexisting conditions\", a special problem for families who may change carriers when a parent changes jobs. However with the passage of the Affordable Care Act of 2010, denial of coverage for preexisiting conditions is now illegal. On the other hand, commercial insurance policies often have inadequate depth and breadth of coverage for services such as home care or occupational therapy. In addition, many of these policies have high deductibles and copayments or a lifetime ceiling on benefits. Families of CSHCN may find themselves without coverage for their child's health care needs after facing health care costs of several hundred thousands of dollars.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Managed care",
"    </span>",
"    &nbsp;&mdash;&nbsp;Classic managed care offers some potential benefits for CSHCN, including care coordination, preventive services, improved access to and satisfaction with primary care, and decreased out-of-pocket cost for covered services [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/48\">",
"     48",
"    </a>",
"    ]. Participation in well-planned managed care can result in improved satisfaction with care [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    On the other hand, potential disadvantages of managed care for children with special health care needs exist and may include [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/50,51\">",
"     50,51",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Limited access to and choice of specialty service providers",
"     </li>",
"     <li>",
"      Increased out-of-pocket costs for out-of-network services",
"     </li>",
"     <li>",
"      Disruption of long-standing doctor-patient relationships if the managed care plan has a limited panel of providers",
"     </li>",
"     <li>",
"      Provision of specialty care by specialists in adult medicine, rather than pediatric subspecialists",
"     </li>",
"     <li>",
"      Adverse panel profiling by the managed care organization for the primary care provider who cares for numerous CSHCN",
"     </li>",
"     <li>",
"      Reduced service use compared with CSHCN with fee-for-service insurance, particularly when capitated programs carve out services",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Seven design elements recommended to enhance preventive and primary care for CSHCN under managed care include [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/52\">",
"     52",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Specially trained primary care providers",
"     </li>",
"     <li>",
"      Improved screening and risk assessment",
"     </li>",
"     <li>",
"      Multidisciplinary teams for evaluation and diagnosis",
"     </li>",
"     <li>",
"      Individual and group health education",
"     </li>",
"     <li>",
"      Flexible gatekeeping arrangements",
"     </li>",
"     <li>",
"      Comprehensive case management services",
"     </li>",
"     <li>",
"      Coordination with public health, education, and social services",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Managed care organizations that care for the population of CSHCN should be monitored for [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/53\">",
"     53",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Access to care",
"     </li>",
"     <li>",
"      Utilization of services",
"     </li>",
"     <li>",
"      Quality of care",
"     </li>",
"     <li>",
"      Satisfaction with care",
"     </li>",
"     <li>",
"      Expenditures for care",
"     </li>",
"     <li>",
"      Health outcomes",
"     </li>",
"     <li>",
"      Family impact",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     MEDICAL HOME",
"    </span>",
"    &nbsp;&mdash;&nbsp;The American Academy of Pediatrics (AAP) describes the medical home as a care system that seeks and acknowledges a shared responsibility with the family and the community for the complete care of the child and provides medical care that is [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/54,55\">",
"     54,55",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Accessible, using a community-based team if possible",
"     </li>",
"     <li>",
"      Comprehensive, including preventive, primary, and specialty care",
"     </li>",
"     <li>",
"      Continuously available",
"     </li>",
"     <li>",
"      Coordinated across time and the continuum of care",
"     </li>",
"     <li>",
"      Compassionate and family centered",
"     </li>",
"     <li>",
"      Culturally competent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The benefits of a medical home for children with chronic conditions include streamlined care for the child and family; efficient use of limited resources; decreased out-of-pocket expenditures; expanded expertise and competence for the involved providers; establishment of a forum for problem solving; and improved satisfaction for the patient, family, and provider [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/56,57\">",
"     56,57",
"    </a>",
"    ]. In addition, the medical home provides an effective model for implementing successful transitions for children with special health care needs (CSHCN) as they grow up [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/58\">",
"     58",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H17\">",
"     'Transitioning: The special-needs child grows up'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Pediatric primary care providers and families may be reluctant to have the primary care office serve as the medical home. Providers may wonder whether they are qualified to care for CSHCN [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/23,59\">",
"     23,59",
"    </a>",
"    ], and families may prefer to receive all their child's care at the tertiary care center where the specialists exist. However, active involvement of the primary care provider improves coordination of services and",
"    <span class=\"nowrap\">",
"     patient/family",
"    </span>",
"    and provider satisfaction [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/56,60\">",
"     56,60",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pediatric health care providers must be prepared to advocate actively for needed resources and to assure that these young people and their families receive the medical, developmental, social, and emotional support they need. The pediatric primary care provider has many roles in the care of the child with special needs [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/23\">",
"     23",
"    </a>",
"    ]. He or she:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Assures the provision of preventive services, including immunizations, screening, and anticipatory guidance",
"     </li>",
"     <li>",
"      Assists in differentiation of acute intercurrent illnesses from acute exacerbation of the underlying chronic condition",
"     </li>",
"     <li>",
"      Encourages \"routine\" management of the chronic condition",
"     </li>",
"     <li>",
"      Assures good communication between the family and all providers involved in the child's care",
"     </li>",
"     <li>",
"      Is familiar with available community resources and serves as a liaison between these services and the child's other providers",
"     </li>",
"     <li>",
"      Understands the child in the context of his or her family and community",
"     </li>",
"     <li>",
"      Serves as the leader of the child's care team, providing the family with the information necessary to set realistic goals",
"     </li>",
"     <li>",
"      Promotes normal growth and development for the child and family",
"     </li>",
"     <li>",
"      Focuses on the child, rather than the condition",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The provision of health care for the child with special needs is more time consuming than is the provision of care for the healthy child. The care may seem less burdensome to the pediatric health care provider if he or she is able to allow these children to have extended appointments, develop appointment-tracking systems to ensure continuity of care, and use problem-oriented medical records. A nurse practitioner can assist in the care of these patients by functioning as the case manager or by assuming the care of healthy children so the pediatric health care provider can focus on the child with special needs. Assistance in coordination of care may be available from other members of the office staff, local public health department, state Title V case managers, or case managers from the tertiary-care center where the child receives specialty care. The cost of care coordination in the primary care office may be reimbursable by appropriately documenting services rendered and coded as such [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/61\">",
"     61",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The Center for Medical Home Improvement (CHMI) provides information and resources for pediatric health care providers who would like to establish a medical home for their patients with special health care needs (",
"    <a class=\"external\" href=\"file://www.medicalhomeimprovement.org/\">",
"     www.medicalhomeimprovement.org",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     TRANSITIONING: THE SPECIAL-NEEDS CHILD GROWS UP",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 90 percent of children with special health care needs (CSHCN) survive into adulthood [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/62\">",
"     62",
"    </a>",
"    ]. The transition to self-sufficiency, financial independence, and adult care providers poses particular problems [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/63\">",
"     63",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The developmental and psychosocial needs of the young adult with special health care needs often are difficult to meet in an environment designed for school-age children.",
"     </li>",
"     <li>",
"      Adolescents and young adults with special needs must learn to cope with emerging issues of sexuality.",
"     </li>",
"     <li>",
"      The young adult with special needs may have difficulty making decisions regarding education and vocational choices because of developmental problems or family dependency.",
"     </li>",
"     <li>",
"      The transition to a new adult care provider may interrupt the continuity of coordination of care; patients may be hesitant to break long-standing and trusted relationships with their pediatric providers.",
"     </li>",
"     <li>",
"      Internists and the staff of adult inpatient units or outpatient clinics often have little or no training or experience in caring for patients with conditions like spina bifida or cystic fibrosis.",
"     </li>",
"     <li>",
"      Young adults with chronic illness may be terminated from their parents' health coverage at the age of 21 years or the completion of college education and will need to become financially self-sufficient. When this occurs, they may encounter major difficulties in securing adequate health insurance on their own.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The medical, psychologic, developmental, and social implications for this rapidly growing population often remain unaddressed by the health care system, and unfortunately, funding to develop appropriate \"transitioning\" programs is rarely available [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Transition planning",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Self-sufficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pediatric health care providers can help prepare their young patients for self-sufficiency and independent living by helping the parents of these children begin to think about the future as early as possible [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/65\">",
"     65",
"    </a>",
"    ]. Health care providers can ask the parents questions to encourage them to think and plan for the future:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      \"Have you thought about what your toddler might do after he or she finishes high-school?\"",
"     </li>",
"     <li>",
"      \"Does your child have a special interest or talent that can be a starting place for thinking about future work or career?\" [",
"      <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/65\">",
"       65",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Families should be encouraged to allow the child to try new things and to include the child in programs and activities with typically developing children.",
"   </p>",
"   <p>",
"    Pediatric health care providers can continue to facilitate planning for the future by initiating prevocational counseling during early childhood and encouraging exploration of various careers through part-time jobs, volunteer work, or mentorship during the primary and secondary school years [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/66\">",
"     66",
"    </a>",
"    ]. Adolescents with special needs should be encouraged to take responsibility for self-care, budgeting an allowance, and household chores [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/66\">",
"     66",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    If possible, health care providers should facilitate connection with families of older CSHCN (eg, through formal support and information organizations or informal connections among patient families). These connections can provide support and enable one family to benefit from the other's experiences (both positive and negative). The family of the older child provides a valuable source of information for developing a vision for the future [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/65\">",
"     65",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Planning for transition should be part of the annual individualized education program (IEP) for all students who receive special education services between 14 years of age and graduation [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/23\">",
"     23",
"    </a>",
"    ]. The plan should include a program to teach self-determination and leadership skills and should be based upon the student's preferences in the areas of employment, community living, recreation, relationships, transportation, and community integration. The involvement of a multispecialty team may facilitate a successful transition. In one retrospective cohort study, physically disabled adolescents whose transition to adulthood services was team based (including a consultant in rehabilitation medicine, psychologist, social worker, and various therapists) were 2.5 times more likely to participate in society than those whose transition was handled in an ad hoc manner, despite similar resource use by both groups [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/67\">",
"     67",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Health care",
"    </span>",
"    &nbsp;&mdash;&nbsp;The American Academy of Pediatrics (AAP), American Academy of Family Physicians (AAFP), and the American College of Physicians-American Society of Internal Medicine (ACP-ASIP) have developed a consensus statement on health care transitions for young adults with special health care needs [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/68\">",
"     68",
"    </a>",
"    ]. The goal of the transition is to maximize lifelong functioning and potential through the provision of continuous, high-quality, developmentally appropriate health care services as the individual moves from adolescence to adulthood. Important aspects of ensuring a successful transition include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The identification of a health care professional who assumes responsibility for current care, care coordination, future care planning, and attends to the challenges of transition [",
"      <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/68\">",
"       68",
"      </a>",
"      ]; the transition is facilitated when the pediatric health care provider speaks directly with the internist or family clinician who will assume care and provides a written copy of the medical summary described below.",
"     </li>",
"     <li>",
"      The preparation and maintenance of an up-to-date medical summary that is portable and accessible [",
"      <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/68\">",
"       68",
"      </a>",
"      ]; the summary should include pertinent medical history, surgery, therapies, medications, and immunizations [",
"      <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/23\">",
"       23",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The creation of a written health care transition plan by age fourteen years [",
"      <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/68\">",
"       68",
"      </a>",
"      ]; the adolescent and family should participate in the formulation of the plan; at a minimum, the plan should include the services that need to be provided and identification of who will provide the services and how they will be financed.",
"     </li>",
"     <li>",
"      The application of the same guidelines for primary and preventive care for all adolescents and young adults, including those with special health care needs. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/35/19000?source=see_link&amp;anchor=H3#H3\">",
"       \"Guidelines for adolescent preventive services\", section on 'Comprehensive guidelines for adolescents'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The medical home model provides an effective means for facilitating the transition to adult health care, since the components of the transition are similar to the components of the medical home (",
"    <a class=\"graphic graphic_table graphicRef78923 \" href=\"UTD.htm?20/5/20572\">",
"     table 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/58\">",
"     58",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H16\">",
"     'Medical home'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Resources",
"    </span>",
"    &nbsp;&mdash;&nbsp;A list of resources to help health care providers, patients, and families address the transition to adulthood is available in the table (",
"    <a class=\"graphic graphic_table graphicRef59408 \" href=\"UTD.htm?10/5/10332\">",
"     table 5",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     GOALS FOR 2020",
"    </span>",
"    &nbsp;&mdash;&nbsp;The needs of children with special health care needs (CSHCN) are complicated and often overwhelming to the child and the family. The pediatric health care provider must be prepared to provide a medical home to address the child's and family's complex problems. The Maternal and Child Health Bureau of the United States government has identified two goals to meet for children with special health care needs by the year 2020 [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/69\">",
"     69",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Increase the proportion of children, including those with special health care needs, who have access to a medical home",
"     </li>",
"     <li>",
"      Increase the proportion of CSHCN who receive their care in family-centered, comprehensive, coordinated systems",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Goals for 2010 that continue to be important include [",
"    <a class=\"abstract\" href=\"UTD.htm?27/5/27737/abstract/70\">",
"     70",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      All families of CSHCN will have adequate private",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      public health insurance to pay for the services they need",
"     </li>",
"     <li>",
"      All children will be screened early and continuously for special health care needs",
"     </li>",
"     <li>",
"      Families of CSHCN will partner in decision-making at all levels and will be satisfied with the services they receive",
"     </li>",
"     <li>",
"      Community-based service systems will be organized so families can use them easily",
"     </li>",
"     <li>",
"      All youth with special health care needs will receive the services necessary to make transitions to all aspects of adult life, including adult health care, work, and independence",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The commitment of local pediatric health care providers, in concert with their local and state health departments, the American Academy of Pediatrics, and locally available services, is key in meeting these goals.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     FAMILY RESOURCES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following websites provide advocacy and educational resources for parents and health care providers:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      American Academy of Pediatrics (AAP) &ndash;",
"      <a class=\"external\" href=\"file://www.medicalhomeinfo.org/\">",
"       www.medicalhomeinfo.org",
"      </a>",
"     </li>",
"     <li>",
"      Americans with Disabilities (ADA) Technical Assistance &ndash;",
"      <a class=\"external\" href=\"file://www.usdoj.gov/crt/ada/adahom1.htm\">",
"       www.usdoj.gov/crt/ada/adahom1.htm",
"      </a>",
"     </li>",
"     <li>",
"      Family Voices &ndash;",
"      <a class=\"external\" href=\"file://www.familyvoices.org/\">",
"       www.familyvoices.org",
"      </a>",
"     </li>",
"     <li>",
"      National Information Center For Children with Disabilities &ndash;",
"      <a class=\"external\" href=\"file://www.nichcy.org/\">",
"       www.nichcy.org",
"      </a>",
"     </li>",
"     <li>",
"      The National Respite Locator service &ndash;",
"      <a class=\"external\" href=\"file://www.respitelocator.org/\">",
"       www.respitelocator.org",
"      </a>",
"     </li>",
"     <li>",
"      Parent Advocacy Coalition for Educational Rights (PACER) &ndash;",
"      <a class=\"external\" href=\"file://www.pacer.org/\">",
"       www.pacer.org",
"      </a>",
"     </li>",
"     <li>",
"      Special Education Resources on the Internet (SERI) &ndash;",
"      <a class=\"external\" href=\"file://www.seriweb.com/\">",
"       www.seriweb.com",
"      </a>",
"     </li>",
"     <li>",
"      Technical Assistance Alliance for Parent Centers &ndash;",
"      <a class=\"external\" href=\"file://www.taalliance.org/\">",
"       www.taalliance.org",
"      </a>",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Children with special health care needs (CSHCN) are those who have or are at increased risk of developing a chronic physical, developmental, behavioral, or emotional condition and who also require health and related services of a type or amount beyond that usually required by children. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Definitions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Respiratory diseases, speech and intelligence impairments, and",
"      <span class=\"nowrap\">",
"       mental/nervous",
"      </span>",
"      system disorders are the most common activity-limiting conditions in children. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Chronic health conditions have biologic, developmental, psychologic, and social implications for children and their families. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Implications of chronic conditions in childhood'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Chronic conditions also affect the family's economic status. The costs of health care of children with special needs are paid in several ways (eg, Medicaid, supplemental security income (SSI), Title V of the Social Security Act, commercial insurance, and managed care). (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Financial issues'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A \"medical home\" model of care provides several benefits for children with chronic medical conditions and their providers, including streamlined care; efficient use of limited resources; expanded expertise and competence for the involved providers; establishment of a forum for problem solving; and improved satisfaction. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Medical home'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The transition to self-sufficiency, financial independence, and adult care providers requires advance planning and preparation. A list of resources to help patients, families, and health care providers through this transition is available in the table (",
"      <a class=\"graphic graphic_table graphicRef59408 \" href=\"UTD.htm?10/5/10332\">",
"       table 5",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Transitioning: The special-needs child grows up'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Advocacy and educational resources for parents and health care providers are listed above. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Family resources'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/1\">",
"      Stein RE. Chronic physical disorders. Pediatr Rev 1992; 13:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/2\">",
"      Stein RE, Silver EJ. Operationalizing a conceptually based noncategorical definition: a first look at US children with chronic conditions. Arch Pediatr Adolesc Med 1999; 153:68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/3\">",
"      Desguin BW, Holt IJ, McCarthy SM. Comprehensive care of the child with a chronic condition. Part 1. Understanding chronic conditions in childhood. Curr Probl Pediatr 1994; 24:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/4\">",
"      Perrin EC, Newacheck P, Pless IB, et al. Issues involved in the definition and classification of chronic health conditions. Pediatrics 1993; 91:787.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/5\">",
"      McPherson M, Arango P, Fox H, et al. A new definition of children with special health care needs. Pediatrics 1998; 102:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/6\">",
"      Newacheck PW, Strickland B, Shonkoff JP, et al. An epidemiologic profile of children with special health care needs. Pediatrics 1998; 102:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/7\">",
"      Boyle CA, Boulet S, Schieve LA, et al. Trends in the prevalence of developmental disabilities in US children, 1997-2008. Pediatrics 2011; 127:1034.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/8\">",
"      Newacheck PW, Halfon N. Prevalence and impact of disabling chronic conditions in childhood. Am J Public Health 1998; 88:610.",
"     </a>",
"    </li>",
"    <li>",
"     Chevarley FM. Research Findings #24: Utilization and Expenditures for Children with Special Health Care Needs. January 2006. Agency for Healthcare Research and Quality, Rockville, MD. www.meps.ahrq.gov/data_files/publications/rf24.shtml (Accessed on April 28, 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/10\">",
"      van Dyck PC, Kogan MD, McPherson MG, et al. Prevalence and characteristics of children with special health care needs. Arch Pediatr Adolesc Med 2004; 158:884.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/11\">",
"      Newacheck PW. Poverty and childhood chronic illness. Arch Pediatr Adolesc Med 1994; 148:1143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/12\">",
"      Mayer ML, Skinner AC, Slifkin RT, National Survey of Children With Special Health Care Needs. Unmet need for routine and specialty care: data from the National Survey of Children With Special Health Care Needs. Pediatrics 2004; 113:e109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/13\">",
"      Stein RE, Westbrook LE, Bauman LJ. The Questionnaire for Identifying Children with Chronic Conditions: a measure based on a noncategorical approach. Pediatrics 1997; 99:513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/14\">",
"      Stein RE, Silver EJ, Bauman LJ. Shortening the questionnaire for identifying children with chronic conditions: what is the consequence? Pediatrics 2001; 107:E61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/15\">",
"      Bethell CD, Read D, Stein RE, et al. Identifying children with special health care needs: development and evaluation of a short screening instrument. Ambul Pediatr 2002; 2:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/16\">",
"      Bethell CD, Read D, Neff J, et al. Comparison of the children with special health care needs screener to the questionnaire for identifying children with chronic conditions--revised. Ambul Pediatr 2002; 2:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/17\">",
"      Gay JC, Muldoon JH, Neff JM, Wing LJ. Profiling the health service needs of populations: description and uses of the NACHRI Classification of Congenital and Chronic Health Conditions. Pediatr Ann 1997; 26:655.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/18\">",
"      Sullivan SA, Olson LM. Developing condition-specific measures of functional status and well-being for children. Clin Perform Qual Health Care 1995; 3:132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/19\">",
"      Pless IB, Satterwhite B, Van Vechten D. Division, duplication and neglect: patterns of care for children with chronic disorders. Child Care Health Dev 1978; 4:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/20\">",
"      Palfrey JS, Levy JC, Gilbert KL. Use of primary care facilities by patients attending specialty clinics. Pediatrics 1980; 65:567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/21\">",
"      Das M, Spowart K, Crossley S, Dutton GN. Evidence that children with special needs all require visual assessment. Arch Dis Child 2010; 95:888.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/22\">",
"      Neter JE, Schokker DF, de Jong E, et al. The prevalence of overweight and obesity and its determinants in children with and without disabilities. J Pediatr 2011; 158:735.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/23\">",
"      American Academy of Pediatrics Council on Children with Disabilities. Care coordination in the medical home: integrating health and related systems of care for children with special health care needs. Pediatrics 2005; 116:1238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/24\">",
"      American Academy of Pediatrics, Committee on Pediatric Emergency Medicine and Council on Clinical Information Technology, American College of Emergency Physicians, Pediatric Emergency Medicine Committee. Policy statement--emergency information forms and emergency preparedness for children with special health care needs. Pediatrics 2010; 125:829.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/25\">",
"      Sullivan PM, Knutson JF. Maltreatment and disabilities: a population-based epidemiological study. Child Abuse Negl 2000; 24:1257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/26\">",
"      American Academy of Pediatrics: Committee on Child Abuse and Neglect and Committee on Children With Disabilities. Assessment of maltreatment of children with disabilities. Pediatrics 2001; 108:508.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/27\">",
"      Spencer N, Devereux E, Wallace A, et al. Disabling conditions and registration for child abuse and neglect: a population-based study. Pediatrics 2005; 116:609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/28\">",
"      Hibbard RA, Desch LW, American Academy of Pediatrics Committee on Child Abuse and Neglect, American Academy of Pediatrics Council on Children With Disabilities. Maltreatment of children with disabilities. Pediatrics 2007; 119:1018.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/29\">",
"      The pediatrician's role in development and implementation of an Individual Education Plan (IEP) and/or an Individual Family Service Plan (IFSP). American Academy of Pediatrics. Committee on Children with Disabilities. Pediatrics 1999; 104:124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/30\">",
"      American Academy of Pediatrics Council on Children With Disabilities, Cartwright JD. Provision of educationally related services for children and adolescents with chronic diseases and disabling conditions. Pediatrics 2007; 119:1218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/31\">",
"      Weiland SK, Pless IB, Roghmann KJ. Chronic illness and mental health problems in pediatric practice: results from a survey of primary care providers. Pediatrics 1992; 89:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/32\">",
"      American Academy of Pediatrics Committee on Children With Disabilities and Committee on Psychosocial Aspects of Child and Family Health: Psychosocial risks of chronic health conditions in childhood and adolescence. Pediatrics 1993; 92:876.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/33\">",
"      Curtis CE, Luby JL. Depression and social functioning in preschool children with chronic medical conditions. J Pediatr 2008; 153:408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/34\">",
"      Stein RE, Westbrook LE, Silver EJ. Comparison of adjustment of school-age children with and without chronic conditions: results from community-based samples. J Dev Behav Pediatr 1998; 19:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/35\">",
"      Hendriks AH, De Moor JM, Oud JH, Franken WM. Service needs of parents with motor or multiply disabled children in Dutch therapeutic toddler classes. Clin Rehabil 2000; 14:506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/36\">",
"      Newacheck PW, Inkelas M, Kim SE. Health services use and health care expenditures for children with disabilities. Pediatrics 2004; 114:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/37\">",
"      Newacheck PW, Kim SE. A national profile of health care utilization and expenditures for children with special health care needs. Arch Pediatr Adolesc Med 2005; 159:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/38\">",
"      Davidoff AJ. Insurance for children with special health care needs: patterns of coverage and burden on families to provide adequate insurance. Pediatrics 2004; 114:394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/39\">",
"      Oswald DP, Bodurtha JN, Willis JH, Moore MB. Underinsurance and key health outcomes for children with special health care needs. Pediatrics 2007; 119:e341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/40\">",
"      Szilagyi PG, Shone LP, Klein JD, et al. Improved health care among children with special health care needs after enrollment into the State Children's Health Insurance Program. Ambul Pediatr 2007; 7:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/41\">",
"      Kogan MD, Newacheck PW, Honberg L, Strickland B. Association between underinsurance and access to care among children with special health care needs in the United States. Pediatrics 2005; 116:1162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/42\">",
"      Kuhlthau KA, Perrin JM. Child health status and parental employment. Arch Pediatr Adolesc Med 2001; 155:1346.",
"     </a>",
"    </li>",
"    <li>",
"     Perrin JM, Shane MW, Bloom SR. Home and Community Care for Chronically Ill Children, Oxford University Press, New York 1993. p.89.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/44\">",
"      Newacheck PW, McManus MA. Financing health care for disabled children. Pediatrics 1988; 81:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/45\">",
"      Boulet SL, Boyle CA, Schieve LA. Health care use and health and functional impact of developmental disabilities among US children, 1997-2005. Arch Pediatr Adolesc Med 2009; 163:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/46\">",
"      Kempe A, Beaty BL, Crane LA, et al. Changes in access, utilization, and quality of care after enrollment into a state child health insurance plan. Pediatrics 2005; 115:364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/47\">",
"      Council on Children With Disabilities. From the American Academy of Pediatrics: Policy statements--Supplemental Security Income (SSI) for children and youth with disabilities. Pediatrics 2009; 124:1702.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/48\">",
"      Mitchell JM, Gaskin DJ. Do children receiving Supplemental Security Income who are enrolled in Medicaid fare better under a fee-for-service or comprehensive capitation model? Pediatrics 2004; 114:196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/49\">",
"      Grossman LK, Rich LN, Michelson S, Hagerty G. Managed care of children with special health care needs: the ABC Program. Clin Pediatr (Phila) 1999; 38:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/50\">",
"      Managed care and children with special health care needs: a subject review. American Academy of Pediatrics Committee on Children with Disabilities. Pediatrics 1998; 102:657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/51\">",
"      Davidoff A, Hill I, Courtot B, Adams E. Effects of managed care on service use and access for publicly insured children with chronic health conditions. Pediatrics 2007; 119:956.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/52\">",
"      McManus MA, Fox HB. Enhancing preventive and primary care for children with chronic or disabling conditions served in health maintenance organizations. Manag Care Q 1996; 4:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/53\">",
"      Newacheck PW, Stein RE, Walker DK, et al. Monitoring and evaluating managed care for children with chronic illnesses and disabilities. Pediatrics 1996; 98:952.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/54\">",
"      American Academy of Pediatrics Ad Hoc Task Force on Definition of the Medical Home: The medical home. Pediatrics 1992; 90:774.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/55\">",
"      Medical Home Initiatives for Children With Special Needs Project Advisory Committee. American Academy of Pediatrics. The medical home. Pediatrics 2002; 110:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/56\">",
"      Kisker CT, Fethke CC, Tannous R. Shared management of children with cancer. Arch Pediatr Adolesc Med 1997; 151:1008.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/57\">",
"      Porterfield SL, DeRigne L. Medical home and out-of-pocket medical costs for children with special health care needs. Pediatrics 2011; 128:892.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/58\">",
"      Kelly AM, Kratz B, Bielski M, Rinehart PM. Implementing transitions for youth with complex chronic conditions using the medical home model. Pediatrics 2002; 110:1322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/59\">",
"      Young PC, Shyr Y, Schork MA. The role of the primary care physician in the care of children with serious heart disease. Pediatrics 1994; 94:284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/60\">",
"      Jessop DJ, Stein RE. Providing comprehensive health care to children with chronic illness. Pediatrics 1994; 93:602.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/61\">",
"      Antonelli RC, Antonelli DM. Providing a medical home: the cost of care coordination services in a community-based, general pediatric practice. Pediatrics 2004; 113:1522.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/62\">",
"      Blum RW. Transition to adult health care: setting the stage. J Adolesc Health 1995; 17:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/63\">",
"      Scal P. Transition for youth with chronic conditions: primary care physicians' approaches. Pediatrics 2002; 110:1315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/64\">",
"      Transition of care provided for adolescents with special health care needs. American Academy of Pediatrics Committee on Children with Disabilities and Committee on Adolescence. Pediatrics 1996; 98:1203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/65\">",
"      Olsen DG, Swigonski NL. Transition to adulthood: the important role of the pediatrician. Pediatrics 2004; 113:e159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/66\">",
"      Johnson CP. Transition into adulthood. Pediatr Ann 1995; 24:268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/67\">",
"      Bent N, Tennant A, Swift T, et al. Team approach versus ad hoc health services for young people with physical disabilities: a retrospective cohort study. Lancet 2002; 360:1280.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/68\">",
"      American Academy of Pediatrics, American Academy of Family Physicians, American College of Physicians-American Society of Internal Medicine. A consensus statement on health care transitions for young adults with special health care needs. Pediatrics 2002; 110:1304.",
"     </a>",
"    </li>",
"    <li>",
"     Healthy People 2020. Maternal, Infant, and Child Health. file://www.healthypeople.gov/2020/topicsobjectives2020/objectiveslist.aspx?topicid=26 (Accessed on May 02, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/5/27737/abstract/70\">",
"      McPherson M, Honberg L. Identification of children with special health care needs: a cornerstone to achieving healthy people 2010. Ambul Pediatr 2002; 2:22.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2840 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-201.77.166.39-6D34BE7A96-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_5_27737=[""].join("\n");
var outline_f27_5_27737=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H24\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      SURVEY TOOLS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      IMPLICATIONS OF CHRONIC CONDITIONS IN CHILDHOOD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Biologic",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Development/learning",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Transportation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Psychologic",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Social",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      FINANCIAL ISSUES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Medicaid and SSI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Title V of the Social Security Act",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Commercial insurance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Managed care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      MEDICAL HOME",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      TRANSITIONING: THE SPECIAL-NEEDS CHILD GROWS UP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Transition planning",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Self-sufficiency",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Health care",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Resources",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      GOALS FOR 2020",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      FAMILY RESOURCES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/2840\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/2840|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?18/39/19070\" title=\"figure 1\">",
"      Prevalence chronic conditions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?35/50/36653\" title=\"figure 2\">",
"      Cost of chronic illness",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/2840|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?17/38/18027\" title=\"table 1\">",
"      Resource use disabled children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?2/5/2140\" title=\"table 2\">",
"      SSI eligibility children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?1/41/1692\" title=\"table 3\">",
"      Presumptive eligibility SSI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?20/5/20572\" title=\"table 4\">",
"      CSHCN transition adulthood",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?10/5/10332\" title=\"table 5\">",
"      CSHCN transition resources",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/38/37480?source=related_link\">",
"      Definitions of specific learning disability and laws pertaining to learning disabilities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/35/19000?source=related_link\">",
"      Guidelines for adolescent preventive services",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/54/26473?source=related_link\">",
"      Physical abuse in children: Epidemiology and clinical manifestations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/60/11209?source=related_link\">",
"      Promoting safety in children with disabilities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/58/32679?source=related_link\">",
"      Support services for the care of chronically ill children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/59/24505?source=related_link\">",
"      Visual development and vision assessment in infants and children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f27_5_27738="Bronchocentric granuloma Low";
var content_f27_5_27738=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F81739%7EPULM%2F68811&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F81739%7EPULM%2F68811&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Bronchocentric granulomatosis in a patient with ABPA",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 392px; height: 294px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Low magnification photomicrograph (original magnification 100x) showing a necrotizing granuloma centered on an airway. A centrally necrotic lumen (upper right) is surrounded by epithelioid and palisaded histiocytes to form a necrotizing granuloma adjacent to a pulmonary artery (lower left), the only clue that the lesion is centered on a bronchiole.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Bronchocentric granulomatosis in a patient with ABPA",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 392px; height: 294px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Higher magnification photomicrograph (original magnification 200x) from&nbsp;a specimen showing transition from respiratory epithelium to granulomatous inflammation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_5_27738=[""].join("\n");
var outline_f27_5_27738=null;
var title_f27_5_27739="Education in pulmonary rehab";
var content_f27_5_27739=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F67040&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F67040&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Educational components of pulmonary rehabilitation",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Anatomy and physiology of the lung",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pathophysiology of lung disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Airway management",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Breathing training strategies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Energy conservation and work simplification techniques",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Medications",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Self-management skills",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Benefits of exercise and safety guidelines",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Oxygen therapy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Environmental irritant avoidance",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Respiratory and chest therapy techniques",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Symptom management",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Psychological factors, coping, anxiety, panic control",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stress management",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        End of life planning",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Smoking cessation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Travel/leisure/sexuality",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nutrition",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_5_27739=[""].join("\n");
var outline_f27_5_27739=null;
var title_f27_5_27740="Ovarian cancer survival";
var content_f27_5_27740=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F64569&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F64569&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Carcinoma of the ovary: FIGO stage and overall survival for patients treated in 1999-2001.",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        FIGO stage",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Number of patients",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"3\">",
"        Overall survival, percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        One&nbsp;year",
"       </td>",
"       <td class=\"subtitle2\">",
"        Two&nbsp;years",
"       </td>",
"       <td class=\"subtitle2\">",
"        Five&nbsp;years",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IA",
"       </td>",
"       <td>",
"        632",
"       </td>",
"       <td>",
"        98.4",
"       </td>",
"       <td>",
"        96.2",
"       </td>",
"       <td>",
"        89.6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IB",
"       </td>",
"       <td>",
"        69",
"       </td>",
"       <td>",
"        100",
"       </td>",
"       <td>",
"        93.9",
"       </td>",
"       <td>",
"        86.1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IC",
"       </td>",
"       <td>",
"        663",
"       </td>",
"       <td>",
"        96.3",
"       </td>",
"       <td>",
"        91.4",
"       </td>",
"       <td>",
"        83.4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IIA",
"       </td>",
"       <td>",
"        72",
"       </td>",
"       <td>",
"        93.0",
"       </td>",
"       <td>",
"        87.2",
"       </td>",
"       <td>",
"        70.7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IIB",
"       </td>",
"       <td>",
"        93",
"       </td>",
"       <td>",
"        93.4",
"       </td>",
"       <td>",
"        84.5",
"       </td>",
"       <td>",
"        65.5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IIC",
"       </td>",
"       <td>",
"        241",
"       </td>",
"       <td>",
"        93.6",
"       </td>",
"       <td>",
"        85.6",
"       </td>",
"       <td>",
"        71.4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IIIA",
"       </td>",
"       <td>",
"        128",
"       </td>",
"       <td>",
"        88.1",
"       </td>",
"       <td>",
"        72.6",
"       </td>",
"       <td>",
"        46.7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IIIB",
"       </td>",
"       <td>",
"        271",
"       </td>",
"       <td>",
"        85.7",
"       </td>",
"       <td>",
"        70.6",
"       </td>",
"       <td>",
"        41.5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IIIC",
"       </td>",
"       <td>",
"        2030",
"       </td>",
"       <td>",
"        84.8",
"       </td>",
"       <td>",
"        64.5",
"       </td>",
"       <td>",
"        32.5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IV",
"       </td>",
"       <td>",
"        626",
"       </td>",
"       <td>",
"        72.4",
"       </td>",
"       <td>",
"        48.4",
"       </td>",
"       <td>",
"        18.6",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    FIGO: International Federation of Gynecology and Obstetrics.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Original table modified for this publication. From: Heintz AP, Odicino F, Maisonneuve P, et al. Carcinoma of the ovary. Int J Gynaecol Obstet 2006; 95:S161. Table used with the permission of Elsevier Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_5_27740=[""].join("\n");
var outline_f27_5_27740=null;
var title_f27_5_27741="Change in blood glucose forearm and fingerstick";
var content_f27_5_27741=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F54372&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F54372&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 515px\">",
"   <div class=\"ttl\">",
"    Change in blood glucose using forearm and fingerstick testing after a 75 g oral glucose load at time 0 and intravenous insulin at time 115 minutes",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 495px; height: 205px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Jungheim K, Koschinsky T. Glucose monitoring at the arm: risky delays of hypoglycemia and hyperglycemia detection. Diabetes Care 2002; 25:956.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_5_27741=[""].join("\n");
var outline_f27_5_27741=null;
var title_f27_5_27742="Dose dense AC-T breast cancer";
var content_f27_5_27742=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F55933&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F55933&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Dose-dense doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) chemotherapy for adjuvant treatment of breast cancer",
"    <sup>",
"     [1]",
"    </sup>",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"4\" width=\"25%\">",
"     </colgroup>",
"     <tbody>",
"      <tr class=\"divider_bottom\">",
"       <td colspan=\"4\">",
"        <p>",
"         Cycle length: 14 days.",
"        </p>",
"        Total cycles: 4.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Drug",
"       </td>",
"       <td class=\"subtitle1\">",
"        Dose and route",
"       </td>",
"       <td class=\"subtitle1\">",
"        Administration",
"       </td>",
"       <td class=\"subtitle1\">",
"        Given on days",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Doxorubicin",
"        </strong>",
"       </td>",
"       <td>",
"        60 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        IV",
"       </td>",
"       <td>",
"        Dilute with normal saline (NS) to a final concentration of 2 mg/mL and administered as an IV bolus over three to five minutes into a free flowing IV infusion of NS or 5 percent dextrose in water (D5W). The presence of local erythematous streaking along the vein as well as facial flushing may be signs that administration is too rapid. If needed, doxorubicin can be further diluted after reconstitution in NS or D5W and given as a slow IV infusion administered over 15 to 60 minutes",
"        <sup>",
"         [2]",
"        </sup>",
"        .",
"       </td>",
"       <td>",
"        Day 1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Cyclophosphamide",
"        </strong>",
"       </td>",
"       <td>",
"        600 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        IV",
"       </td>",
"       <td>",
"        Dilute with 250 to 500 mL NS or D5W and administer over 30 to 60 minutes. Rapid infusions may produce nasal burning or congestion that is relieved by slowing the rate.",
"       </td>",
"       <td>",
"        Day 1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"4\">",
"        After complete of AC, administer:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Paclitaxel",
"        </strong>",
"       </td>",
"       <td>",
"        175 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        IV",
"       </td>",
"       <td>",
"        Dilute with 250 to 500 mL NS or D5W (final concentration of 0.3 to 1.2 mg/mL) and administer over three hours*.",
"       </td>",
"       <td>",
"        Day 1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Pretreatment considerations:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Hydration:",
"        </strong>",
"        Patients receiving cyclophosphamide should maintain adequate oral hydration (2 to 3 L/day during administration and for one to two days thereafter) and void frequently to reduce the risk of hemorrhagic cystitis",
"        <sup>",
"         [3]",
"        </sup>",
"        .",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Emesis risk:",
"        </strong>",
"        HIGH (&gt;90 percent frequency of emesis). Refer to UpToDate topic on \"Prevention and treatment of chemotherapy-induced nausea and vomiting\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Prophylaxis for infusion reactions:",
"        </strong>",
"        Paclitaxel may cause severe hypersensitivity reactions. Premedication regimen should include dexamethasone (either 20 mg orally twelve and six hours before, or 20 mg IV 30 minutes before drug administration) plus both an H1 (diphenhydramine 25 to 50 mg IV) and an H2 receptor antagonist (ranitidine 50 mg or famotidine 20 mg IV) 30 to 60 minutes prior to paclitaxel administration. Severe infusion reactions (eg, skin rash, flushing, dyspnea, urticaria, back pain, hypotension, chest pain, tachycardia) occur primarily during the first and second infusions, typically within the first hour after the start of the infusion. Further information on infusion reactions, including management, is available. Refer to UpToDate topic on \"Infusion reactions to systemic chemotherapy\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Vesicant/irritant properties:",
"        </strong>",
"        Doxorubicin is a vesicant and can cause significant tissue damage if an extravasation occurs. For peripheral infusions, the IV line should be recently placed into a large, intact vein, with good blood return established immediately prior to starting the infusion. The IV or catheter site should be continuously monitored throughout drug administration infusion. Paclitaxel can cause significant tissue damage; avoid extravasation. Refer to UpToDate topic on \"Extravasation injury from chemotherapy and other non-neoplastic vesicants\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Infection prophylaxis:",
"        </strong>",
"        Hematopoietic growth factors (filgrastim [G-CSF] 5 mcg/kg subcutaneously rounded to 300 mcg or 480 mcg on days 3 through 10, or pegfilgrastim 6 milligrams subcutaneously on day 2 or 3) with each cycle is",
"        <strong>",
"         required",
"        </strong>",
"        . Refer to UpToDate topic on \"Use of granulocyte colony stimulating factors in patients with chemotherapy-induced neutropenia\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Dose adjustment for baseline liver or renal dysfunction:",
"        </strong>",
"        Dose adjustment is not necessary for doxorubicin or paclitaxel in renal impairment. The need for cyclophosphamide dose reduction in renal insufficiency is controversial. For patients with preexisting hepatic impairment, dose adjustments in doxorubicin, cyclophosphamide, and paclitaxel may be needed. Refer to UpToDate topics on \"Chemotherapy-related nephrotoxicity and dose modification in patients with renal insufficiency\" and \"Chemotherapy hepatotoxicity and dose modification in patients with liver disease\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Cardiac issues:",
"        </strong>",
"        The risk of doxorubicin-associated cardiac dysfunction is related to cumulative dose. The risk is increased in patients with underlying heart disease, when anthracyclines are used concurrently with other cardiotoxic agents or radiation, and in patients previously treated with mediastinal or chest wall irradiation. Doxorubicin is contraindicated for patients with recent myocardial infarction, severe myocardial dysfunction, severe arrhythmia, or previous therapy with high cumulative doses of doxorubicin",
"        <sup>",
"         [2]",
"        </sup>",
"        . A baseline assessment of left ventricular ejection fraction (LVEF) is recommended, with periodic reassessment of during therapy. Further information on anthracycline-associated cardiotoxicity, including discussion about prevention and treatment, is available. Refer to UpToDate topic on \"Cardiotoxicity of anthracycline-like chemotherapy agents\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Monitoring parameters:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull; CBC with differential and platelet count every two weeks prior to each treatment cycle.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull; Serum electrolytes and liver and renal function tests every two weeks prior to each treatment cycle.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull; Assess changes in neurologic function prior to each treatment cycle of paclitaxel.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull; During treatment with doxorubicin or paclitaxel, assess line site periodically during infusion of chemotherapy for signs and symptoms of extravasation.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Suggested dose alterations for toxicity:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Myelotoxicity:",
"        </strong>",
"        Subsequent cycles should be delayed until the absolute neutrophil count is greater than 1000/mm",
"        <sup>",
"         3",
"        </sup>",
"        and platelet count greater than 100,000/mm",
"        <sup>",
"         3",
"        </sup>",
"        . If there is more than a three week delay in treatment, a dose reduction of 25 percent is recommended",
"        <sup>",
"         [1]",
"        </sup>",
"        . Refer to UpToDate topic on \"Use of granulocyte colony stimulating factors in patients with chemotherapy-induced neutropenia\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Neurologic toxicity:",
"        </strong>",
"        For patients who develop severe neuropathy (grade 3 or 4) that persists for a week or longer, the dose of paclitaxel should be reduced by 20 percent for subsequent courses of paclitaxel; hold if severe toxicity persists after dose reduction",
"        <sup>",
"         [4]",
"        </sup>",
"        . Refer to UpToDate topic on \"Neurologic complications of non-platinum chemotherapy\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Dose adjustment for liver or renal dysfunction:",
"        </strong>",
"        Guidelines for managing doxorubicin, cyclophosphamide, and paclitaxel in patients who have changes in kidney or liver function during therapy are addressed in detail separately. Refer to UpToDate topics on \"Chemotherapy-related nephrotoxicity and dose modification in patients with renal insufficiency\" and \"Chemotherapy hepatotoxicity and dose modification in patients with liver disease\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"4\">",
"        <strong>",
"         If there is a change in body weight of at least 10 percent, dose should be recalculated for all drugs.",
"        </strong>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <strong>",
"     This table is provided as an example of how to administer this regimen; there may be other acceptable methods. This regimen must be administered by a clinician trained in the use of chemotherapy. The clinician is expected to use his or her independent medical judgment in the context of individual circumstances to make adjustments, as necessary.",
"    </strong>",
"    <div class=\"footnotes\">",
"     IV: intravenous; G-CSF: granulocyte colony-stimulating factor; CBC: complete blood count.",
"     <br/>",
"     * Paclitaxel can be administered in NS, D5W, or NS/D5W at varying concentrations between 0.3 to 1.2 mg/mL. Use glass or polypropylene bottles or polypropylene or polyolefin plastic bags, and administer through polyethylene-lined administration sets with a microporous membrane 0.22 microns.",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <br/>",
"     <ol>",
"      <li>",
"       Citron ML, et al. J Clin Oncol 2003; 21:1431.",
"      </li>",
"      <li>",
"       Adriamycin (doxorubicin hydrochloride) injection. US FDA-approved manufacturer's package insert. US National Library of Medicine. (Available online at dailymed.nlm.nih.gov, accessed on December 19, 2011).",
"      </li>",
"      <li>",
"       Cytoxan (cyclophosphamide) injection. US FDA-approved manufacturer's package insert. US National Library of Medicine. (Available online at dailymed.nlm.nih.gov, accessed on December 19, 2011).",
"      </li>",
"      <li>",
"       Taxol (paclitaxel) injection. US FDA-approved manufacturer's package insert. US National Library of Medicine. (Available online at dailymed.nlm.nih.gov, accessed on December 19, 2011).",
"      </li>",
"     </ol>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_5_27742=[""].join("\n");
var outline_f27_5_27742=null;
var title_f27_5_27743="HSG oblique view fibroid";
var content_f27_5_27743=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F55045&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F55045&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 488px\">",
"   <div class=\"ttl\">",
"    Hysterosalpingogram with an oblique view showing a submucous myoma that disappeared when more dye was injected",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 468px; height: 309px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Baramki, TA. Hysterosalpingography. Fertil Steril 2005; 83:1595. Copyright &copy; 2005 Elsevier Science, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_5_27743=[""].join("\n");
var outline_f27_5_27743=null;
